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Executive Summary 
Introduction  
In 2008, an estimated 2 billion adults globally were either overweight or obese 
(Finucane et al., 2011; Lobstein et al., 2004). In Australia, obesity is a major public 
health issue, with two out of three adults either overweight or obese (Australian 
Bureau of Statistics, 2015). Obesity has serious health effects: raised BMI is an 
established risk factor for diabetes, cardiovascular disease, some cancers, 
osteoarthritis and hypertension (GBD 2010 Country Collaboration, 2013; 
Wiseman, 2008). The costs to the Australian government associated with adult 
obesity were estimated to be $5.3b in 2014/2015 (Duckett and Swerissen, 2016).  
In high income countries, the prevalence of obesity has a socioeconomic gradient, 
whereby rates are highest amongst the most disadvantaged groups. In Australia in 
2011, the lowest socioeconomic group encountered rates of overweight and obesity 
disease burden 2.3 times those of the highest socioeconomic group (Australian 
Institute of Health and Welfare, 2017). The importance of reducing health 
inequities is recognized globally (World Health Organization, 2013). The 
Australian government has proposed to target those experiencing socioeconomic 
disadvantage in order to reduce health inequities (Australian Health Ministers’ 
Advisory Council, 2017).  
A solutions-based approach to prevent obesity needs high quality cost-
effectiveness analyses to address which interventions are effective as well as being  
value-for-money (Moodie and Carter, 2010). Policy makers considering the 
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introduction of an intervention should also be informed of the distribution of 
health benefits across socioeconomic groups so that health inequities are not 
further increased.   
Context 
This PhD project is part of a National Health and Medical Research Council 
funded Centre of Research Excellence (CRE) in Policy Research on Obesity and 
Food Systems (grant no. 1041020). The health economics stream of the CRE aims 
to evaluate the cost-effectiveness of 40 non-health sector interventions for the 
prevention of obesity. It is usual practice in cost-effectiveness analysis (CEA) to 
focus on ‘efficiency’ with the aim of maximizing health benefits for the lowest cost 
or minimizing cost for a specified outcome. Most CEAs of public health 
interventions either ignore health equity impacts or limit themselves to a 
description of their nature without any quantification. This makes it difficult for 
policy makers to prioritise or rank policies in terms of their cost-effectiveness and 
equity impacts in an objective way. Operationalising equity in the context of cost-
effectiveness advice for obesity prevention policies becomes the challenge.  
Research Questions 
The ‘decision maker’ approach to economic evaluation will be adopted, whereby 
the objectives of policy decision makers are emphasised (Sugden and Williams, 
1978b).  The overall research questions are: 
1. How can equity be incorporated in CEAs of obesity prevention policies? 
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2. Are there appropriate equity weights for use in CEAs of Australian obesity 
prevention policies?  
The following specific research questions are also answered by this thesis: 
1a. What is the equity impact of a sugar sweetened beverage (SSB) tax in 
Australia across SEP groups in terms of health and financial effects?  
2a. Can appropriate equity weights for use in Australian CEA studies for 
obesity prevention policies be derived using people’s preferences?  
2b. Can appropriate equity weights for use in Australian CEA studies for 
obesity prevention policies be derived using epidemiological data? 
Publications constituting the thesis 
My PhD is submitted as a thesis by publication. The specifics of the four journal 
articles, their publication status and the research question they address are 
detailed below.  
Research 
Question  Citation 
1 Lal A, Moodie M, Peeters A, Carter R. (2017) Inclusion of equity 
in economic analyses of public health policies: systematic review 
and future directions. Aust NZ J Publ Heal. doi: 10.1111/1753-
6405.12709. 
1a Lal A, Mantilla-Herrera AM, Veerman L, Backholer K, Sacks G, 
Moodie M, Siahpush M, Carter R, Peeters A. (2017) Modelled 
health benefits of a sugar sweetened beverage tax across 
different socioeconomic groups in Australia: a cost-effectiveness 
and equity analysis. PLoS Med 14(6). 
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2a Lal A, Siahpush M, Moodie M, Peeters A, Carter R.  (2017) 
Weighting health outcomes by socioeconomic position using 
stated preferences. Pharmacoeconomics Open. doi 
10.1007/s41669-017-0036-1. 
2a, 2b Lal A, Mohebbi  M, Sweeney R, Peeters A, Moodie M, Carter R. 
Equity weights for socioeconomic position: two methods – 
survey of stated preferences and epidemiological data. Revised 
manuscript submitted to Value in Health 21/10/17. 
Conference Presentations 
The following peer-reviewed conference abstracts and presentations have been 
produced as a result of the research conducted for this thesis. 
• Lal A, Mantilla-Herrera AM, Veerman L, Moodie M, Carter R, Peeters A.  
Markov modelling incorporating socioeconomic position: application to an 
analysis of a sugar sweetened beverage tax.  Australian Health Economics 
Society Conference. 21-22 September 2017, Sydney. 
• Lal A, Mantilla-Herrera AM, Veerman L, Moodie M, Carter R, Peeters A.  
Cost-effectiveness and equity impacts of a sugar sweetened beverage tax in 
Australia. Australian and New Zealand Obesity Society Annual Scientific 
Meeting. 18 October 2016, Brisbane. 
• Lal A, Mantilla-Herrera AM, Veerman L, Moodie M, Carter R, Peeters A.  
Cost-effectiveness and equity impacts of a sugar sweetened beverage tax in 
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Australia. School of Health and Social Development HDR conference. 19 
August 2016, Melbourne. 
• Lal A, Mantilla-Herrera AM, Moodie M, Carter R, Peeters.  A Sugar 
sweetened beverage tax: Cost-effectiveness, health and financial impacts by 
socioeconomic position group.  International Congress on Obesity, 1 May 
2016, Vancouver, Canada. 
• Lal A, Moodie M, Peeters A, Carter R. Sugar sweetened beverage tax: 
Protocol for cost-effectiveness analysis by socio-economic position group. 
Victorian Obesity Consortium 2015 Symposium, 10 December 2015, 
Melbourne. 
Prizes and Awards 
• Finalist, early career researcher awards, Australian and New Zealand 
Obesity Society, October 2016. 
• Winner, best poster at Higher Degree by Research conference, Centre for 
Population Health Deakin University, August 2016. 
Findings and significance 
The key methods for addressing health equity concerns in CEA presented in the 
systematic literature review included: i) the use of health inequality measures to 
show the differences in health gains between SEP groups when two or more 
interventions are being compared; ii) the analysis of financial impacts, such as out-
of-pocket treatment expenditures avoided across groups; iii) the use of subgroup 
specific morbidity and mortality data in the modelling and iv) the use of equity 
8 
 
weights. The use of equity impact analysis techniques within economic analyses of 
public health interventions is limited, with only 14 published CEAs comparing 
health impacts across SEP groups. 
At a population level, the CEA of a 20% value-added SSB tax in Australia 
demonstrated the use of SEP specific modelling, enabling equity impact analysis. 
The findings suggested whilst the financial burden of the tax would be felt more 
by low SEP groups, they would have greater out of pocket healthcare costs and 
more health gains would be disproportionately accumulated in those groups. From 
my examination of the literature, this was the first CEA of a public health 
intervention in Australia that has included health inequality measures to allow 
comparisons and ranking of five different tax scenarios for their health equity 
impact. Each scenario had the highest proportion of HALYs gained amongst the 
most disadvantaged quintiles. This type of analysis will be of value in contexts 
where priority setting of a range policies is being considered. My study was also 
the first to examine the total out-of-pocket financial impacts, including healthcare 
costs and taxes across SEP groups in an economic analysis of an SSB tax, important 
factors when considering the equity of the policy.    
Suitable equity weights for use in Australia were not available from the previous 
literature. Given the lack of consensus on the algorithm for deriving equity 
weights, I sought to derive demand-side health equity weights for the Australian  
context using three methods. Two methods derived plausible equity weights that 
could potentially be used to weight health gains of disadvantaged groups in a CEA. 
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This was the first study to derive equity weights for socioeconomic position in 
Australia, based on: i) epidemiological data; and ii) people’s preferences and probit 
models. The epidemiological based weights ranged from 1.2 to 1.5.  Using people’s 
preferences, the weights ranged from 1.3 (95% CI: 1.2, 1.4) to 1.8 (95% CI: 1.6, 2.0) 
The practical application of this type of weight could be carried out in the future, 
when there is a trade-off between improving total health and health equity. As an 
example, a program with an ICER of $75,000/QALY would generally be considered 
cost-ineffective in Australia; yet the ICER could potentially be reduced to 
$50,000/QALY if an equity weight of 1.5 was applied to the QALY estimates used 
in the calculation of the cost-effectiveness ratio. 
There are still important gaps in research in this field, particularly in applied 
empirical work, but this doctorate has added to the limited body of relevant 
research. The methods discussed here enables equity to be incorporated into the 
decision-making process in a quantitative and transparent way, with the intention 
of providing policy-makers with more helpful evidence about the health equity 
consequences of potential policies alongside CEA.  
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Chapter 1. Introduction 
1.1 Background 
There has been a global rise in obesity in high-income countries over the last 30 
years, with many middle and low income countries also joining this trend (Sassi et 
al., 2009). In 2008, an estimated 2 billion adults globally were either overweight 
or obese (Finucane et al., 2011; Lobstein et al., 2004). In Australia, obesity is a 
major public health issue, with two out of three adults either overweight or obese 
(Australian Bureau of Statistics, 2015). High Body Mass Index (BMI) accounted for 
the second highest proportion of total burden of disease (5.5%) in Australia in 2011 
(Australian Institute of Health and Welfare, 2016). Obesity has serious health 
effects; diabetes, cardiovascular disease, some cancers, osteoarthritis and 
hypertension are established risk factors for raised BMI (GBD 2010 Country 
Collaboration, 2013; Wiseman, 2008). The costs to the Australian government 
associated with adult obesity include healthcare costs, welfare payments and 
forgone tax revenue and were estimated to be $5.3b in 2015/2014 (Duckett and 
Swerissen, 2016).  
The prevalence of obesity has a socioeconomic gradient, whereby rates are highest 
amongst the most disadvantaged groups (Figure 1). In Australia in 2011, rates of 
overweight and obesity disease burden in the lowest socioeconomic group were 
2.3 times those of the highest socioeconomic group (Australian Institute of Health 
and Welfare, 2017). The rates of obesity-related comorbidities are also higher in 
lower socioeconomic groups; there is a general pattern of decreasing disease 
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burden due to overweight and obesity as socioeconomic group increases 
(Australian Institute of Health and Welfare, 2017). This is particularly apparent for 
diabetes (rate ratio of 2.8 for Quintile 1: Quintile 5), chronic kidney disease (2.8) 
and coronary heart disease (2.5) (Australian Institute of Health and Welfare, 
2017).  It is therefore important that policies and programs targeting obesity 
prevention do not widen these already large health inequalities between 
socioeconomic position (SEP) groups.  
Figure 1. The prevalence of obesity by SEIFA quintile, Australia 2014/2015.  
 
SEIFA, socioeconomic index for areas; Q1, most disadvantaged; Q5 least disadvantaged. 
Source:  Australian Bureau of Statistics (2015) 
 
The main influencers of the global obesity epidemic over the last 30 years appear 
to be primarily changes in the global food system, specifically, the increase in 
supply of cheap energy-dense palatable foods and food being more accessible and 
convenient (Cutler et al., 2003). This is coupled with decreasing physical activity 
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due to mechanisation and motorisation (Swinburn et al., 2011). However, the 
determinants of obesity are complex and include physiological, individual 
behaviours and environmental factors both locally and globally (Swinburn et al., 
2011).  
The unequal distribution of obesity is a result of the complex system operating at 
global, national, and local levels, influencing how we trade, live, learn, recreate 
and work (Figure 2) (Friel and Broom, 2007). Generally, the poorer health of lower 
socioeconomic groups is a result of the unequal distribution of power, income and 
resources, known as ‘structural determinants’ (Wilkinson and Marmot, 2003). 
These in turn impact social determinants of health – that is, people’s daily living 
circumstances, such as their work and leisure, their home and the built 
environment in which they live and which influence their chance of leading a 
healthy life (Marmot et al., 1997) 
Behavioural choices are also influenced by a person’s position in the social 
hierarchy (Friel et al., 2007). People need to be empowered to make choices about 
eating healthy food and being physically active (Friel, 2009). For this to happen, 
the healthy choice needs to meet the conditions of being the physically, financially 
and socially easiest choice to make, as well as the most desirable (Friel, 2009). 
Australian researchers found that households in the lowest income quintile would 
need to spend up to 48% of their weekly income to buy a healthy basket of food, 
while those in the highest income quintile would only have to spend 9% of their 
weekly income (Barosh et al., 2014). As income levels decrease, energy-dense, 
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Figure 2. Conceptual framework of the social determinants of inequalities 
in obesity (Friel et al., 2007). 
 
nutrient-poor foods become the most affordable way to obtain daily calories 
(Drewnowski, 2009). Low-income groups are more likely to have less access to 
buy healthy food (Papas et al., 2007); further, fast food restaurants are more 
prevalent in areas with greater socioeconomic disadvantage (Thornton et al., 
2016). 
Neighbourhood characteristics of the built environment have been linked to 
opportunities for physical activity. In disadvantaged areas poorer physical design, 
accessibility and proximity to neighbourhood facilities and lower levels of safety 
have been suggested as mediating the inequalities in leisure time physical activity 
(van Lenthe et al., 2005). Lack of money and lack of access to transport are also 
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barriers to physical activity cited by lower socioeconomic groups (Chinn et al., 
1999).    
The importance of reducing health inequities is recognized globally. Action to 
achieve health equity is considered imperative by The World Health Organization 
(WHO) in its 2013-2020 Global Action Plan for the Prevention and Control of 
Noncommunicable Diseases (World Health Organization, 2013). As a member 
state of the WHO, Australia has committed to addressing noncommunicable 
diseases in line with the Global Action Plan (Australian Health Ministers’ Advisory 
Council, 2017). Australia’s National Strategic Framework for Chronic Conditions 
proposes to target those experiencing socioeconomic disadvantage in order to 
reduce health inequities (Australian Health Ministers’ Advisory Council, 2017). 
A solutions-based approach to obesity prevention needs high quality cost-
effectiveness analyses to address which interventions are both effective and offer 
value-for-money (Moodie and Carter, 2010).  Policy makers considering the 
introduction of an intervention should also be informed of the distribution of 
health benefits across socioeconomic groups.   
This PhD project is part of a National Health and Medical Research Council 
funded Centre of Research Excellence (CRE) in Policy Research on Obesity and 
Food Systems (grant no. 1041020). The health economics stream of the CRE aims 
to evaluate the cost-effectiveness of 40 non-health sector interventions for the 
prevention of obesity, with a focus on Australian population wide policy 
interventions. As part of a two stage assessment of benefit, a set of ‘second stage’ 
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filters are considered that are of importance to decision makers but not captured 
in the technical cost-effectiveness protocol (CEA) protocol; the equity impact is 
one of them. Operationalising equity in the context of cost-effectiveness advice for 
obesity prevention policies becomes the challenge. 
1.2 Research Problem 
In all health care systems, there is a need to make choices about the allocation of 
resources between competing demands and as a result, priority setting has become 
increasingly significant. It is usual practice in CEA to focus on ‘efficiency’ with the 
aim of maximizing health benefits for the lowest cost or minimizing cost for a 
specified outcome. Most CEAs of public health interventions either ignore health 
equity impacts or limit themselves to a description of their nature without any 
quantification. This makes it difficult for policy makers to prioritise or rank 
policies in terms of their cost-effectiveness and equity impacts in an objective way. 
Economic evaluation techniques are being enhanced to provide useful evidence 
about health equity impacts and trade-offs. Recent studies have used 
distributional CEA  (whereby the health gains of SEP groups are analysed 
separately) and health inequality measures (Asaria et al., 2014), however use of 
these techniques in the evaluation of public health interventions is rare. Only one 
previously published CEA of an obesity prevention policy performed a subgroup 
SEP CEA (Rush et al., 2014). 
There is an implicit equity approach in CEA that assigns an equal value to each 
unit of health gain regardless of the intervention or its recipients. Whilst the 
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unweighted aggregation of health benefits can be considered egalitarian, it does 
not consider who gains or loses, and therefore has potential equity consequences 
(Hurley, 2000). One approach proposes to integrate efficiency and equity by 
weighting quality adjusted life years (QALYs).  Equity weights are a way of 
formally incorporating alternative equity positions into economic evaluation 
(Wailoo et al., 2009).  
Four previous studies have derived weights from stated preferences of whether a 
low SEP group should be given priority for health programs over a high SEP group 
(Dolan and Tsuchiya, 2011; Lindholm et al., 1998; Norman et al., 2013; Wiseman, 
2004). All studies indicated that people were willing to prioritise the low SEP 
group. However, the different approaches employed to both elicitations of 
preferences and derivation of the weights, resulted in derived weights of quite 
different magnitudes and therefore may be context and method specific. Use of 
preferences to derive weights also has inherent weaknesses. Presently, the equity 
weights for SEP are unsatisfactory for use in CEA in Australia. 
1.3 Aim and research questions 
This thesis aims to identify methods to quantify equity impacts in CEAs, for the 
prevention of health conditions such as obesity, which have been shown to have a 
socioeconomic gradient. The ‘decision maker’ approach to economic evaluation 
will be adopted, whereby the objectives of policy decision makers are emphasised 
(Sugden and Williams, 1978b).   
The overall research questions from a decision maker perspective are: 
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1. How can equity be incorporated in CEAs of obesity prevention policies? 
2. Are there appropriate equity weights for use in CEAs of Australian 
obesity prevention policies?  
The following specific research questions are also answered by this thesis: 
1a. What is the equity impact of a sugar sweetened beverage (SSB) tax in 
Australia across SEP groups in terms of health and financial effects?  
2a. Can appropriate equity weights for use in Australian CEA studies for 
obesity prevention policies be derived using people’s preferences?  
2b. Can appropriate equity weights for use in Australian CEA studies for 
obesity prevention policies be derived using epidemiological data? 
 
1.4 Structure of the thesis   
This thesis by publication is presented as a collection of four papers (three 
published and one submitted as at the time of thesis submission). The thesis is 
structured into six major chapters as summarised below.  There is no stand-alone 
‘Methods’ chapter as each of the studies entails distinct methods that are 
explained in each of the individual journal articles. 
Chapter 2: Normative foundations and applied methods: examines how 
equity fits into economic frameworks. Two distinct approaches exist in normative 
economics: ‘welfarism’ and ‘non-welfarism’. The applied methods that fit under 
these frameworks are described and their treatment of equity is discussed.  
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Chapter 3: Literature review of methods for incorporating equity into cost-
effectiveness analyses: provides a critique and synthesis of the existing literature 
of the methods of incorporating equity into economic evaluations. It includes the 
paper titled “Inclusion of equity in economic analyses of public health policies: 
systematic review and future directions”. This paper reviews the studies that used 
SEP subgroup economic analyses and focuses on methods for equity impact 
analysis. In Australia, there have been no published studies that have incorporated 
equity into economic evaluations of obesity prevention policies. This provided the 
rationale for incorporating an equity impact analysis into the CEA of a sugar-
sweetened beverage tax (Chapter 4). A separate literature review of studies that 
have derived equity weights for SEP is also presented. It is apparent that suitable 
equity weights for SEP in Australia for use in CEA have not been derived and 
provides the justification for deriving equity weights for SEP (Chapters 5 and 6).     
Chapter 4: Cost effectiveness and equity of a sugar sweetened beverage tax 
includes the published paper titled, “Modelled health benefits of a sugar sweetened 
beverage tax across different socioeconomic groups in Australia: a cost-effectiveness 
and equity analysis”. This study demonstrates the quantification of health equity 
and financial impacts on SEP groups. It estimates the cost-effectiveness, health 
gains and financial effects, including costs to individuals, across SEP groups of a 
20% SSB tax for Australia. The health equity impacts of different tax scenarios are 
compared. 
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Chapter 5: Weighting health outcomes by socioeconomic position using 
stated preferences and social welfare functions includes the paper titled 
“Weighting health outcomes by socioeconomic position using stated preferences.” 
This study used people’s preferences to estimate the shapes of health-related 
Social Welfare Functions (SWF) to derive equity weights for use in CEA. A SWF 
was used to denote the trade-off society is willing to make to endorse a 
distribution of health that is more equitable.   
Chapter 6: Equity weights for socioeconomic position: two methods includes 
the paper titled “Equity weights for socioeconomic position: two methods – using 
surveys of stated preferences and using epidemiological data.”  This study explored 
two additional methods of deriving equity weights for SEP: firstly, people’s 
preferences from a discrete choice survey were fitted to a probit model and 
secondly, SEP specific epidemiological data were used to create weights.    
Chapter 7: Discussion and conclusions provides a synthesis of the key results of 
each of the studies and an overview of the thesis findings. The significance and 
limitations of the studies are presented, including the implications for public 
health policy. Recommendations for future research are offered. 
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Chapter 2. Normative foundations and applied methods 
This thesis is concerned with resource allocation decisions in public health. 
Primarily, it focuses on how the equity impacts of policy and funding decisions 
are inadequately considered under methods of economic evaluation that are 
currently being used. The need for greater consideration of equity is important 
because health equity is one of the key stated objectives of public health policy 
globally (Crombie et al., 2005).  
Equity is an inherently subjective concept, and is further elaborated in this 
chapter. As such there are a number of different schools of thought and 
philosophies of social justice that might be drawn on in arriving at what the 
equity goal of health policy-making for decision makers might be.  The research 
presented in the chapters that follow take the view that the goal of incorporating 
equity considerations in economic evaluation is to minimise the differences in 
health outcomes that exist between socioeconomic position (SEP) subgroups. 
Other views of what the equity goal (if any) should be do exist, and these are 
influenced by different ideologies as to what the aims of health policy–makers 
should be, when considering funding decisions.  
Economic evaluation of health programs and policies, is based on the principles 
of ‘normative’ economics. That is, the health economist’s role is to specify the 
resource allocations that should be followed if certain objectives are to be 
achieved.  This chapter presents a discussion of the most prominent normative 
frameworks in the literature, along with influential philosophies of social justice 
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with which they arguably align. It also clearly defines key ideas and important 
terms to aid understanding of the literature related to applying equity goals in 
health policy decision-making. Finally, it provides an overview of the main health 
economic approaches to aid funding decisions (including types of economic 
evaluation) and the extent to which equity is considered. 
2.1 Key equity concepts for economic evaluation and priority setting 
 
2.1.1 Distinguishing between health inequality and health inequity 
There is an important distinction between the concepts of health inequality and 
health inequity. Health inequality is a descriptive term depicting any differences 
that exist in the level of a chosen metric between population subgroups. Health 
inequities are inequalities in health status between population subgroups that are 
considered unjust or that reflect the consequences of an underprivileged position 
(Braveman and Gruskin, 2003; Reidpath et al., 2012). As such, not all health 
inequalities are health inequities. For example, when comparing adults aged 80 
years or above to those aged 20 to 30 years, the greater prevalence of heart 
disease in the older population would be considered an inequality, but not unfair 
or inequitable. However, the higher prevalence of heart disease present in the 
lowest SEP group in Australia, compared to the highest SEP (Australian Institute 
of Health and Welfare, 2012) is a health inequality that is considered a health 
inequity.  
Health inequities may exist between many different population subgroups – for 
example, men and women, urban and rural or between different ethnic groups in 
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a population. This thesis focuses on differences that exist between subgroups 
categorised by socioeconomic position. These SEP differences are important 
because in high-income countries, the single strongest predictor of an 
individual’s health is their position on the socioeconomic spectrum (Mackenbach 
et al., 2008; Stringhini et al., 2010; Wilkinson and Marmot, 2003). SEP refers to 
socially derived economic factors, such as income, wealth, education level, 
occupation or area of residence (Galobardes et al., 2007). Those who are more 
disadvantaged are generally more likely to suffer from diseases, have higher 
mortality rates and lower life expectancies (Adler et al., 1993; Clarke and Leigh, 
2011; Marmot et al., 1997; Marmot et al., 1987; Stringhini et al., 2017; Wilkinson 
and Marmot, 2003).  
2.1.2 Healthcare equity and health equity 
Health economists have a tendency to use equity as a universal construct 
(Mooney, 2009b). The goal of measurement dictates the definition (Mooney, 
2009b).  The most common definitions of equity in healthcare are: (i) equal 
access for equal need (i.e. those with equal health need have equal access, 
regardless of socioeconomic factors) and (ii) equal use for equal need (i.e. those 
with equal health needs have equal utilisation of healthcare regardless of 
socioeconomic factors) (Mooney, 2003). These definitions however are not 
universally representative of the health economics field as a whole, with equality 
of outcomes being used by a variety of researchers (Blakely et al., 2014; Tsuchiya 
and Dolan, 2009; Williams, 1997) and finding at least lip service in policy 
statements (Australian Health Ministers’ Advisory Council, 2017). 
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Equity is often not defined adequately and health equity has not received the 
attention it deserves. The focus has been on the presence of inequities in people’s 
ability to access healthcare rather than their levels of health per se. The reasons 
for this focus on healthcare is not clear (Mooney, 2009b).  However, if the 
allocation of healthcare is perceived as the means that is best suited to correct 
health outcomes, then the concept of equity will concentrate on healthcare, or if 
reducing inequities in access to healthcare is more achievable, or easier to 
quantify, than reducing inequities in health outcomes, this becomes the basis on 
which equity is measured. It may also be partly because there are several 
structural and social determinants of health that are beyond the scope of health 
policy-makers to address; although this in turn suggests a narrow health service 
focus that may struggle to achieve meaningful reductions in health outcome 
inequality.   
This being said, the focus of this doctorate is on the health sector. Approaches to 
incorporate equity are likely to differ between clinical medicine and public health 
due to the individualised nature of clinical medicine, in contrast to the whole of 
population focus of public health (Cookson et al., 2009). In public health, 
tackling inequality may require discrimination between groups of relatively 
healthy people, for example, targeted promotion of breast-feeding to low SEP 
mothers. In contrast, in clinical care settings, equity is defined as equality of 
access or use. Discriminating between populations groups in the volume and 
quality of care provided in the clinical care setting would be considered ethically 
and politically unacceptable (Cookson et al., 2009).  
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Culyer et al (1993) argue that health is considered a commodity of special status 
and good health is necessary for an individual to flourish. They therefore assert 
that it should be health that is equally distributed. Olsen et al (2011) argue that 
equal health status across the population is unachievable due to biological 
variation and individual preferences. Culyer acknowledges that health equality 
cannot be an absolute ethical imperative (Culyer and Wagstaff, 1993). He 
suggests using a Social Welfare Function (SWF) embodying an aversion factor for 
inequality of health status. A SWF is an economic construct used to define a 
society’s total welfare, as will be explained in Section 2.2. Culyer et al (1993) also 
suggest the use of weights within a SWF that give the health of some members of 
society a higher priority than others (explained in detail in Chapter 3).      
While equity is important in both clinical and public health settings, this thesis 
focuses on public health. In this context, the goal is to allow every person an 
equal opportunity to live the healthiest life they can. Health equity is therefore 
defined as equity of health outcomes. Discussion is focused on equity in health 
status and on incorporating equity into public health policies, rather than 
healthcare interventions.  
2.1.3 Horizontal and vertical equity 
In the health economics literature, equity is often conceptualised in terms of 
‘horizontal’ and ‘vertical’ equity (Mooney, 2003; Wagstaff, 2000). Horizontal 
equity refers to members of society with equal needs receiving the same health 
resources (regardless of socioeconomic factors), and vertical equity refers to 
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those who have different needs receiving appropriately different amounts of 
health resources (Mooney and Jan, 1997). In this thesis the goal of vertical equity 
of health is prioritised, specifically focusing on the differences in health status 
between socioeconomic groups.   
2.2 Social welfare functions 
A ‘social welfare function’ (SWF) is an economic construct used to define a 
society’s total welfare, based on the factors that are considered to affect the 
economic welfare of a society (Hurley, 2014). SWFs can determine the trade-off 
between efficacy and equity - that is, the extent members of society prefer equal 
shares to a greater overall gain (Dolan and Olsen, 2002).  
In health economics, the social objective function is often defined as a function of 
individuals’ level of health (Wagstaff, 1991), referred to as the health-related 
social welfare function (HRSWF) (Dolan, 1998). In the HRSWF, ‘health’ could 
refer to the number of quality adjusted life years (QALYs), for example. Below is a 
specification of a HRSWF with a constant elasticity of substitution, meaning the 
concavity of the curve is constant (Dolan and Tsuchiya, 2011).   
𝑊𝑊 = [𝛼𝛼𝐻𝐻𝑎𝑎−𝑟𝑟 +  𝛽𝛽𝐻𝐻𝑏𝑏−𝑟𝑟  ]−1𝑟𝑟  ,𝐻𝐻𝑎𝑎,𝐻𝐻𝑏𝑏 
𝛼𝛼 + 𝛽𝛽 = 1, 𝑟𝑟 ≥  −1, 𝑟𝑟 ≠ 0 
In this equation, ‘W’ is the health-related SWF and ′𝐻𝐻𝑎𝑎′ and ′𝐻𝐻𝑏𝑏′ are the average 
levels of health of groups of equal size. ‘r ‘ measures the degree of aversion to 
inequality and is represented by the shapes of the indifference curves. SWFs can 
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be graphed as social indifference curves depicting the trade-offs a policy-maker 
faces between allocating resources towards achieving health gains for two 
population subgroups, A and B. The indifference curves are lines showing 
different bundles of health between which society is indifferent. The different 
shapes of the curves imply different responses to the relative importance of the 
individuals in society.   
Figure 3 depicts the health production possibility frontier (PPF) and indifference 
curves with differing levels of ‘r’ .  The PPF for groups A and B defines the set of 
possible combinations of health outcomes a society can produce given the 
available resources. Combinations outside the PPF are unachievable, and choices 
inside the PPF are wasteful because for the same set of resources a greater level of 
health can be achieved. The point at which the indifference curve is tangential to 
the health PPF represents the optimal distribution of health gains across the two 
groups.   
The PPF and the SWF can be used to analyse different values for ‘r’.  If r = -1, 
there is no aversion to inequality because only total aggregated health matters, 
represented by the utilitarian indifference curve with a straight line. The point U 
is where health is maximised and group A would gain the most health. If r > -1, 
then there is aversion to inequality resulting in intermediate indifference curves 
convex to the origin. This represents the objective of pursuing both efficiency as 
well as some level of equitable redistribution of possible levels of health from 
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Figure 3: The health related social welfare function (SWF) and the health 
production frontier (Dolan and Olsen, 2002). 
 
Figure notes: Point U = health maximisation; point R: health of group A and B is equal; 
point W efficiency and equity are pursued; PPF health production possibility frontier. 
 
group A to group B (point W). At the extreme, the worst-off individual is all that 
matters and ‘r’’ assumes a value of infinity. Under this construct, social welfare is 
improved if it improves the position of the group that is worst off and the 
indifference curve will be an L shaped max-min curve. The larger the value of ‘r’, the closer one gets to point R, where the health of group A is the same as the 
health of the group B. The three points on the PPF represent three views of 
distributive justice. How ‘health’ is distributed across socioeconomic groups will 
depend on whether the distribution is considered fair.  
2.3 Key economic frameworks and their consideration of equity  
Normative economic analysis aims to answer questions about how to judge 
whether one option is better than another from an economic perspective. For 
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governments this involves how to best allocate resources and whether one policy 
is preferred to another. This inevitably involves value judgements (Hurley, 2014). 
In contrast, positive economic analysis endeavours to be objective and verifiable, 
reporting on effects of policies.  
Two distinct normative economic approaches have developed through time; 
orthodox welfarism and non-welfarism (Brouwer et al., 2008). These are 
overviewed below. 
2.3.1 Orthodox welfarism 
Orthodox welfarism has four central principles (Brouwer et al., 2008): 
i) ‘utility maximisation’, which assumes that individuals rationally maximize 
their welfare by ordering options and choosing the preferred option. Their 
preferences are expressed through observed interactions in the market, hence 
the role of markets in orthodox economics is often accompanied by a 
libertarian philosophy, with an emphasis on freedom of choice (Richardson, 
2002b); 
ii) ‘individual sovereignty’, which is the belief that individuals are the best 
judges of their own welfare, thus explicitly rejecting the role of paternalism, 
whereby governments intervene in individuals’ autonomy; 
iii) ‘consequentialism’, which is the notion that every policy must be judged 
only on the resulting effects; and 
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iv) ‘welfarism’, which holds that the only relevant information needed for 
ranking of alternative allocations of resources is the utility of individuals, and 
this can simply be summed. 
Under orthodox welfarism, market forces are relied on to determine the optimal 
allocation of healthcare resources based on peoples’ willingness-to-pay and 
capacity-to-pay (Hurley, 1998). Modern welfare economics replaced the utility 
maximising criterion with the Pareto criteria to rank alternative policies. Under 
the Pareto criteria, improvement can be achieved if one person can be made 
better off without making another worse off (Hurley, 2014). However, there can 
still be inequality after a Pareto improvement; few policies benefit some 
individuals without harming others (Coast, 2004).  
This led to the development of the Potential Pareto criterion (or the Kaldor-Hicks 
criterion), whereby a policy is preferred to another if the gains to the 
beneficiaries of a policy are sufficient to fully compensate any parties left worse 
off, whilst still leaving the beneficiaries better off than they were prior to the 
change (Hurley, 2014). This potential Pareto improvement criterion did not 
require such compensation to actually be transferred in order to be considered 
welfare increasing for society (Coast, 2004; Hurley, 2014), such that equity is not 
part of the efficiency judgement (Hurley, 2014).  
Thus, welfarism considers questions of distribution fundamentally political rather 
than economic, allowing economists to focus on issues of efficiency (Hurley, 
2014).   
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2.3.2 Non-welfarism 
Non-welfarist approaches differ from welfarism by basing resource allocation 
decisions on more than just the utilities of individuals expressed through the 
market. Under non-welfarist approaches, the objective of government is to 
improve population health by allocating healthcare resources according to need 
rather than a person’s willingness (or ability) to pay (Hurley, 1998). For example, 
programs like Medicare in Australia ensure that those in need have access to 
healthcare even if they do not have the resources to purchase them. There is a 
rejection of orthodox welfarist assumptions, based on both economic grounds 
(i.e. markets cannot be relied on to bring about optimal solutions in health), as 
well as notions of social justice (i.e. what is fair and just to individuals and 
society). The former goes to a well-developed critique of neoclassical economic 
assumptions in healthcare, explained below.  The latter recognises health as a 
‘merit good’ and a basic right of citizenship – it is characterised by the belief that 
access to basic healthcare should be based on non-market principles and be 
independent of a person’s income.  
The balance of opinion amongst health economists is that the competitive 
market model underpinning orthodox welfarist resource allocation decisions 
does not fit the healthcare market for several reasons. For many health services, 
there is no market price; consumers have little choice about what, how much and 
sometimes when to consume, and producers are often not price-takers or 
required to meet their costs from sales of their output (Rice, 2009).  
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Further, a number of factors lead to market failure in healthcare. These include: 
i) consumers are unlikely to have consumer sovereignty in many elements of 
their health care - that is, have sufficient information or understanding about 
the product to be the best judges of their own needs and wants in order to 
make rational market decisions;  
ii) it is unlikely that all healthcare providers take on the values and wishes of 
their patients, acting as ‘perfect agents’ on their behalf (Rice, 2009). Because 
the perfect agency relationship is unlikely to be attained, there is asymmetry 
of information between consumer and provider;  
iii) often there is an insufficient number of competing firms or barriers to 
entry. In many cases, there are few providers of particular specialist health 
products or services, and monopoly, oligopoly and monopolistic competition 
is common (Rice, 2009);  
iv) consumption benefits are not always internalised in the market 
transaction - that is, there are externalities. A definitive example of a demand 
side externality is immunisation services in which the benefits of consuming a 
product spill over to other parties; and 
v) healthcare may be considered a quasi ‘public good’ - that is, a good where 
consumption by one person does not diminish its consumption by another 
and it is available to anyone regardless of whether or not one is able to pay for 
it (Penne, 2004). The quantity of the public good supplied depends on the 
collective willingness-to-pay through taxes or fees levied by the government. 
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Public goods are underproduced, or not produced at all, by markets (Rice, 
2009).  
For these reasons, the operation of a competitive market, by itself, will not result 
in socially optimal health outcomes. This does not mean, however, that elements 
of competition or a market-oriented approach are excluded from all aspects of 
the health sector. Many countries with strong government involvement in the 
health sector to meet the merit good objective, still have private sector 
involvement for certain services (e.g. service provision) and certain roles 
(supplementary health insurance).  
In the health sector, this has led to the development of non-welfarist normative 
foundations in which the policy focus is on health (‘extra-welfarism’) or the 
political mandate of the government of the day (‘decision-maker approach’) 
(Coast, 2004); (Sugden and Williams, 1978a). These approaches have the same 
objective of maximising health outcomes from available resources, but they differ 
in the theoretical underpinnings and in how advice is operationalised through 
applied economic evaluation (Coast, 2004). This is covered in the following 
sections.  
2.3.3 Extra-welfarism 
Extra-welfarism is classified as a ‘non-welfare’ approach to economic evaluation 
of health and is an alternative view to welfare economics. A single ‘extra-welfarist’ 
approach to empirical normative analysis does not exist (Hurley, 2014). Brouwer 
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et al (2008) emphasize four ways in which extra-welfarist frameworks differ from 
the welfarist framework. Extra-welfarism permits:  
1) the use of outcomes other than utility as the maximand;  
2) sources of valuation of relevant outcomes can come from those who are 
not the affected individuals, such as stakeholders or ‘experts’;  
3) the weighting of outcomes (whether utility or other) does not need to be 
preference-based; and  
4) interpersonal comparisons of well-being in a range of dimensions are 
permissible.  
Extra-welfarism distinguishes between comparing the health ‘characteristic’ from 
comparing the consumption of the healthcare ‘commodity’ (Culyer, 1991). 
Economist Amartya Sen heavily influenced extra-welfarism, arguing that 
evaluation of health should focus on human capabilities ─ that is, what the person 
manages to do or be and can be seen as the opportunities the person faces 
(Hurley, 2014). Sen’s framework is known as the ‘capabilities’ approach within 
extra-welfarism. Under Sen’s approach, evaluations of alternative healthcare 
interventions attempt to assess the influence of each intervention on these 
capabilities (Birch and Donaldson, 2003). The capability approach has not been 
widely operationalised for economic evaluation however one study used this 
approach for the evaluation of an HIV/AIDS program aimed to empower 
communities (Greco et al., 2016) and a multidimensional instrument has been 
developed to operationalise the capability approach for outcome measurement in 
mental health research(Simon et al., 2013). 
34 
 
Sen’s views represent one variant of extra-welfarism. Non-welfarist approaches 
are largely based on achieving societal health objectives, but differ on whether 
health alone should be the outcome for economic evaluation in health (Coast, 
2004). Brouwer et al (2008) explains that in extra-welfarism, utility information 
is complemented with ‘non-utility information’. Non-utility information, 
particularly in terms of how utility is conceived, can include health, human rights 
and ethical concerns, but the predominant non-utility outcome of interest within 
health economics is health status. The main health-related outcome measure for 
the evaluation of health programs, services, and technologies is the quality-
adjusted life-year (QALY) (Hurley, 2014). The focus on health comes from several 
factors, such as: i) the fact that health policy-makers emphasize health as the 
outcome of interest; ii) that indicators of health are observable and comparable 
(Hurley, 2014); iii) that health is of central importance to health providers; and 
iv) that its complexity lends itself to a central role for third party expert 
involvement and associated agency relationships. 
2.3.4 Decision-maker approach 
The Decision Maker Approach (DMA) is a more recent development in economic 
theory that can be regarded as another form of non-welfarism – one that focuses 
on societal objectives determined by decision-makers (Coast, 2004; Sugden and 
Williams, 1978a). Here, the decision-maker acts as an agent for the public, and 
the analyst assists the decision-maker in achieving the stated goals.  
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Under DMA, health economists are able to select from any of the applied 
economic techniques regardless of whether they are associated with welfarist or 
extra-welfarist foundations, directed by the relevance of the techniques to the 
research question (Sugden and Williams, 1978a). This allows the analysts to go 
further than the limitations of welfarism and extra-welfarism, provided the values 
involved are supported by the decision-makers. Paternalism is acceptable under 
this approach to resource allocation, whereby policies that maximise the 
objectives of the decision-makers should be adopted. Using a DMA to economic 
evaluation, the factors in the SWF, and the weights attached to each factor within 
the function, are determined by decision-makers (Sugden and Williams, 1978b).  
2.3.5 Summary of the key economic frameworks 
Orthodox welfarism is well entrenched in the literature with very elegant articles 
and complex mathematics, but has limited use in the real health sector (Coast, 
2004) (Sugden and Williams, 1978a). Extra-welfarism is also well established, and 
more policy relevant, but is also subject to criticism. For example, it has a 
monistic value system based on QALYs, and a belief that all that needs to be 
included in the individual patient's welfare function or utility function is health 
(Mooney, 2009a). It also fails to capture equity. The Decision-Making School is 
much less established in terms of its theoretical literature, but has strong policy 
relevance.  
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2.4 Applied methods of economic evaluation and equity 
The role of the health economist is to indicate the resource allocation decision 
that should be adhered to if given objectives are to be achieved; that is, is option 
‘A’ better than option ‘B’’. They do this by specifying what constitutes ‘value’ in 
the concept of ‘value-for-money’. They explore what ‘efficiency’ means and what 
‘maximising societal welfare with available resources’ means. It should come as 
no surprise then that the various forms of economic evaluation in evidence today 
have a logical foundation in the normative frameworks identified in 2.3 above. 
2.4.1 Methods based on orthodox welfarism 
Cost-benefit analysis 
Cost-benefit analysis (CBA) operationalises orthodox welfare economic principles 
into a method that can inform decision-making. Efficiency is defined by the 
potential Pareto criterion outlined above (Hurley, 2014). Benefits (outcomes) and 
costs of alternative courses of action are measured in monetary units and a policy 
is worthwhile when compared to the alternative(s), if the net benefit in dollar 
terms is positive.  
In effect, CBA tries to mimic the market by assigning dollar values to benefit in 
much the same way market price relates demand to supply. There are various 
ways in which this can be done1, but they all focus on an individuals’ ‘willingness-
to-pay’ to assess many of the benefits (and costs) associated with an intervention, 
                                                 
1 Contingent valuation (CV), for example, where individuals are asked in a hypothetical survey the 
maximum amount they are willing-to-pay (WTP) to have a commodity, or the minimum amount 
they would be willing-to-accept (WTA) as compensation if deprived of it (Olsen et al., 2001).  
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such that an intervention for which individuals have a demonstrated higher 
willingness-to-pay, is more highly valued. This implicitly incorporates one’s 
income into decision-making, which may skew healthcare resource allocation 
towards more socioeconomically advantaged groups (Hurley, 2014). Both the 
Pareto criterion and the net-benefit criterion are insensitive to distributional 
concerns (Hurley, 2014).  
2.4.2 Methods based on extra-welfarist approaches for the economic evaluation of 
health interventions 
To many in the field of medicine and public health, placing a dollar value on 
human life is unacceptable (Garber, 2000). The emergence of non-welfarist 
applied methods arose from objections to assigning monetary values to lives 
saved. Extra-welfarists emphasise health as the main outcome for normative 
analysis in the health sector (Hurley, 2000).  
Non-welfarist applied methods include cost-effectiveness analysis (CEA), cost-
utility analysis (CUA), cost consequences analysis (CCA). The major distinction 
between these various applied techniques is how benefits are measured and 
valued. In CEA outcomes are measured in physical outcomes familiar to 
clinicians (e.g. cost per cancer detected; cost per pain free day; cost per unit 
change in BMI, etc.). In CUA outcomes are measured as quality adjusted life years 
(QALYs) and CUA is often seen as a variant of CEA.  In CCA the chosen cost-
effectiveness ratio is placed alongside a broad range of outcomes that are usually 
simply listed.  
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Cost-effectiveness analysis (CEA; CUA) 
Cost-effectiveness analysis (CEA; CUA) compares the relative costs and outcomes 
of a policy, program or intervention to address an identified health problem. The 
results of CEAs are usually summarized as incremental cost-effectiveness ratios 
(ICERs) that represent the additional costs (or cost savings) and benefits gained 
(or foregone) of implementing the intervention of interest measured against the 
most likely alternative intervention for that identified health problem, known as 
a comparator. The most generic outcomes under CEA are either Life Years Saved 
(LYS) or Quality Adjusted Life Years (QALYs). QALYs reflect both the quality and 
quantity of life years gained as a result of the intervention.  
To help determine value-for-money, an ICER threshold is often applied (e.g. < 
AUD 50,000 per QALY), below which an intervention is presumed ‘efficient’ 
(Grosse, 2008). It is usual practice in CEA to focus on ‘efficiency’ with the aim of 
maximizing health benefits for the lowest cost or minimizing cost for a specified 
outcome. Whilst cost-benefit analysis is impacted by income, the use of a non-
monetary measure such as the QALY, incorporates its own equity assumptions 
(Brouwer et al., 2008). The unweighted aggregation of health benefits can be 
considered egalitarian, however it does not consider who gains or loses, and 
therefore has potential equity consequences (Hurley, 2000). Most CEAs either 
ignore health equity impacts or limit themselves to a description of their nature 
without quantification. 
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Assessing Cost-Effectiveness (ACE) prevention methods 
This doctorate sits within a National Health and Medical Research Council 
(NHMRC) funded Centre for Research Excellence – the CRE in Policy Research 
on Obesity and Food Systems. In the Economics Stream of this CRE, 40 non-
health sector interventions for the prevention of obesity will be evaluated. An 
approach called “Assessing Cost Effectiveness” or the ACE approach has been 
utilised to do this. ACE is a variant of PBMA where every effort has been taken to 
improve rigour in the measurement of outcomes and to avoid methodological 
confounding. 
ACE methods use a standardised evaluation protocol such as a common reference 
year, perspective, timeframe and methods for measuring costs and benefits 
(Ananthapavan et al., 2014). The ACE methodology has been used in several 
previous priority setting projects in Australia such as ACE-Prevention, to analyse 
150 interventions for the prevention of non-communicable diseases (Vos et al., 
2010), ACE-Obesity to analyse 13 interventions to prevent obesity in children 
(Carter et al., 2009) and in the U.S. CHOICES project, to analyse four childhood 
obesity interventions (Gortmaker et al., 2015). 
Key features of the ACE approach include (Carter et al., 2009):  
• the justification for the selection of interventions is provided; 
• the methods are standardised, reported and open to assessment; 
• country specific data are used, wherever possible; 
40 
 
• a range of results around point estimates is reported, demonstrating the 
uncertainty of cost, process, outcome and value estimates; and 
• the incremental cost effectiveness ratios are presented alongside a broader 
decision-making framework called 'second stage filter' or ‘implementation’ 
analysis. 
A key aspect of the ACE methodology is the two-stage assessment of benefits, 
where the technical CEA results are considered together with second stage filters 
of importance to decision-makers. These include equity, level of evidence, 
sustainability, acceptability, feasibility and side effects.  
Previously, equity was considered qualitatively as one of the key second stage 
filters, making it difficult for policy makers to prioritise or rank policies in terms 
of their cost-effectiveness and equity impacts in an objective way. Methodological 
improvements are required to quantitatively incorporate equity into the technical 
analyses (Ananthapavan et al., 2014).  This is the mission for this doctorate. 
2.5 Conclusion  
This chapter has summarised the main economic theories and the treatment of 
health equity in the associated economic evaluation techniques. Orthodox 
welfarism considers questions of distribution and equity to be fundamentally 
political rather than economic, allowing efficiency to be the focus with 
economists as the honest analyst.  
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Non-welfarist approaches allow greater scope than orthodox welfarism for 
integrating concerns for equity. However, in CEA under extra-welfarism, the 
unweighted aggregation of health benefits does not consider who gains or loses, 
and therefore has potential equity consequences (Hurley, 2000).  
The decision-maker approach allows health economists to go beyond the 
restrictions of welfarism and extra-welfarism, taking into account the practical 
needs of the decision-maker and the values they consider important, such as 
health equity. The following chapter explains the methods of quantifying equity 
into CEA and critically reviews the studies that have used these methods. 
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Chapter 3. Literature review of methods for incorporating equity into 
cost-effectiveness analyses 
This chapter explores a central aim of the thesis - the methods that quantify equity 
impacts in cost-effectiveness analyses (CEAs) of), health conditions that have been 
shown to have a socioeconomic gradient, impacting more on disadvantaged 
groups. The focus is on CEAs of public health interventions that promote health 
and prevent illness. 
What is already known about incorporating equity into CEAs? 
Most CEAs either ignore health equity impacts or limit themselves to a description 
of their nature, without any quantification or consideration of changes to 
intervention design to address inequality. In response to growing policy concerns 
about health equity, CEA techniques would be more relevant to decision-making if 
they incorporated information about both the health efficiency and equity 
implications of the alternative policy options being evaluated. 
What does this chapter add to existing knowledge? 
The main approaches for incorporating equity into CEA used in previously 
published studies included:  
• the use of health inequality measures to show the inequality differences 
when two or more interventions are being compared;  
• the analysis of financial impacts, such as out-of-pocket treatment 
expenditures avoided;  
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• the use of SEP specific inputs for mortality and morbidity, especially in the 
studies that analysed effects across different SEP groups;  
• the use of equity weights; and  
• equity constraint analysis.  
The use of economic evaluation to investigate socioeconomic health inequity 
impacts of public health policies is relatively new and rarely undertaken. More 
work is required to allow ease of interpretation and comparison of measures being 
reported. 
What insights does this chapter provide for informing policy decision 
making? 
Health equity assessment within CEA allows transparency of the trade-offs 
between cost-effectiveness of interventions and any alternative health equity 
objective. In the context of priority setting, future CEAs for the prevention of 
health conditions for which there is a socioeconomic gradient should, whenever 
possible, include health equity impact analyses. This will enable the distributional 
health effects amongst SEP groups to be examined, and will facilitate the 
comparison of interventions for their effect on health equity. This can be 
performed using distributional CEAs using SEP subgroups and health inequality 
measures.  
The presentation of literature review findings of methods for incorporating equity 
into cost-effectiveness analyses are set out below. First, the published journal 
article Lal A, Moodie M, Peeters A and Carter R. (2017) Inclusion of equity in 
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economic analyses of public health policies: systematic review and future directions. 
Aust. NZ J Public Health. doi: 10.1111/1753-6405.12709.  Second, an overview of 
studies that have derived equity weights for socioeconomic position is presented. 
This provides context on previous methodological approaches used to establish 
equity weights, existing knowledge gaps and limitations, as well as demonstrating 
the important contribution of the analytical research presented subsequently in 
this thesis. Third, the chapter covers equity constraint analysis (not included in 
the review paper). Fourth, on the basis of this review of relevant literature, the 
rationale for the original research presented in subsequent thesis chapters is 
detailed.   
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Given health budget constraints, priority setting for new programs is unavoidable, whether done explicitly 
or implicitly. Policy makers may use cost-
effectiveness analysis (CEA) to help inform 
resource allocation decisions. It is usual 
practice in CEA to focus on ‘efficiency’ with 
the aim of maximizing health benefits for the 
lowest cost or minimising cost for a specified 
outcome. Efficiency is important, but only 
one of several policy objectives. Government 
statements about health usually include 
important notions of equity – reducing 
disadvantage, access to health services, 
and/or affordability.1 Further, when the 
community in developed countries is asked 
what they want from their health care system, 
a ‘fair’ distribution of health gains is often 
seen as an important objective.2-10
Cost-effectiveness analysis (CEA) compares 
the relative costs and outcomes of a policy 
or program. The results of CEAs are usually 
summarised as incremental cost-effectiveness 
ratios (ICERs) that represent the additional 
costs and benefits of an intervention 
measured against a comparator. To present 
a helpful metric across different types of 
interventions, results are often presented as 
the ‘net cost per quality adjusted life year’ 
(QALY). To help determine value-for-money, 
an ICER threshold is often applied (e.g. 
<AUD$50,000 per QALY), below which an 
intervention is presumed ‘efficient’. When 
a policy is being analysed for its cost-
effectiveness, information regarding the 
equity in the distribution of health outcomes 
is rarely provided.11,12
Most CEAs either ignore health inequality 
impacts or limit themselves to a description 
of their nature without any quantification 
or consideration of intervention design 
changes to address inequality. While this 
applies across clinical medicine and public 
health, approaches to incorporate equity 
are likely to differ between these settings. 
The individualised nature of health care, for 
instance, is different to the population focus 
of public health, where confronting inequality 
may require discrimination between groups 
of relatively healthy people, for example, 
in the number and quality of preventative 
programs. In clinical care settings, this would 
be problematic. Equity is important in both 
settings, but here we focus on public health. 
In any country, differences in health status 
can be observed across the population. 
Explicit health equity assessment is not 
always necessary. However, it can become 
important when, for example, a public health 
intervention is not cost-effective, and the 
question then arises of how much it reduces 
health inequality to not exclude this potential 
source of value.11
The health equity impact plane in Figure 1  
illustrates the trade-offs between cost 
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Abstract
Objectives: To assess current approaches to inclusion of equity in economic analysis of public 
health interventions and to recommend best approaches and future directions.
Methods: We conducted a systematic review of studies that have used socioeconomic position 
(SEP) in cost-effectiveness analyses. Studies were identified using MedLine, EconLit and HEED 
and were evaluated based on their SEP specific inputs and methods of quantification of the 
health and financial inequalities.
Results: Twenty-nine relevant studies were identified. The majority of studies comparing 
two or more interventions left interpretation of the size of the health and financial inequality 
differences to the reader. Newer approaches include: i) use of health inequality measures 
to quantify health inequalities; ii) inclusion of financial impacts, such as out-of-pocket 
expenditures; and iii) use of equity weights. The challenge with these approaches is presenting 
results that policy makers can easily interpret.
Conclusions: Using CEA techniques to generate new information about the health equity 
implications of alternative policy options has not been widely used, but should be considered 
to inform future decision making.
Implications for public health: Inclusion of equity in economic analysis would facilitate a more 
nuanced comparison of interventions in relation to efficiency, equity and financial impact.
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effectiveness and an alternative health equity 
objective.11 Cost-effectiveness of the health 
program is shown on the vertical axis and 
the health equity impact on the horizontal 
axis. The latter represents the net impact 
after allowing for program opportunity costs 
and benefits. A policy that falls in Quadrant I 
improves both total health and equity (“win-
win”); in Quadrant III, the policy harms both 
(“lose-lose”). In these two cases, the impacts 
on health maximisation and health equity are 
in the same direction, so there are no trade-
offs. In Quadrant II, the policy has a positive 
impact total health but a negative impact on 
equity (“win-lose”), and in Quadrant IV, the 
policy has a negative impact on total health 
but a positive impact on equity (“lose-win”).
The main method of quantifying the health 
impact among different population groups 
within a CEA is to conduct subgroup CEAs, 
which entails a separate CEA for each 
socioeconomic position (SEP) subgroup to 
determine the costs and health gains in each 
group. Where interventions only require a 
whole of population CEA and are not set 
up for subgroup CEAs (e.g. population-
wide strategies that are not targeted at 
certain groups), the subgroup health gains 
can be modelled. Despite measurement 
challenges, estimating the health gains of 
subgroups in population health strategies 
has the potential to allow policy makers 
to assess interventions not only for their 
cost-effectiveness, but also for their potential 
impact on health inequality. The objectives 
of this type of analysis are transparency and 
policy relevance, particularly where there is 
potential to increase inequalities in health 
status in already disadvantaged groups. 
If interventions result in financial costs (or 
expenditure avoided) to individuals, it is 
also important to include this as part of the 
equity analysis. When a fiscal policy is being 
analysed it is necessary to consider whether 
it is regressive (taking a proportionally higher 
amount from those on lower incomes), or 
progressive (taking a proportionally higher 
amount from those on higher incomes). If 
the analysis shows that a higher proportion 
of expenditure comes from disadvantaged 
groups, it can then be determined whether 
and how the financial impact could be 
reduced.
There is an important distinction to be made 
between ‘health inequality’ and ‘health 
inequity’. Health inequities are differences 
in health status between population groups 
that are the result of economic and social 
conditions.14,15 They are considered avoidable 
and unfair. Inequity is a normative term linked 
to notions of social justice. Health inequality 
on the other hand, is a descriptive term that 
reports the distribution of a chosen metric. 
When conducting a subgroup CEA to 
measure the health equity impact, the 
choice of the relevant population subgroup 
depends on which characteristic – SEP, 
ethnicity, geographical location, or gender 
– is important in the decision context. In 
the developed world, the single strongest 
predictor of an individual’s health is his/her 
position on the socioeconomic spectrum.16 
SEP can be measured by income, education, 
place of residence or occupation. On average, 
those at the lower end of the spectrum, 
irrespective of how SEP is measured, 
are more likely to suffer from diseases, 
have higher mortality rates and lower life 
expectancies.16-20 This social gradient of health 
is also important for many racial and ethnic 
health differences because SEP can differ 
substantially by race and ethnicity.21-24 In an 
analysis of government policies in thirteen 
countries, Crombie found that inequalities 
in health were most commonly presented as 
the difference in health status between SEP 
and that all countries had set an overarching 
goal to reduce such inequalities.25 Our study is 
focused on socioeconomic health inequalities 
of public health interventions. 
In response to growing policy concerns 
about health equity, economic evaluation 
techniques are being enhanced to provide 
useful evidence about health equity 
impacts and trade-offs. However, there 
has been no systematic evaluation of 
the advantages and disadvantages of 
the different published works that have 
incorporated equity for SEP into CEA. The 
aim of the present work was to review the 
studies that used SEP subgroup economic 
analyses to investigate socioeconomic 
health inequalities in the context of public 
health interventions. Subgroup CEA is a 
basis on which other methods of equity, 
such as measures of health inequality, equity 
weighting and opportunity cost analysis 
could be incorporated.13 We aimed to assess 
the application, challenges and suitability 
of methods utilised in different contexts. 
Recommendations for future studies to 
improve the information available to policy 
makers are discussed.
Methods
Search strategy
Studies were identified using the following 
academic databases: Medline Complete, 
Health Economic Evaluations Database 
(HEED) and EconLit. All original research 
articles published in English were open for 
inclusion, with no restrictions on years of 
publication. Additional snowballing searches 
of reference lists were undertaken. 
The specific search terms were: (“cost-
effectiveness” OR “cost-utility” OR “cost-
benefit” OR “cost-consequence” OR “economic 
evaluation” OR “economic analysis”) AND 
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(socioeconomic* OR “social class” OR “social 
hierarchy” OR “social inequality” OR depriv* 
OR disadvantage* OR income OR educational 
OR occupation OR residence) NOT “low-
income countr*”.
To estimate a percentage of the total number 
of economic evaluations of public health 
programs or policies that have used SEP 
subgroup analysis, the Econlit database 
was used. Econlit classifies studies under 
the subheading “Health government policy 
regulation; public health”. The specific search 
terms used were: (“cost-effectiveness” OR 
“cost-utility” OR “cost-benefit”). 
Study selection and inclusion criteria
Included studies were assessed for their 
relevance by one reviewer (AL). Studies 
that assessed public health interventions 
using economic evaluation techniques 
that compare alternative courses of action 
in terms of both costs (resource use) and 
consequences (outcomes, effects) and 
stratified SEP group/s were included. Cost-
utility analysis (CUA) is a form of CEA whereby 
the health outcomes are measured in terms 
of both the length of life and the quality of 
that life (usually QALYs). Cost-effectiveness 
analysis measures outcomes in physical units 
meaningful to clinicians and patients, such 
as a ‘cost per death averted’. Our aim was to 
include interventions that address a whole 
population across a socioeconomic gradient, 
as well as interventions targeted only at lower 
SEP groups. Accordingly, included studies 
were those that were aimed at a whole 
population, a community, or were targeted 
at specific individuals and groups of people 
within a country, community or organisation. 
Studies were excluded by one reviewer (AL) if 
they: 1) were not public health interventions 
or policies; 2) examined groups that were 
not SEP-based, such as ethnic group or age 
differences; or 3) analysed a low-income 
country as one population. 
Study appraisal 
Data on the following variables were 
extracted: country, aims, perspective, 
study type, intervention and comparator, 
population subgroups, SEP specific modelling 
inputs, health outcomes and financial 
outcomes.
The studies were appraised based on: i) the 
number and type of SEP specific inputs in the 
model; ii) level of complexity of quantification 
of the health inequality; iii) methods of 
incorporating the equity analysis into the 
CEA; and iv) inclusion of financial costs. 
Results
The literature search yielded a total of 426 
papers. The reading of titles and abstracts 
indicated that 44 of the articles were 
potentially eligible. After examination of the 
full text of these articles, the final number 
of studies included was 31. Reasons for 
excluding full-text articles are shown in Figure 
2. Of the 576 economics evaluations of public 
health interventions identified in Econlit 
database, 5% were studies that used SEP 
subgroup CEA.
Overview of included studies 
Date of publication ranged from 2010 to 
2015. Of the 31 included studies, 15 examined 
two or more SEP subgroups and 16 studies 
analysed a low SEP group only. A summary 
of each of these studies including the SEP 
specific inputs and outcomes and policy 
relevance of each study is provided in the 
supplementary files. 
Studies examining two or more SEP 
subgroups
Intervention types 
The main type of intervention analysed 
(n=8) was vaccination programs for the 
prevention of a range of conditions, 
including rotavirus,26,27 pneumonia,28 
human papillomavirus,29,30 measles31 and 
tuberculosis.32 Three studies looked at fiscal 
policies, including an increase in tobacco 
taxes33,34 and a subsidy and tax decrease 
for fresh fruit and vegetables.35 There were 
also studies that examined bowel screening 
programs,36 a ban on trans fats,37 promotion 
of physical activity in adults,38 promotion of 
physical activity and nutrition in children39 
and coronary heart disease management.40
Seven studies were CUAs30,34,36-40 and eight 
studies were CEAs.26-29,31-33,35 Seven studies 
compared two or more interventions to 
current practice,28,30,31,34-37 while the remainder 
compared a single intervention to current 
practice. Studies originated from a range of 
low, middle and high-income countries.41 
There were three interventions each from 
the United Kingdom,36-38 India26,27,32 and 
Ethiopia,26,28,31 two from China29,33 and 
New Zealand,30,39 and one each from the 
Netherlands,34 Australia40 and France.35
Measures of socioeconomic position
The most commonly used measure of SEP 
was household income or wealth quintiles, 
utilised in eight of the 15 studies.26-29,31-33,35 
Five studies used area level deprivation 
or disadvantage that took into account 
multiple factors such as employment, income, 
education and housing.30,36,38-40 One study 
used education level as the indicator of SEP.34 
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Assessment of the studies 
Aims of the studies: For 14 of the 15 
studies,26-38,40 the main aims included the 
evaluation of the health outcomes across SEP 
groups. The remaining study did not explicitly 
mention an aim to analyse the health benefits 
by SEP groups.39 
SEP specific inputs in modelling: A 
comprehensive SEP specific model, using 
rates of effectiveness, disease specific 
incidence, morbidity and mortality rates, 
specific to the subgroups was found in 10 
studies.26-28,30,31,34,36-38,40 Two studies used a 
simplistic model where the intervention 
effect size was the only SEP-specific input in 
the model.35,39
Studies examining one SEP subgroup
Intervention types 
Of the 14 studies examining a targeted 
SEP group, six were CUAs,42-47 and eight 
were CEAs.48-55 The majority of the studies 
originated from the USA (n=9);42,45-47,49,50,52,54,55 
three came from the UK;43,44,53 and one each 
from Australia51 and Iran.48
Measures of socioeconomic position
Eight studies used low income as a measure 
of SEP42,45,46,48,50,52,55,56 and six studies used an 
area-based level of disadvantage.43,44,49,51,53,54
Assessment of the studies 
Aims of the studies: The aims of all the studies 
analysing one SEP group were to examine 
the cost-effectiveness of the intervention 
targeting a low SEP group. 
SEP specific inputs in modelling: For the 
modeling of morbidity and mortality in the 
CUAs, one study used SEP specific mortality 
inputs,44 while the other four studies used 
general population inputs.42,45-47 In the 
CEA studies, all studies used SEP-specific 
effectiveness/efficacy rates either from the 
trial on which the study was based or from 
published sources.
Interpretation and quantification of 
the health inequality
In 12 of the 14 studies that aimed to evaluate 
the differences in health benefit between 
SEP groups, the health outcomes of each SEP 
group were presented, such as QALY gain per 
person.30,34,38,40 While it was left to the reader 
to interpret the size of the differences, the 
studies did state which SEP group had the 
highest or lowest gains. Two of the studies 
confined their attention to the highest and 
lowest groups, and did not include the health 
gains of the middle groups in their results.30,38 
Three studies presented the results as 
the total QALYs in each SEP group. Two of 
the studies36,37 used population quintiles. 
However, one study used different-sized 
groups and stated that the highest health 
gains occurred in the middle SEP groups.34 
This was true for the overall number of QALYs, 
however these absolute differences will vary 
depending on the size of the group. In this 
study, calculation of the ratio of QALYs gained 
per smoker would have changed the result 
to the highest gains being in the highest SEP 
group. 
Health equity impact plane
One study used a diagram of a health equity 
impact plane to summarise the net costs 
and the reduction in absolute inequality of 
coronary heart disease mortality for each 
policy option.37
Health inequality measures
Measures of health inequality are single 
numbers that quantify the size of SEP 
inequalities in health and can be classified as 
simple or complex.57 Simple measures make 
pairwise comparisons of health between 
two subgroups, such as a lower and a higher 
SEP group. Complex health inequality 
measurements produce a single number that 
considers all SEP groups separately and assess 
how the rate of health gains vary across the 
gradient of SEP.57 Measures of inequality can 
be relative or absolute. 
Simple health inequality measures were 
included in one study35 – a health disparities 
index – defined as the variation in the odds 
ratio for the first vs. other income deciles 
for each policy. The opportunity to quantify 
and compare the inequality impact of 
interventions was missed by four28,30,31,34 of 
the seven studies that analysed two or more 
interventions.28,30,31,34-37 
Complex health inequality measures were 
used by two studies, both of which used a 
slope index of inequality.36,37 The study by 
Asaria et al. provided a new methodological 
framework for undertaking distributional 
cost-effectiveness analysis (DCEA) to 
combine the objectives of maximising 
health and minimising unfair variation in 
health when evaluating population health 
interventions.36 Their methods included 
complex health inequality indices alongside 
CUA. They analysed two redesign options for 
an existing screening program: i) a targeted 
reminder for disadvantaged groups; and 
ii) a universal reminder. A battery of both 
relative and absolute measures of inequality 
for each intervention were presented. Five 
decimal places are shown to differentiate the 
numbers, and the differences in the size of 
the inequality measures between strategies 
appear very small. The importance of these 
small differences is not explained. 
Equity Weights
There is an implicit equity approach in CEA 
that assigns an equal value to each unit of 
health gain regardless of the intervention 
or its recipients. Equity weights are a way 
of formally incorporating alternative equity 
positions into economic evaluation.58 The 
weights are numbers that represent the 
relative importance of equity for SEP.
Two studies used a form of equity weighting 
when quantifying the health inequality 
impact. Asaria et al.36 report the Kolm and 
Atkinson indices to measure inequality 
(see Supplementary Table 1), allowing for 
different levels of aversion to inequality, 
a measure of the overall health gains that 
society is willing to give up in order to achieve 
a more equal distribution of health. They 
present a low, medium and high value of 
aversion to inequality. All of the inequality 
measures, calculated across a range of 
inequality aversion levels, show that no 
screening was the least unequal and the 
universal reminder as the most unequal 
of the strategies. Banham et al.40 present a 
method for weighting resource allocation, 
in situations where distribution of the same 
level of resources per capita to each SEP 
group would increase the inequalities due 
to different intervention effect sizes. If the 
policy objective is to reduce inequalities, 
the approach suggests weighting resource 
allocation, using the highest quintile as a 
benchmark and based on the difference 
between highest and lowest quintile specific 
intervention effects. For example, the 
weight for Quintile 1 would be 1.65, based 
on the difference between the effect sizes 
of Quintiles 5 and 1 of 18.8% and 11.4% 
respectively, divided by 11.4%.
Financial impacts 
Financial impacts are measured in terms 
of market place transactions, consisting of 
out-of-pocket expenses avoided or incurred 
because of the intervention.
The novel framework of extended cost-
effectiveness analysis (ECEA) emerged 
Lal et al.
2017 Online Australian and New Zealand Journal of Public Health 5
© 2017 The Authors
from this review and includes two financial 
aspects of inequality across wealth strata 
of a population: i) the out-of-pocket (OOP) 
expenditure avoided; and ii) the level of 
financial risk protection (FRP) provided by the 
value of insurance afforded. ECEA was used 
by six studies from low and middle income 
countries.41,26,28,29,31-33 Four studies have used 
the ECEA framework fully with the health 
benefits measured in ‘deaths averted’ across 
income quintiles and financial impacts of out-
of-pocket treatment expenditures avoided 
and the FRP afforded.26,28,32,33 Two studies 
omitted the FRP and reported a percentage 
change in expected income.29,31 For example, 
Verguet et al. provide an alternate scenario 
to Universal Public Financing (UPF) of 
tuberculosis treatment in India, by reducing 
the cost of borrowing for the poor. Instead 
of health gains and the insurance value of 
UPF accruing primarily to the poor, lowering 
costs of borrowing for the poor could 
potentially achieve some of the health gains 
of UPF, lower costs to the public sector and 
improvements in the net income position of 
the top two income quintiles, but at the cost 
of leaving the poor more deeply in debt.32
Of the 29 studies, three studies examined 
fiscal policies;33-35 however, only one reported 
the financial impact. Comprehensive 
financial impacts were presented showing 
that increased tobacco taxation can be a 
pro-poor policy instrument in China, by 
substantially decreasing tobacco expenditure 
in the poorest quintile and by decreasing 
expenditure on tobacco-related diseases and 
providing financial risk protection mainly 
concentrated in the poorest households.33
Analysis of opportunity cost
The opportunity cost could be the QALYs 
forgone when there is an equity-efficiency 
trade-off, such as between improving overall 
population health and the equity goal of 
reducing the health inequality between 
SEP groups. The latter may require diversion 
of additional resources to these harder to 
reach groups. The net equity impact of an 
intervention includes the health benefits 
forgone as well as the health benefits 
gained. The forgone health gains or health 
opportunity costs that could have resulted 
from implementing the next best alternative 
program may be unequally distributed 
among SEP groups.
The opportunity costs were analysed by one 
study.36 The authors’ method of estimating 
the distribution of opportunity cost was 
to assume that the additional costs come 
from a fixed health budget and the health 
opportunity cost of the disinvestment of 
these funds within the National Health 
Service was one QALY per £20,000. The base 
case assumed that the opportunity costs 
were distributed equally across all population 
subgroups. Subsequently, two sensitivity 
analyses were performed assuming the 
costs were borne entirely by the healthiest 
subgroup and secondly by the unhealthiest 
subgroup. The results are presented as social 
welfare indices with five decimal places to 
distinguish the differences in magnitude. 
These differences are not easily interpreted 
and an explanation of the implications of the 
small differences in magnitude would have 
been useful. 
Discussion
The aim of this paper was to examine 
studies that have used SEP subgroup CEA 
analysis and to assess how they identify 
and measure health inequalities in public 
health interventions. The key methods from 
the studies included: i) the use of health 
inequality measures to show the inequality 
differences when two or more interventions 
are being compared; ii) the analysis of 
financial impacts such as out-of-pocket 
treatment expenditures avoided; iii) the 
use of SEP specific inputs for mortality and 
morbidity, especially in the studies that 
analysed effects across different SEP groups; 
and iv) the use of equity weights. 
We found the main weakness to be 
that in most studies where two or more 
interventions were being compared, there 
was a reliance on disaggregated data and the 
interpretation of the size differences of the 
inequality was left to the reader. Also, some 
studies did not include financial impacts 
when they were a potentially important 
aspect of the intervention and some studies 
confined their attention to the highest and 
lowest SEP groups and potentially omitted 
important results from the middle groups. 
The study by Asaria et al.36 broke new 
ground in providing a DCEA framework by 
presenting complex inequality measures, 
including aversion to inequality values and 
equity weighting analysis. The framework 
demonstrated how alternative social 
judgments influence the assessment of which 
strategy is best. Social welfare analysis can 
be a useful way of ranking interventions to 
decide which one best minimises health 
inequalities and/or maximises health, taking 
into account people’s aversion to inequality. 
The study demonstrated the use of equity 
weights to explore the implications of 
alternative value judgments. One of the 
features of Asaria et al.’s methodology36 is the 
transparency about value judgments and the 
use of sensitivity analyses to reflect alternative 
value judgments. Lack of consensus on an 
equity weight algorithm has raised doubts 
about equity weight analysis.11 However, this 
type of analysis is recommended to be used 
as an aid to analyse the implications of using 
alternative value judgments via sensitivity 
analysis and not necessarily as an algorithm 
for making decisions.11
ECEA has also emerged as a framework for 
incorporating health and financial inequality 
impacts into economic evaluation in low 
and middle-income countries. Examining 
the financial impacts across SEP groups is 
an important advance in analysing equity in 
CEA. Although the framework has only been 
used in low and middle-income countries, 
aspects of ECEA would be useful in analyses 
originating from high income countries also; 
the analysis of out-of-pocket costs incurred 
and averted across SEP groups is highly 
relevant in any country when the impacts 
differ. 
When assessing the equity impact of an 
intervention, the distribution of both health 
gains and opportunity costs are important. 
The distribution of the latter will depend 
on how the intervention is funded. For 
example, if the funding comes from public 
health expenditure, health losses may be 
distributed unequally to those who are worse 
off, as they rely more on public services.13 
The study by Asaria et al.36 is the only one 
to present preferred strategies for when 
health opportunity costs are borne by the 
least healthy, the healthiest or are equally 
distributed. An important area for future 
research is to deliver improved estimates 
of the distribution of opportunity costs, 
and to determine a realistic distribution 
that plausibly reflects the impact of likely 
disinvestment decisions.
The use of health inequality measures is a 
constructive way forward where the aim is to 
compare different intervention options for 
their health inequality impact to allow ease of 
comparison and ranking of the interventions. 
Simple health inequality measures are easy 
to calculate and interpret, however they only 
take two SEP subgroups into account. The 
advantage of using complex health inequality 
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measures is that they allow for a number of 
different interventions to be compared for 
their health inequality impact, taking into 
account each subgroup and its size. Whether 
one should consider measure of effect or 
the total impact depends on whether the 
size of the low SEP groups is considered a 
changeable aspect by policy-makers, (for 
example the income distribution), or whether 
to focus on the effect that is modifiable by 
public health policy.57 
A limitation of the use of health inequality 
measures is that they are subject to 
misinterpretation. The slope index of 
inequality and the relative index of inequality, 
for example, are complex to interpret and 
can easily lead to misunderstandings.57 The 
article by Asaria et al.36 would have benefited 
from more explicit interpretations of some 
of the inequality measures, including the 
implication of the size of the differences, 
to improve ease of understanding. Future 
studies should include a clear interpretation 
of each measure. The use of figures to 
compare results of health inequality measures 
of various policies could be useful. 
Given that all the studies considering equity 
for SEP across population groups were 
published in the past five years, application 
of this type of analysis is still in its infancy. In 
the health economics literature, for example, 
there is a well-developed literature on the 
pros and cons of including equity weights in 
economic appraisal, but only a limited and 
emerging literature on how to construct 
those equity weights. The estimate of 5% 
of economic evaluations in public health 
using SEP subgroup analysis is likely to be an 
underestimate, as the search only included 
the Econlit database. Econlit includes 
economics and business journals, however, 
an estimated 2.5 times as many health 
economics authors publish in PubMed listed 
journals.59 If this is the case, the percentage is 
likely to be closer to 1.5%. PubMed was not 
used for the estimation because it does not 
have a classification system by category.36,13
With regard to SEP specific mortality and 
morbidity in the modelling of health 
outcomes, it is important to note that the 
use of subgroup specific parameters, such as 
lower life expectancy and higher morbidity 
burden, may result in the evaluation of one 
subpopulation being less cost-effective than 
another. For example, lower SEP groups 
may have lower life expectancy and higher 
comorbidities resulting in lower health 
gains and higher ICERs. For this reason, an 
intervention that is cost-effective overall may 
not be cost-effective in lower SEP groups. 
Sensitivity analyses could include the use of 
general population life expectancy, quality of 
life estimates and treatment cost variations 
to compare the difference in results. Blakely 
et al.30 used this technique, although not for 
SEP, by applying non-Maori morbidity rates 
to Maoris and presented both sets of results. 
This was done because higher background 
mortality and morbidity rates for Maoris 
meant that in the baseline analysis a life 
saved for Maori was weighted less than a 
life saved for non-Maori. By comparing the 
two analyses, it is possible to check whether 
disadvantaged groups are being further 
disadvantaged. 
A recent article reviewed formal methods 
that consider equity in the context of CEA for 
health technology assessment (HTA), covering 
multiple concepts and values relating 
to equity.12 It identified one of the major 
obstacles hindering the use of formal equity 
methods in decision making, as the variety 
of concepts and values discussed under the 
notion of equity. Focusing on one key aspect 
of equity, such as SEP, allows for clarity. The 
methods of incorporating equity common 
to both HTA – an aspect of clinical medicine 
– and public health were equity weights and 
opportunity cost analysis.
One of the advantages of subgroup CEA 
is that it is an existing modelling method 
that health economists are familiar with 
performing, particularly in health technology 
assessment for heterogeneous characteristics, 
such as treatment effects. However, data 
requirements are more demanding and social 
distributions of key parameters are required. 
Trials are usually not designed or powered 
to detect subgroup effects as this requires 
additional resources, both for the collection 
and analysis of subgroup data. When health 
inequality impacts are a desired output of an 
intervention, the collection of SEP subgroup 
effectiveness data needs to be factored into 
the study protocol and budget.
Given the extra data requirements and 
costs involved, choices need to be made 
about when to conduct explicit health 
inequality analysis. When priority-setting 
decisions are being made around a set 
of potential interventions, as well as full 
economic evaluation studies to inform 
which interventions are both effective and 
cost-effective, the technical results of such 
evaluations need to be considered within a 
decision-making framework that explicitly 
considers health inequalities.60 Analysis 
of the health inequality impacts may also 
help with the restructuring of programs to 
encourage participation among lower SEP 
groups. The analysis can be done before they 
are implemented, but also retrospectively 
performed on existing programs. 
The methods of DCEA and ECEA are not 
widely used, however, future studies should 
consider using these techniques to provide 
policy makers with more useful information 
about the equity implications of policy 
options. When two or more interventions 
are being considered the inclusion of health 
inequality measures facilitates comparisons 
across key efficiency/equity objectives 
and should be included in future studies 
to enhance the information available to 
decision-makers. If financial impacts such 
as expenditure incurred or avoided are 
an important aspect of the policy, these 
should be included as part of the analysis. 
Equity weighting analysis can be used to 
quantify how much concern for equity is 
required when a trade-off between equity 
and cost-effectiveness is needed. It has been 
demonstrated that various weights can be 
applied, allowing the appropriate weight to 
be considered by decision makers along with 
stakeholders.11 Further research could gauge 
the usefulness of these methods for decision-
makers and stakeholders. It is important that 
results and inequality measures presented are 
easy to interpret. Feedback will be helpful to 
identify which health inequality measures are 
most useful in practice. 
Conclusions
As a reaction to growing policy concerns 
about health equity, there has been a move 
towards using CEA techniques to generate 
new information about the health equity 
implications of alternative policy options. The 
use of economic evaluation to investigate 
socioeconomic health inequality impacts 
of public health policies is relatively new 
and more work is required to allow ease of 
interpretation and comparison of measures 
being reported. The new techniques 
described have not been widely used to 
inform decision making, but it is hoped 
that these options are considered and used 
to provide policy makers with additional 
information about the health equity impacts 
of public health policies.
Lal et al.
2017 Online Australian and New Zealand Journal of Public Health 7
© 2017 The Authors
References
1. Department of the Prime Minister and Cabinet. Council 
of Australian Governments Report on Performance 2016. 
Canberra (AUST): Government of Australia; 2016.
2. Norman R, Hall J, Street D, Viney R. Efficiency and 
equity: A stated preference approach. Health Econ. 
2013;22(5):568-81.
3. Lim MK, Bae EY, Choi SE, Lee EK, Lee TJ. Eliciting public 
preference for health-care resource allocation in South 
Korea. Value Health. 2012;15(1):S91-S4.
4. Diederich A, Swait J, Wirsik N. Citizen participation in 
patient prioritization policy decisions: An empirical 
and experimental study on patients’ characteristics. 
PLoS One. 2012;7(5):1-10.
5. Dolan P, Tsuchiya A. Determining the parameters in a 
social welfare function using stated preference data: An 
application to health. Appl Econ. 2011;43(18):2241-50.
6. Wiseman V. Aggregating public preferences for 
healthcare: Putting theory into practice. Appl Health 
Econ Health Policy. 2004;3(3):171-9.
7. Schwappach DL. Resource allocation, social values 
and the QALY: A review of the debate and empirical 
evidence. Health Expect. 2002;5(3):210-22.
8. Abasolo I, Tsuchiya A. Is more health always better 
for society? Exploring public preferences that violate 
monotonicity. Theory Decis. 2013(4):539.
9. Lindholm L, Rosén M, Emmelin M. An epidemiological 
approach towards measuring the trade-off between 
equity and efficiency in health policy. Health Policy. 
1996;35(3):205-16.
10. Lindholm L, Rosen M, Emmelin M. How many lives 
is equity worth? A proposal for equity adjusted 
years of life saved. J Epidemiol Community Health. 
1998;52(12):808-11.
11. Cookson R, Mirelman AJ, Griffin S, Asaria M, Dawkins 
B, Norheim OF, et al. Using cost-effectiveness analysis 
to address health equity concerns. Value Health. 
2017;20(2):206-12.
12. Johri M, Norheim OF. Can cost-effectiveness analysis 
integrate concerns for equity? Syst Rev. 2012;28(2):125-32.
13. Cookson R, Drummond M, Weatherly H. Explicit 
incorporation of equity considerations into economic 
evaluation of public health interventions. Health Econ 
Policy Law. 2009;4(Pt 2):231-45.
14. Braveman P, Gruskin S. Defining equity in health. J 
Epidemiol Community Health. 2003;57(4):254-8.
15. Reidpath DD, Olafsdottir AE, Pokhrel S, Allotey P. The 
fallacy of the equity-efficiency trade off: Rethinking 
the efficient health system. BMC Public Health. 2012;12 
Suppl 1:1-5.
16. Wilkinson R, Marmot M. The Social Determinants of 
Health: The Solid Facts. Copenhagen (DNK): World 
Health Organisation; 2003.
17. Marmot MG, Kogevinas M, Elston MA. Social/economic 
status and disease. Annu Rev Publ Health. 1987;8:111-35.
18. Adler NE, Boyce WT, Chesney MA, Folkman S, Syme SL. 
Socioeconomic inequalities in health. No easy solution. 
JAMA. 1993;269(24):3140-5.
19. Marmot M, Ryff CD, Bumpass LL, Shipley M, Marks 
JS. Social inequalities in health: Next questions and 
converging evidence. Soc Sci Med. 1997;44(6):901-10.
20. Clarke P, Leigh A. Death, dollars and degrees: 
Socioeconomic status and longevity in Australia. Econ 
Pap. 2011;30(3):348-55.
21. Hayward MD, Crimmins EM, Miles TP. The significance of 
socioeconomic status in explaining the gap in chronic 
health conditions. Am Sociol Rev. 2000;65(6):910-30.
22. Williams DR, Collins C. US socioeconomic and racial 
differences in health: Patterns and explanations. Annu 
Rev Sociol. 1995;21:349.
23. Dubay LC, Lebrun LA. Health, behavior, and health 
care disparities: Disentangling the effects of income 
and race in the United States. Int J Health Serv. 
2012;42(4):607-25.
24. Farmer MM, Ferraro KF. Are racial disparities in health 
conditional on socioeconomic status? Soc Sci Med. 
2005;60(1):191-204.
25. Crombie L, Irvine L, Elliott L, Wallace H. Closing the 
Health Inequalities Gap: An International Perspective. 
Copenhagen (DNK): World Health Organization; 2005.
26. Verguet S, Murphy S, Anderson B, Johansson KA, Glass 
R, Rheingans R. Public finance of rotavirus vaccination 
in India and Ethiopia: An extended cost-effectiveness 
analysis. Vaccine. 2013;31(42):4902-10.
27. Rheingans R, Anderson Iv JD, Anderson B, Chakraborty 
P, Atherly D, Pindolia D. Estimated impact and cost-
effectiveness of rotavirus vaccination in India: Effects of 
geographic and economic disparities. Vaccine. 2014;32 
Suppl 1:A140-A50.
28. Johansson KA, Memirie ST, Pecenka C, Jamison DT, 
Verguet S. Health gains and financial protection from 
pneumococcal vaccination and pneumonia treatment 
in ethiopia: results from an extended cost-effectiveness 
analysis. PLoS One. 2015;10(12):e0142691.
29. Levin CE, Sharma M, Olson Z, Verguet S, Shi J-F, Wang 
S-M, et al. An extended cost-effectiveness analysis of 
publicly financed HPV vaccination to prevent cervical 
cancer in China. Vaccine. 2015;33(24):2830-41.
30. Blakely T, Kvizhinadze G, Karvonen T, Pearson AL, Smith 
M, Wilson N. Cost-effectiveness and equity impacts of 
three HPV vaccination programmes for school-aged 
girls in New Zealand. Vaccine. 2014;32(22):2645-56.
31. Driessen J, Olson ZD, Jamison DT, Verguet S. Comparing 
the health and social protection effects of measles 
vaccination strategies in Ethiopia: An extended cost-
effectiveness analysis. Soc Sci Med. 2015;139:115-22.
32. Verguet S, Laxminarayan R, Jamison DT. Universal public 
finance of tuberculosis treatment in India: An extended 
cost-effectiveness analysis. Health Econ. 2015;24(3): 
318-32.
33. Verguet S, Gauvreau CL, Mishra S, MacLennan M, 
Murphy SM, Brouwer ED, et al. The consequences 
of tobacco tax on household health and finances 
in rich and poor smokers in China: An extended 
cost-effectiveness analysis. Lancet Glob Health. 
2015;3(4):e206-16.
34. Over EA, Feenstra TL, Hoogenveen RT, Droomers 
M, Uiters E, van Gelder BM. Tobacco control policies 
specified according to socioeconomic status: Health 
disparities and cost-effectiveness. Nicotine Tob Res. 
2014;16(6):725-32.
35. Dallongeville J, Dauchet L, de Mouzon O, Requillart V, 
Soler LG. Increasing fruit and vegetable consumption: 
A cost-effectiveness analysis of public policies. Eur J 
Public Health. 2011;21(1):69-73.
36. Asaria M, Griffin S, Cookson R, Whyte S, Tappenden 
P. Distributional cost-effectiveness analysis of health 
care programmes - a methodological case study of the 
UK bowel cancer screening programme. Health Econ. 
2015;24(6):742-54.
37. Allen K, Pearson-Stuttard J, Hooton W, Diggle P, 
Capewell S, O’Flaherty M. Potential of trans fats policies 
to reduce socioeconomic inequalities in mortality from 
coronary heart disease in England: Cost effectiveness 
modelling study. BMJ. 2015;351:h4583.
38. Gulliford M, Charlton J, Bhattarai N, Rudisill C. Social and 
material deprivation and the cost-effectiveness of an 
intervention to promote physical activity: Cohort study 
and Markov model. J Public Health. 2014;36(4):674-83.
39. Rush E, Obolonkin V, McLennan S, Graham D, Harris 
JD, Mernagh P, et al. Lifetime cost-effectiveness of a 
through-school nutrition and physical programme: 
Project Energize. Obes Res Clin Pract. 2014;8(2):e115-22.
40. Banham D, Lynch J, Karnon J. An equity-effectiveness 
framework linking health programs and healthy life 
expectancy. Aust J Prim Health. 2011;17(4):309-19.
41. The World Bank. Countries and Economies. Washington 
(DC): World Bank Group; 2016.
42. An R. Nationwide expansion of a financial incentive 
program on fruit and vegetable purchases among 
Supplemental Nutrition Assistance Program 
participants: A cost-effectiveness analysis. Soc Sci 
Med. 2015;147:80-8.
43. Barton GR, Goodall M, Bower P, Woolf S, Capewell 
S, Gabbay MB. Increasing heart-health lifestyles in 
deprived communities: Economic evaluation of lay 
health trainers. J Eval Clin Pract. 2012;18:835-40.
44. Goyder E, Hind D, Breckon J, Dimairo M, Minton J, 
Everson-Hock E, et al. A randomised controlled trial and 
cost-effectiveness evaluation of ‘booster’ interventions 
to sustain increases in physical activity in middle-aged 
adults in deprived urban neighbourhoods. Health 
Technol Assess. 2014;18(13):1-210.
45. Johnson-Masotti AP, Pinkerton SD, Sikkema KJ, Kelly 
JA, Wagstaff DA. Cost-effectiveness of a community-
level HIV risk reduction intervention for women living 
in low-income housing developments. J Prim Prev. 
2005;26(4):345-62.
46. Ruger JP, Weinstein MC, Hammond SK, Kearney MH, 
Emmons KM. Cost-effectiveness of motivational 
interviewing for smoking cessation and relapse 
prevention among low-income pregnant women: 
A randomized controlled trial. Value Health. 
2008;11:191-8.
47. Wilson KJ, Brown HS 3rd, Bastida E. Cost-effectiveness 
of a community-based weight control intervention 
targeting a low-socioeconomic-status Mexican-origin 
population. Health Promot Pract. 2015;16(1):101-8.
48. Barfar E, Rashidian A, Hosseini H, Nosratnejad S, Barooti 
E, Zendehdel K. Cost-effectiveness of mammography 
screening for breast cancer in a low socioeconomic group 
of Iranian women. Arch Iran Med. 2014;17(4):241-5.
49. Crane LA, Leakey TA, Ehrsam G, Rimer BK, Warnecke 
RB. Effectiveness and cost-effectiveness of multiple 
outcalls to promote mammography among low-
income women. Cancer Epidemiol Biomarkers Prev. 
2000;9:923-31.
50. Finkelstein EA, Khavjou O, Will JC. Cost-effectiveness 
of WISEWOMAN, a program aimed at reducing heart 
disease risk among low-income women. J Womens 
Health. 2006;15(4):379-89.
51. Pukallus M, Plonka K, Kularatna S, Gordon L, Barnett 
AG, Walsh L, et al. Cost-effectiveness of a telephone-
delivered education programme to prevent early 
childhood caries in a disadvantaged area: A cohort 
study. BMJ Open. 2013;3(5). pii:e002579.
52. Gustafson A, Khavjou O, Stearns SC, Keyserling 
TC, Gizlice Z, Lindsley S, et al. Cost-effectiveness 
of a behavioral weight loss intervention for low-
income women: The Weight-Wise Program. Prev Med. 
2009;49(5):390-5.
53. Lawson KD, Fenwick EA, Pell AC, Pell JP. Comparison 
of mass and targeted screening strategies for 
cardiovascular risk: Simulation of the effectiveness, 
cost-effectiveness and coverage using a cross-sectional 
survey of 3921 people. Heart. 2010;96(3):208-12.
54. Schweitzer ME, French MT, Ullmann SG, McCoy CB. 
Cost-effectiveness of detecting breast cancer in lower 
socioeconomic status African American and Hispanic 
women through mobile mammography services. Med 
Care Res Rev. 1998;55:99-115.
55. Goldstein JA, Winston FK, Kallan MJ, Branas CC, 
Schwartz JS. Medicaid-based child restraint system 
disbursement and education and the Vaccines for 
Children Program: comparative cost-effectiveness. 
Ambul Pediatr. 2008;8(1):58-65.
56. Wilson ECF, Peacock SJ, Ruta D. Priority setting in 
practice: What Is the best way to compare costs and 
benefits? Health Econ. 2009;18(4):467-78.
57. Mackenbach JP, Kunst AE. Measuring the magnitude of 
socio-economic inequalities in health: An overview of 
available measures illustrated with two examples from 
Europe. Soc Sci Med. 1997;44(6):757-71.
58. Wailoo A, Tsuchiya A, McCabe C. Weighting must 
wait: incorporating equity concerns into cost-
effectiveness analysis may take longer than expected. 
PharmacoEconomics. 2009;27(12):983-9.
59. Rubin RM, Chang CF. A bibliometric analysis of health 
economics articles in the economics literature: 1991-
2000. Health Econ. 2003;12(5):403-14.
60. Ananthapavan J, Sacks G, Moodie M, Carter R. 
Economics of obesity — learning from the past to 
contribute to a better future. Int J Environ Res Public 
Health. 2014;11(4):4007-25.
Supporting Information
Additional supporting information may be 
found in the online version of this article:
Supplementary Table 1: Cost-utility and 
Cost-effectiveness Studies including SEP 
subgroup analyses.
Supplementary Table 2: Studies examining 
only a low SEP group.
Equity in public health economic analyses
54 
 
3.3 Equity Weights 
The literature describes two ways to apply health equity weights in to an outcome 
of interest. Specifically, by i) specifying ‘equity weights’ for health benefits to 
different groups of people; or ii) specifying ‘equity parameters’ (reviewed in the 
journal article) that quantify the degree of importance placed on health equity 
versus health maximization2. In both approaches, sensitivity analysis would be 
conducted to demonstrate how much concern for reducing inequality is required 
(eg high or low) to endorse either a fairer or a health maximising option.  
3.3.1 Equity weights for health benefits 
The application of benefit-side equity weights can compensate for health 
inequalities by weighting QALYs according to characteristics of the people 
receiving them. These weights can quantitatively express the extent to which 
society is willing to trade overall health benefits to promote a more equitable 
distribution of health. If the health gains of a group are valued more highly, the 
equity weight for that group would exceed 1. The weights can then be used to 
adjust the QALY gains resulting from an intervention in that group to be relatively 
higher than the group without weights (Norman et al., 2013). The weighting of 
QALYs of disadvantaged groups greater than 1, fits under the vertical equity 
                                                 
2 A cost-side equity weight has also been proposed for use in the economic evaluation of primary 
healthcare services in Australian Indigenous populations (Ong et al., 2009) This weight is based on 
the 'processes' of health service delivery for the definition of equity that is' equitable access for 
unequal need'. The amount of resources to be reallocated to these groups to achieve more 
equitable access must be ascertained to derive the weight.  
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approach, whereby those who have different needs receiving appropriately 
different amounts of health resources (Mooney, 2007). The equity weights are 
considered a type of non-utility information that may be derived from a number of 
sources (Hurley, 2014).  
A systematic review of the literature was conducted to identify papers that had 
derived health equity weights for socioeconomic position. The following searches 
were carried out on Medline complete, Health Economic Evaluations Database 
and EconLit: (“equalit*” OR “inequity” OR “inequalit*” OR “efficiency”) AND 
("equity weight*" OR “social welfare function”). All original research articles, 
reviews, commentaries or editorials were open for inclusion. Additional 
snowballing searches of reference lists were undertaken.  The search strategies 
yielded a total of 118 unique records of which 25 were selected based on the 
relevant criteria for full text screening and 4 were retained for review (Figure 4). 
Four studies have calculated equity weights for SEP using empirical surveys to 
elicit preferences from either public opinion (Dolan and Tsuchiya, 2011; Norman et 
al., 2013; Wiseman, 2004) or politicians (Lindholm et al., 1998). There are several 
ways of estimating weights, such as through willingness-to-pay, person trade-off 
exercises or discrete choice experiments (Cookson et al., 2009). Typically, 
respondents are surveyed and asked to make choices designed to reveal the extent 
to which they would choose equality (equal benefits received by all groups) or 
equity (more benefits to the lowest SEP group). Of the four studies that based 
their weights on stated preferences for whether a low SEP group should be given 
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priority for health programs over a high SEP group, all found the majority of 
people were willing to give priority to the low SEP group.  
Figure 4. Literature search strategy  
 
 
 
 
 
 
 
 
However, each study used a different approach to elicitation of preferences and for 
the derivation of weights, resulting in quite different magnitudes for the derived 
weights. Table 1 details these studies, the methods used and the weights derived.  
Two of the studies originated from Australia. Firstly, Wiseman et al. (2004) asked 
participants to allocate a budget of $10m to programs benefiting low and high 
income groups, however further details about the specific question asked were not 
provided. However, the quality of this study (Wiseman, 2004) is questionable, 
Records identified through 
database searching  
  
Sc
re
en
in
g 
In
cl
ud
ed
 
El
ig
ib
ili
ty
 
Id
en
tif
ic
at
io
Additional records identified 
through reference checking 
    
Records after duplicates removed   
(n =118) 
Full-text articles 
assessed for eligibility  
(n = 25) 
Full-text articles excluded, 
with reasons (n =21) 
Not about equity weights  
(n= 18) 
Not about socioeconomic 
groups (n=3) 
Studies included in 
review (n = 4) 
57 
 
with regard to: i) 50% of the 373 respondents being based on a convenience 
sample; ii) problems that respondents experienced in answering the questions; 
and iii) 20%-27% of the sample did not answer the priority setting questions. 
While the authors derived weights from two different methods, guidance on 
intended use was not provided and conclusions were not made about which 
method was best or which weights were the most appropriate. The second 
Australian study (Norman et al., 2013) combined various dimensions such as 
gender, smoking status and income, in a discrete choice experiment. They 
estimated utility functions based on the gain in life expectancy and the 
characteristics of the hypothetical population group. While many weights were 
derived, a separate weight for SEP was not.  
Dolan et al. (2011) used stated preferences from the general public in England, who 
were asked to choose between two health programs that varied in the number of 
years of life that would be added to low and high SEP groups. The results seem 
plausible, but because this was conducted in the UK, they may be context specific.  
Lindholm et al. (1998) surveyed Swedish politicians who were asked to choose 
between programs designed to prevent myocardial infarction deaths amongst blue 
or white collar workers. This resulted in a situation specific weight for 
cardiovascular disease. Scandinavian countries also have a strong 
egalitarian/solidarity orientation (Bendixsen et al., 2017) that may not transfer 
readily to other countries. 
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Table 1. Studies including equity weight elicitation 
Study, 
Country Participants 
Framing of SEP variable in 
questionnaire Weighting method 
Results 
Preference 
given to 
low SEP 
group?  
Weights 
Norman et 
al (2013), 
Australia 
n=616, general 
population 
Binary levels for dimensions of 
gender, smoking status, income, 
whether the individual maintained a 
healthy lifestyle, carer status and total 
life expectancy. Asked to choose 
between two programs each 
impacting on the health of 100 
people. 
Marginal utility of gain in life expectancy. 
Utility function based on increase in life 
expectancy if the policy was implemented 
and the set of recipient characteristics. Use 
of random effects probit models. The value 
of an additional year of life for a 
hypothetical group is divided by the value of 
an additional year for the reference group.  
Yes  Various and no 
separate 
weight for SEP. 
Weights range 
0.17–1.68. 
Dolan et al 
(2011), UK 
n=417, general 
population 
Choice between Program A life 
expectancy gains in the highest social 
class or Program B gains in lowest 
social class. 
Marginal rates of substitution in a social 
welfare function. Degree of aversion to 
inequality also measured. 
Yes 6.8–9.9 
Wiseman et 
al (2014), 
Australia 
n=374 citizens 
attending 
medical clinics 
How to allocate $AUD10m to: (1) Low 
SEP assuming household income of 
$30,000 per year; and (2) High SEP 
assuming household income of 
$100,000 per year. 
1) Cardinal pie method (PM): sum 
allocations of each individual for each 
option and derive average total expenditure. 
2) Cardinal rank ordering (RO): constructed 
from the PM preference set.  
Yes Targeting low 
SEP program 
7.4, 6.4, 6.6. 
Targeting high 
SEP program 
2.6, 3.6, 3.4. 
Lindholm et 
al (1998), 
Sweden 
n=449 
politicians 
A scenario describing a trade-off 
between a health maximisation 
program and equity. Program A 
results in an unequal distribution of 
health. Program B has a smaller effect 
than A, but leads to an equal 
distribution of health. 
Inequity aversion (E) is defined as the ratio 
between health effects per number of 
population for program A and program B. 
1−E is the weight society attaches to equity 
in health. 
Yes 0.85 specific to 
cardiovascular 
disease 
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Because of the different methods used to calculate weights for SEP in these 
studies, it is not known whether results differ due to the method employed or due 
to underlying preferences. Adding to this, results may well be context specific, 
which makes generalisability more difficult. Unpacking these influences requires 
further research, particularly research where differences in method are not a 
confounding factor.  
There are inherent issues with using individual preference data. Firstly, the 
framing of the questions can influence responses; secondly, the public may not 
have carefully considered judgements about complex distributive issues; and 
thirdly, majority opinion can be ethically unacceptable (Johri and Norheim, 2012). 
For these reasons, it has been argued that public opinion by itself may not be 
appropriate to determine the specific value of weights (Johri and Norheim, 2012).  
Methods for deriving weights for SEP that are not based on people’s preferences 
are to date limited to one study. This study entailed a situation where distributing 
the same resource per capita to each SEP group would increase the inequalities 
due to different intervention effect sizes (Banham et al., 2011). The approach 
suggests the use of a benchmark, such as the highest SEP quintile intervention 
effect, and weights based on the difference between highest and lowest quintile 
specific intervention effects. This method, however, is limited to good quality 
studies being available to provide evidence of effectiveness by SEP. For many 
health interventions, however, such evidence can be difficult to obtain. 
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Equity weighting for SEP groups is not necessarily technically complicated, but has 
proven to be difficult to use in economic evaluation. Currently, there are no 
published studies that have used equity weights for SEP groups in any CEA. There 
is disagreement amongst economists as to whether this type of equity weighting 
should be used in practice. Not only is there debate surrounding the use of societal 
preferences for deriving the weights, but even if reliable weights are possible, some 
argue that decision-makers should just be presented with the facts about the 
health inequality impacts (Sassi et al., 2001).  
It is not the intention for equity-weighting analysis to be used as an algorithm for 
resource allocation decisions, applied in an automated way (Cookson et al., 
2017b). It is recommended that it be used as a tool to support decision-making, 
not to take the place of decision-making. Using different weights in sensitivity 
analysis allows the appropriate weight to be considered by decision-makers along 
with stakeholders (Cookson et al., 2017b).  
3.4 Equity constraint analysis 
Equity constraint analysis assesses the cost of selecting fairer but less cost-effective 
options, treating equity as a constraint rather than an objective (Cookson et al., 
2017b). Standard economic evaluation analyses are used to estimate the efficiency 
loss of choosing a more equitable option rather than a more cost-effective 
investment. They answer the question “how much benefit is forgone if a more 
equitable option is chosen?” The loss could be measured, for example, in money or 
life years. A simple version of this analysis would be to compare two programs: a 
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more equitable option that is less cost-effective and a more cost-effective 
investment that is less equitable (Cookson et al., 2017a). The loss in efficiency is 
the difference between the two. If multiple options are being considered, a 
mathematical programming framework can be used.  
Studies using this method have examined scenarios of equality of access to 
treatment of a particular disease versus health maximisation (Cleary et al., 2010; 
Earnshaw et al., 2002). As mentioned in the previous chapter, the approaches to 
equity in clinical care settings and public health are quite different and therefore 
some methods to incorporate equity are more suitable than others. Because 
obesity is more prevalent in low SEP groups, for example, denying the access of a 
program to low SEP groups would not be considered appropriate.  
In this thesis, equity is defined as equity of health outcomes, rather than equal 
access to treatments. Equity constraint analysis is therefore not considered further 
in this thesis.  
3.5 Summary and research gaps 
The review of studies that have incorporated equity impact analysis into CEA of 
public health interventions highlights that this type of analysis is relatively new 
and rarely performed. The use of health inequality measures is uncommon, but is 
a constructive way forward where the aim is to compare different intervention 
options for their health inequality impact, allowing ease of comparison and 
ranking of the interventions. Only one published study of a CEA of an obesity 
prevention intervention used a distributional analysis.  
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In Australia, there have been no previously published studies that have 
incorporated equity impact analyses into economic evaluations of obesity 
prevention policies. This gap provided the rationale for incorporating an equity 
impact analysis into research on obesity prevention policy for Australia. Chapter 4 
seeks to fill this gap, conducting a study of the potential cost-effectiveness, health 
gains, and financial impacts by SEP of a 20% sugar-sweetened beverage (SSB) tax 
for Australia. 
Currently, the derivation of equity weights for SEP has relied on surveys of 
people’s preferences, but there is no consensus on the algorithm for deriving 
equity weights (Cookson et al., 2017b). Because of the different methods used for 
the calculation of weights, it is not known whether the magnitudes differ due to 
methodological confounding or due to underlying preferences. The equity weights 
for socioeconomic position that have been derived to date are unsatisfactory for 
practical application of CEA in Australia. An important aim of this thesis 
therefore, is to derive equity weights to be applied to health benefits of 
disadvantaged groups for use in economic appraisal in Australia, using various 
methods. In Chapter 5, people’s preferences expressed in health-related social 
welfare functions are used to derive the equity weights. I chose Dolan’s et al. (2011) 
methods, because of its suitability to our context of examining preferences for 
health gains according to SEP, as well as ease of execution and the current need 
for studies with consistent methods. In Chapter 6 the derivation of equity weights 
is presented using two more methods. Firstly, by deriving equity weights based on 
people’s preferences using a discrete choice experiment; and secondly, by deriving 
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equity weights based on epidemiological differences between SEP groups. To my 
knowledge, the latter approach has not been previously used.  
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Chapter 4. Cost-effectiveness and equity of a sugar sweetened  
beverage tax in Australia 
This study addresses the first specific aim of this thesis: How can the 
quantification of equity for socioeconomic position be incorporated in cost-
effectiveness analyses of obesity prevention policies. It entails a study which 
incorporated equity analysis into the CEA of a specific intervention targeting 
obesity prevention. The study outcomes are presented as a published journal 
article.   
Lal A, Mantilla-Herrera AM, Veerman L, Backholer K, Sacks G, Moodie M, Siahpush 
M, Carter R, Peeters A. (2017) Modelled health benefits of a sugar sweetened 
beverage tax across different socioeconomic groups in Australia: a cost-effectiveness 
and equity analysis. PLoS Med 14(6). 
What is already known about the topic? 
Previous real-world evaluations of a sugar-sweetened beverage (SSB) tax showed 
that the SSB tax led to a reduction of SSB purchases for the total population, with 
larger effects for lower-income households. It was unknown what the healthcare 
cost savings, health gains, and financial impacts of an SSB tax would be for 
different income groups, in Australia or internationally. 
What does the paper add to existing knowledge? 
The study predicts that the greatest health gains would accrue to the two lowest 
quintiles (most disadvantaged) of the Australian population, leading to the highest 
healthcare cost savings in these quintiles, to both the government and to 
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individuals. The increase in annual expenditure on SSBs is estimated to be AUD35 
per capita in the lowest quintile, a difference of less than $5 compared to the 
highest quintile. Health equity analysis revealed that under five different tax 
scenarios, the health gains would be concentrated in the most disadvantaged 
groups in all scenarios.  
What insights does the paper provide for informing policy decision 
making?  
The SSB tax analysis predicts that this policy is a ‘win-win’ in terms of cost-
effectiveness and increasing health equity. One of the arguments raised against an 
SSB tax is that it affects the most disadvantaged groups the hardest financially. 
The analysis shows that whilst the most disadvantaged group would pay the most 
tax per capita, the difference in tax paid between the lowest and highest group 
would be small and there would be greater out-of-pocket healthcare costs saved in 
the most disadvantaged group. The tax would be cost saving, with every $1 spent 
returning $17 in healthcare costs savings over the life course. It would also 
generate substantial annual tax revenue of over $640m that could be invested into 
programs for disadvantaged groups. 
  


7.  Data storage 
The original data for this project are stored in the following locations. (The locations must be within an appropriate 
institutional setting. If the executive author is a Deakin staff member and data are stored outside Deakin 
University, permission for this must be given by the Head of Academic Unit within which the executive author is 
based.) 
Data format Storage Location Date lodged Name of custodian if other 
than the executive author 
Excel file Deakin Health 
Economics folder 
various  
This form must be retained by the executive author, within the school or institute in which they are based. 
If the publication is to be included as part of an HDR thesis, a copy of this form must be included in the thesis 
with the publication. 
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Abstract
Background
A sugar-sweetened beverage (SSB) tax in Mexico has been effective in reducing consump-
tion of SSBs, with larger decreases for low-income households. The health and financial
effects across socioeconomic groups are important considerations for policy-makers. From
a societal perspective, we assessed the potential cost-effectiveness, health gains, and
financial impacts by socioeconomic position (SEP) of a 20% SSB tax for Australia.
Methods and findings
Australia-specific price elasticities were used to predict decreases in SSB consumption for
each Socio-Economic Indexes for Areas (SEIFA) quintile. Changes in body mass index
(BMI) were based on SSB consumption, BMI from the Australian Health Survey 2011–12,
and energy balance equations. Markov cohort models were used to estimate the health
impact for the Australian population, taking into account obesity-related diseases. Health-
adjusted life years (HALYs) gained, healthcare costs saved, and out-of-pocket costs were
estimated for each SEIFA quintile. Loss of economic welfare was calculated as the amount
of deadweight loss in excess of taxation revenue. A 20% SSB tax would lead to HALY gains
of 175,300 (95% CI: 68,700; 277,800) and healthcare cost savings of AU$1,733 million (m)
(95% CI: $650m; $2,744m) over the lifetime of the population, with 49.5% of the total health
gains accruing to the 2 lowest quintiles. We estimated the increase in annual expenditure on
SSBs to be AU$35.40/capita (0.54% of expenditure on food and non-alcoholic drinks) in the
lowest SEIFA quintile, a difference of AU$3.80/capita (0.32%) compared to the highest quin-
tile. Annual tax revenue was estimated at AU$642.9m (95% CI: $348.2m; $1,117.2m). The
main limitations of this study, as with all simulation models, is that the results represent only
the best estimate of a potential effect in the absence of stronger direct evidence.
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Conclusions
This study demonstrates that from a 20% tax on SSBs, the most HALYs gained and health-
care costs saved would accrue to the most disadvantaged quintiles in Australia. Whilst
those in more disadvantaged areas would pay more SSB tax, the difference between areas
is small. The equity of the tax could be further improved if the tax revenue were used to fund
initiatives benefiting those with greater disadvantage.
Author summary
Why was this study done?
• Previous real-world evaluations of a sugar-sweetened beverage (SSB) tax showed that
the SSB tax led to a reduction of SSB purchases for the total population, with larger
effects for lower-income households.
• It was unknown what the healthcare cost savings, health gains, and financial impacts of
an SSB tax would be for different income groups, in Australia or internationally.
What did the researchers do and find?
• We modelled the effect of a 20% SSB tax in Australia on life expectancy and health-
adjusted life years before and after implementation of the tax, across quintiles of area-
level socioeconomic deprivation.
• Our model predicts that the greatest health gains would accrue to the 2 lowest quintiles
(most disadvantaged), leading to the highest healthcare cost savings in these quintiles.
• We estimate the increase in annual expenditure on SSBs to be AU$35 per capita in the
lowest quintile, a difference of less than $5 compared to the highest quintile.
• Annual tax revenue was estimated at over AU$640 million.
What do these findings mean?
• A 20% SSB tax in Australia is likely to decrease SSB purchase and consumption, leading
to significant health gains and healthcare expenditure savings across all quintiles of
socioeconomic deprivation.
• The tax would generate considerable yearly revenue, which the government could use to
further improve the health of the most disadvantaged.
• As with all simulation models, the model results represent the best estimate of a poten-
tial effect in the absence of stronger direct evidence.
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Introduction
In high-income countries, obesity is more common in the most disadvantaged groups [1].
Reducing inequalities in health between advantaged and disadvantaged groups is an important
objective of public health policy [2]. The evidence of the association between sugar-sweetened
beverage (SSB) intake and increased energy intake, leading to weight gain and obesity, is com-
pelling [3,4]. Obesity is a strong risk factor for diabetes, cardiovascular disease, some cancers,
osteoarthritis, and hypertension [5–7]. Individuals from lower socioeconomic groups have
been found to consume more SSBs [8,9]. The prevalence of obesity-related comorbidities is
also higher in lower socioeconomic groups.
A tax on SSBs is considered to be an important component of the set of recommended pol-
icy approaches to address population obesity [10–12]. Price influences SSB purchase [13],
which in turn may reduce the rate of obesity [14]. There is an economic rationale for taxes
when consumption results in negative externalities. In Australia, the diseases caused by obesity
were estimated to cost tax payers AU$5.3 billion in healthcare costs, forgone tax, and welfare
payments in 2014/2015 [15]. The economic rationale for an SSB tax essentially rests on the
notion of ‘internalising the externality’ within the purchase price.
There is evidence that people with lower incomes are more sensitive to price increases [16]
and are therefore more likely to change their purchasing behaviour in response to price
changes. In Mexico, an evaluation of an SSB tax of approximately 10% introduced in 2014
showed a reduction in purchases of taxed beverages for the total population, with an even
larger effect for lower-income households [17,18].
The financial impact of an SSB tax for different socioeconomic position (SEP) groups has
been examined in terms of the predicted tax burden to individuals and households. A recent
systematic review describing the financial burden of an SSB tax across different SEP groups
identified 5 studies, which found that the tax would be financially regressive, but with small
differences of approximately US$5 between high- and low-income households; the average
additional tax paid per household as a result of the SSB tax would be less than US$30 annually
across all groups [19]. Previous Australian research has predicted that an SSB tax would lead to
cost savings in the health sector [20,21]. But the effect on overall healthcare cost savings and
the health gains in health-adjusted life years (HALYs) across SEP groups have rarely been pre-
viously examined. The overall financial impact on individuals includes the potential healthcare
costs saved by individuals, and this also has seldom been previously estimated across SEP
groups. A rate of 20% is the most commonly advocated tax by public health experts [22]. South
Africa and the UK have recently proposed taxes of this magnitude [23]. The main aim of this
paper, therefore, is to examine the health and financial impacts of a 20% SSB sales tax for Aus-
tralia across socioeconomic groups by comprehensively integrating distributional aspects into
the cost-effectiveness analysis.
This study expands on previous studies in a number of ways. First, the cost-effectiveness
of a 20% SSB tax for Australia by SEP subgroup was estimated, including a wide range
of SSBs and substitute beverages, with a focus on the quantity and distribution of health
gains in HALYs according to an area-based measure of socioeconomic disadvantage,
Socio-Economic Indexes for Areas (SEIFA). Second, the distribution of financial impacts to
individuals across different SEP groups was examined, in terms of out-of-pocket costs
incurred from the tax and healthcare costs saved. Third, the overall economic impact of the
tax was examined in terms of the balance of effects for the health sector and the general
economy.
Cost-effectiveness and equity SSB tax by socioeconomic groups
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Methods
Specification of the tax
A 20% sales tax on SSBs in Australia was modelled. SSBs included soft drinks (pop, soda); fla-
voured water; sports, energy, and fruit drinks; and cordials (concentrates) containing added
sugar. It was assumed that the full amount of the tax would be passed on to the consumer.
Overview
The model estimated the differences in life expectancy and HALYs pre- and post- implementa-
tion of the tax. These differences were based on predicted variations in 9 diseases caused by
obesity. Changes to body mass index (BMI) were modelled based on projected changes in SSB
consumption.
The Australian population aged 2–100 years was modelled over a lifetime, with covariates
based on the Australian Health Survey (AHS) 2011–12 [24] and disease epidemiology based
on a study of the US burden of diseases, injuries, and risk factors in 2010 [25]. The analysis has
2 parts: (1) a whole population analysis and (2) analyses by SEIFA quintile. Fig 1 illustrates the
logic pathway of an SSB tax, identifying the steps involved in measuring the expected impact
of the tax from an obesity perspective.
Assessment of benefit
Effect of the tax on body weight. For the whole population analysis, baseline intake of
drinks was based on data from the AHS 2011–12 [24]. Dietary data were collected based on
24-hour dietary recall on 2 separate days. Mean daily intake of each category of SSB and substi-
tutes of tea, coffee, milk, and 100% fruit juice were extracted from the survey using Stata 14
[26]. Mean intake was calculated by sex, in 5-year age groups.
For the SEP subgroup analyses, individuals in the survey were categorised by SEIFA Index
of Relative Socio-Economic Disadvantage (IRSD) deciles, which were converted to quintiles.
The SEIFA quintiles represent groups of individuals who live in similarly ranked areas, based
on a range of information such as the income, qualifications, and occupation skills of the area
residents [27]. Mean SSB intake for the quintiles was not extracted by age group as the groups
were too small. However, an age multiplier was applied based on proportions of intake by age
from the total population (see S1 Table for mean intake).
The change in intake of SSBs associated with a 20% tax was based on an Australian study
that derived own-price elasticities and cross-price elasticities from Australian household
supermarket purchases and a mathematical demand system model [28]. Own-price elasticities
represent the proportional change in SSB purchases in response to a change in SSB price.
Cross-price elasticities represent the proportional change in purchases of other substitute
drinks (such as coffee) in response to a change in SSB price. We applied the price elasticities
derived for the low- and high-income households, respectively, to the consumption of SSBs in
the lowest and highest SEIFA quintile [28]. The price elasticities for the middle-income house-
holds were applied to SEIFA quintile 3. The price elasticities for quintiles 2 and 4 were interpo-
lated using linear trends estimation from quintiles 1, 3, and 5 in Excel (see S2 Table). The
reductions in quantities of SSBs consumed and increases in substitute drinks consumed were
converted to kilojoule equivalents using nutrient tables for Australia (NUTTAB, 2010) [29].
Estimated changes in body weight for adults were calculated based on published relation-
ships between changes in energy expenditure and body weight at the population level. Changes
in body weight for adults were based on a change of 100 kilojoules per day equalling a 1-kg
change in weight, taking 3 years to achieve the total weight change [30]. The following
Cost-effectiveness and equity SSB tax by socioeconomic groups
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formulas were used for children [31]:
Boys : kilojoules per day per kilogram ¼ 68   2:5  age  4:184 ð1Þ
Girls : kilojoules per day per kilogram ¼ 62   2:2  age  4:184 ð2Þ
These changes in weight were converted to changes in BMI using average Australian height
and weight by gender and single-year age groups up to 19 years and 5-year age groups thereaf-
ter from the AHS 2011–12 [24].
Modelling health outcomes. We used a recently developed model (CRE-Obesity model)
to estimate how a change in the distribution of the prevalence of overweight and obesity
caused by an intervention impacts the epidemiology of several obesity-related diseases, which
in turn influence the total HALYs in the population. This model was based on the Assessing
Cost-Effectiveness in Prevention (ACE-Prevention) obesity model [32,33], which has previ-
ously been used to model the cost-effectiveness of several obesity interventions [34–36]. We
extended the model by considering the incremental costs and benefits by SEIFA quintile, as
well as by including children and adolescents.
The model uses a multi-state, multiple cohort life table approach to translate changes in
mean BMI following an intervention into corresponding HALYs gained. Potential impact frac-
tions were used to quantify the proportional reduction in disease incidence that would occur if
a population were subject to a counterfactual exposure to a risk factor because of an interven-
tion [37]. Disease-specific mortality and morbidity were then combined with all other causes
of mortality and morbidity from the population to estimate the total morbidity and mortality
in the total population. The diseases were diabetes mellitus, ischemic heart disease, stroke,
hypertensive heart disease, colorectal cancer, breast cancer, endometrial cancer, kidney cancer,
and osteoarthritis of the knee and hip.
The CRE-Obesity model calculates incremental HALYs, incremental costs, and cost-effec-
tiveness ratios. Using the SEIFA IRSD, we created quintile-specific sub-models by substituting
key input parameters with SEIFA-quintile-specific data. These parameters included disease
incidence [38–40], mortality rate [41], BMI distribution [42], and population number [43].
We modelled the SSB tax on SEIFA groups as a population-based intervention—that is, the
Fig 1. Logic pathway for modelling the health effects of a sugar-sweetened beverage tax. BMI, body mass index; HALY, health-adjusted life
year.
https://doi.org/10.1371/journal.pmed.1002326.g001
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lifetime health and cost effects from the tax altered the distribution of BMI among all ages (2–
100 years). For individuals aged 2–19 years, who were not modelled as experiencing the
included diseases, the disability related to obesity itself was quantified, using the health-related
quality of life lost due to obesity before and after the intervention, based on the difference
between quality-adjusted life year (QALY) weights [44]. Thus, HALYs gained due to an inter-
vention represent the number of years lived in full health gained, adjusted for morbidity of
obesity-related diseases, and obesity as a whole in the population aged less than 20 years.
Assessment of costs
Intervention costs. Intervention costs were assessed from both a government and indus-
try perspective over the lifetime of the population. In the absence of Australian data on the
administration and compliance costs of implementing a soft drink tax, costing methods from
a US study of 2 states operating an excise tax were converted to the equivalent Australian costs
[45]. Estimates of legislation costs of tobacco plain packaging in terms of establishment, imple-
mentation, ongoing compliance, and administration costs for the Australian Department of
Health, at AU$12.69 million (m) over 10 years, were used as a benchmark [46]. Administration
costs to the beverage industry were assumed to be equal to the costs to government, based on
sales tax evidence in the US [47].
A framework for costing new public health legislation was used to estimate the cost of pass-
ing legislation in the Australian parliament [47], with slight adjustments for the Australian
context. Briefly, it includes parliamentarians’ time, annual expenses for the House of Represen-
tatives and the Senate, legislation drafting, and publication and policy advice. As we could not
identify costs for policy advice in Australia, we used the equivalent Australian dollar costs
from New Zealand (NZ) (see S3 Table).
Healthcare costs. Treatment costs were based on Disease Costs and Impact Study (DCIS)
2001 data from the Australian Institute of Health and Welfare (AIHW) [48], inflated to 2010
prices using AIHW health price inflation values [49]. Costs included hospital services, out-of-
hospital medical services, pharmaceuticals, and health professionals. Healthcare expenditures
saved were estimated based on the predicted reduction in mortality and morbidity from the 9
diseases.
Out-of-pocket healthcare costs. Out-of-pocket healthcare costs are healthcare costs paid
for by individuals and include pharmaceuticals, medical services, practitioners, aids and appli-
ances, and hospital costs. Out-of-pocket healthcare costs by SEIFA quintile were based on the
percentage of individuals’ overall expenditure used for total healthcare expenditure, reported
by the AIHW in 2010 as 17.4% [49]. Proportions of mean household annual healthcare expen-
diture and total household expenditure, together with ‘equivalised’ disposable income by quin-
tile from the Australian Bureau of Statistics Household Expenditure Survey 2010 [50], were
used to calculate quintile-specific out-of-pocket healthcare costs as a percentage of overall
expenditure. Equivalisation is a technique in economics whereby members of a household
receive different weightings. Total household income is then divided by the sum of the weight-
ings to yield a representative income.
Deadweight loss (loss in economic welfare). Deadweight loss (DWL) is an economic
term used to describe the net loss in total economic welfare that can be attributed to the intro-
duction of a new tax or tax increase. The tax drives a price increase that leads to a fall in
demand; this in turn involves reduced benefits flowing to both consumers and producers. As a
result, there is a reduction in both consumer surplus (the difference between the value a con-
sumer places on a product and the price paid) and producer surplus (the price minus the eco-
nomic cost of producing the product) (refer to S1 Fig for additional detail). This loss in
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PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002326 June 27, 2017 6 / 17
economic welfare is calculated for each SSB category for each quintile and for the population
using the following formula:
DWL ¼ 0:5  ðP2—P1Þ  ðQ1—Q2Þ ð3Þ
where P1 is the original price of the SSBs, P2 is the new price of the SSBs, Q1 is the original
quantity demanded of the SSBs, and Q2 is the new quantity demanded of the SSBs.
The total loss of economic welfare is thus the amount of DWL in excess of the taxation reve-
nue collected by the government. There are also behavioural responses associated with these
inherently dynamic impacts that are not fully captured in this formula—desirably, industry
realigns to healthier products, consumers realign to healthier purchases, and the tax revenue
can be utilised for welfare-enhancing initiatives.
Out-of-pocket tax costs. Predicted tax paid per person due to the introduction of a 20%
SSB tax was calculated as the post-tax mean quantity demanded of each category of SSB con-
sumed multiplied by 20% of the current retail price. This assumes that the full burden of the
tax is borne by the consumer. We used prices sourced from a large Australian supermarket
website (Coles; http://www.colesonline.com.au). An average price per litre was taken from a
range of sizes and brands. Mean annual expenditure on food and non-alcoholic drinks by
‘equivalised’ disposable income quintile from the Australian Household Expenditure Survey
2010 [50] was used to calculate percentage of annual expenditure on food and non-alcoholic
drinks.
Tax revenue. The tax revenue predicted to be received by the government was calculated
by multiplying the per person out-of-pocket tax cost by the number of people in each popula-
tion group.
Cost-effectiveness analysis
Table 1 outlines the general methodology of the economic evaluation. The intervention was
assumed to be operating in ‘steady state’ (i.e., running at its full effectiveness potential) and
was measured against current practice. Establishment costs were included in the cost of the
intervention. The additional costs and the associated health benefits (HALYs) resulting from
Table 1. General economic evaluation methods.
Parameter Method
Perspective Societal perspective with costs split into health sector, other government,
industry, and private
Economic framework Cost—utility analysis by subgroup using Socio-Economic Indexes for Areas
(SEIFA) Index of Relative Socio-Economic Disadvantage quintiles, as well as
for the total population
Monetary unit of
measurement
Australian dollars
Base year 2010
Unit of measurement of
outcomes
Health-adjusted life years (HALYs) include disability-adjusted life years
(DALYs) for diseases prevented for adults and a quality of life adjustment for
disability attributed to obesity itself for those aged under 20 years (using
quality-adjusted life year [QALY] weights from the literature)
Comparator Current practice
Discount rate 3%, as recommended by a consensus panel of US health economists and
which approximates the real rate of return on long-term government bonds
[51]
Time frame Lifetime
https://doi.org/10.1371/journal.pmed.1002326.t001
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the tax were used to calculate incremental cost-effectiveness ratios (ICERs), defined as the dif-
ference in net costs of the tax compared to no tax, divided by the difference in net HALYs.
Uncertainty and sensitivity analysis
The impact of uncertainty around input values on the main outcome measures was estimated
by Monte Carlo simulations (Table 2). Means and 95% confidence intervals for BMI effects on
HALYs and intervention costs were reported based on 2,000 iterations using Ersatz version 1.3
software [52].
We performed several sensitivity analyses. We performed one-way sensitivity analyses to
explore the effect of including flavoured milk in the SSBs. As the price elasticity for flavoured
milk was not available, we assumed the same price elasticity as for soft drinks. We also tested
an SSB tax rate of 30% and a 50% pass-through of the 20% tax. Another mechanism for imple-
menting a tax—a 50¢ per litre volumetric tax was also tested. This is in line with alcoholic bev-
erages in Australia, which are taxed per litre of alcohol. A tax of 50¢ per litre is an average 17%
increase in price across all SSB categories.
Health equity analysis
A concentration index quantifies the degree of socioeconomic inequality in a specific health
variable. Concentration indices were calculated for each tax scenario (sensitivity analysis) to
quantify the degree to which HALYs gained are concentrated in disadvantaged groups. The
Table 2. Key model parameters.
Parameter Value 95% confidence
interval
Source and modelling parameters
Change in consumption and weight
Daily intake of SSB and substitutes See S1 Table See S1 Table Normal distribution of gender- and age-specific means from
the Australian Health Survey 2011–12
Own- and cross-price elasticities of demand See S1 Table Not specified Sharma et al. [28]; standard errors calculated based on Z
score with alpha 0.1, 2-tailed (probability 0.05)
Change in consumption of beverages to
change in weight
100-kJ/day
change = 1-kg change in
weight
Hall et al. [30]
Cost of implementing an SSB tax
Cost of passing legislation in parliament $1,090,000 $948,000–
$1,251,000
Gamma distribution, SE $77,497
Administration and compliance time costs
per million people (FTE, government and
industry)
0.32 0.10–0.54 Long et al. [45]
Field audit time costs per million people per
year (FTE, government and industry)
0.30 0.24–0.35 Samples drawn from beta distribution, Long et al. [45]
Field audit direct costs per million people
per year (government and industry)
$10,300 $13,800–
$17,200
Samples drawn from a gamma distribution (5th percentile
$10,300, 95th percentile $17,200) based on an estimate of
field audit direct costs [45]
Accountant yearly salary (government) $84,900 $78,500–
$91,250
Gamma distribution, SE $3,250; ABS mean salary for
accountants and auditors, code 2211, 2212*; assumes 14%
non-salary benefits [53]
Accountant yearly salary (industry) $98,400 $88,500–
$108,300
Gamma distribution, SE $5,044; ABS mean salary for
accountants and auditors, code 2211, 2212*; assumes 14%
non-salary benefits [53]
All costs are in Australian dollars. ABS, Australian Bureau of Statistics; FTE, full-time equivalent; SSB, sugar-sweetened beverage.
*Includes superannuation and payroll tax.
https://doi.org/10.1371/journal.pmed.1002326.t002
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index takes a negative value when HALY gains are greater amongst the most disadvantaged,
and a positive value when HALY gains are greater amongst the least disadvantaged. The con-
centration index was calculated for each tax scenario using the following formula [54]:
C ¼
2
u
XT
t  1
ftutRt   1 ð4Þ
where ut is the mean number of HALYs of the tth SEIFA group, ft is its population share, and
Rt is the fractional rank of SEIFA group t.
Results
Enacting a 20% SSB sales tax in Australia was estimated to result in greater decreases in weight
for the 3 most disadvantaged quintiles than for the 2 least disadvantaged quintiles for both
men and women, with larger decreases in men. Quintile 5 (least disadvantaged) had the lowest
predicted reductions in weight for men and women (Figs 2 and 3).
As a result of a 20% SSB tax, the Australian population was estimated to gain 175,300
HALYs (95% CI: 68,700; 277,800) and save 111,700 years of life (95% CI: 43,600; 175,800)
(Table 3). The HALY gains were highest in the 2 most disadvantaged quintiles, with 49.4% of
the total HALYs gained accruing to these quintiles. Quintile 5 had the lowest HALYs gained
and years of life saved for men and women.
The tax was estimated to be cost saving across all intervention scenarios (sensitivity analy-
ses) and all quintiles. Over the lifetime of the population cohort, expected healthcare cost sav-
ings were AU$1.73 billion, intervention costs were estimated to be AU$119.6m (95% CI:
$91.9m; $162.1m)—approximately $4.8m (95% CI: $3.9m; $6.1m) in the first year and $3.7m
Fig 2. Modelled mean weight decreases in men after introduction of a 20% sugar-sweetened beverage tax by quintile. Q1 is the
most disadvantaged quartile, and Q5 is the least disadvantaged quartile.
https://doi.org/10.1371/journal.pmed.1002326.g002
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Fig 3. Modelled mean weight decreases in women after introduction of a 20% sugar-sweetened beverage tax by quintile. Q1 is the
most disadvantaged quartile, and Q5 is the least disadvantaged quartile.
https://doi.org/10.1371/journal.pmed.1002326.g003
Table 3. Cost-effectiveness results of a 20% sugar-sweetened beverage tax.
Quintile 1 (most
disadvantaged)
Quintile 2 Quintile 3 Quintile 4 Quintile 5 Total
population
Total HALYs saved over lifetime (thousands) 52.3 (15.4, 85.2) 49.9 (28.2,
71.5)
48.8 (19.7,
75.3)
31.7 (26.3,
38.8)
27.4
(12.7,42.7)
175.3 (68.7,
277.8)
Total years of life saved over lifetime
(thousands)
39.9 (12.2, 65.0) 37.2 (21.3,
52.9)
37.1 (15.4,
57.2)
23.4 (20.0,
27.9)
21.0 (9.9,
32.4)
111.7 (43.6,
175.8)
Total healthcare cost savings over lifetime
(millions of dollars)
435.7 (308.1, 564.7) 429.8 (247.1,
606.0)
394.0 (334.9,
461.0)
293.8 (240.8,
358.1)
254.7 (217.5,
296.0)
1,732.9 (650.1,
2,744.0)
Healthcare cost savings per capita over
lifetime (dollars)
104 (74, 136) 103 (59, 146) 95 (74, 186) 71 (58, 86) 61 (52, 71) 83 (31,131)
Net cost per HALY saved Cost saving Cost saving Cost saving Cost saving Cost saving Cost saving
Out-of-pocket healthcare costs saved over
lifetime (millions of dollars)
33.7 (12.7, 53.4) 58.2 (21.8,
92.2)
55.3 (20.8,
87.6)
65.1 (24.4,
103.1)
89.1 (33.4,
141.1)
301.5 (113.1,
477.5)
Out-of-pocket healthcare costs saved as
percent of household expenditure
1.23% 1.43% 1.10% 1.06% 1.11% 1.17%
Out-of-pocket costs of tax (dollars per
person, yearly)
35.40 (18.70, 62.80) 31.10 (15.90,
56.10)
34.70 (21.40,
53.90)
28.90 (11.50,
52.70)
31.60 (17.70,
55.90)
31.30 (17.10,
55.40)
Out-of-pocket costs of tax as percent of
annual expenditure on food and non-alcoholic
drinks
0.54% 0.33% 0.31% 0.24% 0.22% 0.30%
Values in parentheses are 95% CIs; dollar amounts are in Australian dollars. Quintile totals do not add up to the population total as results are based on
quintile-specific data and populations. Lifetime costs and health-adjusted life years (HALYs) are discounted at 3%.
https://doi.org/10.1371/journal.pmed.1002326.t003
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(95% CI: $2.8m; $5.0m) in subsequent years, discounted at 3%. For every dollar invested in the
first 10 years, the tax would result in AU$17 (95% CI: $9; $19) in healthcare cost savings. The
tax revenue generated at the population level was estimated to be AU$642.9m annually (95%
CI: $348.2m; $1,117.2m).
For the total population, the out-of-pocket healthcare costs saved were estimated to be AU
$299.4m (95% CI: $113.8m; $476.2m). Healthcare cost savings as a percentage of household
expenditure by quintile were highest in the most disadvantaged groups. Per capita, the most
disadvantaged quintile was estimated to incur the most tax, at an estimated AU$35.40 (95%
CI: $18.70; $62.80) per year, or 0.54% of expenditure on food and non-alcoholic drinks.
The tax revenue raised outweighed the DWL for the total Australian population, with an
estimated net deadweight impact of +AU$587.9m (95% CI: +$329.2m, +$1,027.6m) per year.
The DWL was more than offset by tax revenue across all quintiles, with substantial net gains in
each quintile (Table 4).
Sensitivity analyses
The SSB tax remained cost saving when (1) the pass-through rate was 50%, (2) the rate of the
tax was 30%, (3) flavoured milk was included as an SSB, and (4) a volumetric tax was applied
at 50¢ per litre (see S4 Table). For each dollar invested in the first 10 years, the resulting health-
care cost savings ranged from $10 to $25 (Table 5).
All tax scenarios have a negative concentration index, indicating that the highest proportion
of HALYs gained is amongst the most disadvantaged quintiles. The 50% pass-through of a
20% tax and the 50¢ per litre tax had the largest negative indices, indicating the most equitable
scenarios (Table 5).
Table 4. Estimated net deadweight impact of a 20% tax on sugar-sweetened beverages.
Population Deadweight loss Tax revenue Net deadweight impact*
Total** 55.0 (19.0, 89.6) 642.9 (348.2, 1,117.2) +587.9 (+329.2, +1,027.6)
Quintile 1 (most disadvantaged) 17.7 (4.2, 29.2) 147.6 (78.0, 261.7) +129.8 (+73.8, +232.5)
Quintile 2 12.1 (3.0, 20.4) 129.4 (66.2, 233.5) +117.3 (+63.2, +213.0)
Quintile 3 15.1 (4.9, 24.4) 127.6 (69.5, 220.0) +112.5 (+64.6, +197.6)
Quintile 4 10.5 (2.4, 17.8) 120.3 (62.2, 219.2) +109.8 (+59.8, +201.4)
Quintile 5 6.3 (1.6, 10.9) 131.3 (73.3, 232.0) +125.0 (+71.7, +221.1)
Values are given in millions of Australian dollars, with 95% CIs in parentheses.
*These values are sometimes shown as negative deadweight losses (double negative), but it is less confusing to show these values as net positive dollar
impacts.
**Quintile totals do not add up to the population total as results are based on quintile-specific data and populations.
https://doi.org/10.1371/journal.pmed.1002326.t004
Table 5. Returns on investment in healthcare cost savings and concentration indices of tax scenarios.
Outcome 20% tax 50% pass-through of
20% tax
30% tax 50¢ per litre
tax
20% tax includes
flavoured milk
Returns on investment in healthcare cost savings in
first 10 years (95% CI)
$17 (9; 19) $10 (8; 11) $25 (21; 25) $11 (9; 13) $20 (16; 21)
Concentration index (standard error) −0.130
(0.037)
−0.145 (0.024) −0.140
(0.036)
−0.144
(0.071)
−0.139 (0.044)
Dollar amounts are in Australian dollars.
https://doi.org/10.1371/journal.pmed.1002326.t005
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The 30% tax rate scenario resulted in the largest difference between the lowest and highest
quintiles in terms of out-of-pocket costs for the tax; however, this scenario resulted in the larg-
est health gains and healthcare costs saved across the population. Compared to a 20% tax, a
50¢ volumetric tax resulted in smaller health gains across all SEIFA quintiles, due to the level
of tax translating to a lower level of price increase across all drink categories.
Discussion
In our study we estimate that a 20% sales tax on SSBs in Australia would result in the largest
number of obesity-related HALYs being averted in the population living in the most disad-
vantaged SEIFA quintiles, and it follows that the most healthcare cost savings overall would
accrue to these groups. The expected out-of-pocket tax expenditure was highest in the most
disadvantaged quintile; however, the difference of 0.32% points (less than 10¢) between the
lowest and highest quintiles in proportion of household spending on food and non-alco-
holic beverages per week was small. Our results indicate that, as a proportion of overall
spending, the lowest SEIFA quintiles would have the largest out-of-pocket healthcare cost
savings.
The DWLs for each SEIFA quintile, as well as for the whole population, were negative. This
indicates that the loss of consumer/producer benefit would be outweighed by the amount of
tax collected under our assumptions. The ‘loss in economic welfare’ is often calculated as the
dollar amount of DWL in excess of dollar taxation revenue collected by the government. In
our analysis there is a substantial net taxation gain suggestive of an improvement in economic
welfare (this underlies the rationale for internalisation of negative externalities). But there are
also behavioural responses associated with this inherently dynamic interaction that are difficult
to model in these formulaic terms—desirably, industry would realign to healthier products
and minimise its loss in producer surplus, consumers would realign to healthier purchases and
minimise their loss in consumer surplus, and, finally, the tax revenue could be utilised for wel-
fare-enhancing initiatives.
In the United Kingdom, it was considered reasonable to assume a pass-through rate of
100%; however, empirical evidence is mixed. The effect of manufacturers or retailers absorbing
part of the tax could decrease the impact of the tax and the resulting health benefits; however,
based on our predicted results for a 50% pass-through, the healthcare cost savings would nev-
ertheless be substantial. There could also be an additional ‘halo effect’—a decrease in purchas-
ing of SSBs from the introduction of the tax caused by increased public health awareness.
This research builds on the growing evidence that a tax on SSBs would deliver the largest
health gains for the lowest socioeconomic groups. It also reinforces previous findings that the
overall amount of tax per capita for a 20% value-added tax is around $30 per year, or less than
60¢ per week, and differences in tax expenditure between the lowest and highest socioeco-
nomic groups are small [19].
The predicted body weight losses in our study are lower than those in Sharma et al.’s study
[28], and this is because we took into account age and sex differences. Tax expenditures in our
study are higher overall, and this is due to different price assumptions, as well as differing base-
line intake of SSBs. The differences in baseline intake can be explained by the differing data
collection methods. We used individual survey data recorded over 2 days from the AHS 2011–
12, from which we took an average daily intake. These averages are close to the estimates from
Euromonitor International of per capita purchases of SSBs in Australia [55]. Our predicted
HALYs saved and expected tax revenue are slightly higher than in the previous Australian
study that also modelled a 20% tax on SSBs [21], but this to be expected given that we included
children in our analysis. Our predicted healthcare cost savings are higher due to a different
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method for calculating cancer treatment costs, based on the incidence rates rather than preva-
lence, and all costs have been updated to 2010.
This is possibly the first cost-effectiveness study to include the explicit health and economic
outcomes by SEP and the resulting DWLs. It also expands on previous Australian research to
include a wider range of SSBs and substitute beverages. We used conservative own-price elas-
ticities that were close to half the value of other published price elasticities for soft drinks
[45,56]. They take into account that SSB prices are not fixed, and households might face a qual-
ity—quantity tradeoff for each beverage and could opt for cheaper brands if they prefer quan-
tity over quality [28].
When comparing our average changes in adult kilojoule intake per day for the population
to a randomised control trial of overweight and obese adults who replaced all caloric SSBs with
non-caloric beverages, the tax has approximately 20%–26% of the impact of the results from
the trial (49 kcal/day decrease in our model versus 260 kcal/day and 187 kcal/day decreases for
overweight and obese individuals, respectively, in the trial) [57]. This proportion of the effect
is similar to the average change in own-price elasticities of consumption across all categories
of SSBs of approximately 23% for all households as a result of a 20% SSB tax when compared
to the trial [28].
As with all simulation models, the model results represent the best estimate of a potential
effect in the absence of stronger direct evidence. We used an aggregate area-based indicator of
SEP (SEIFA), as we were unable to obtain income-specific input data. We therefore assumed
that price elasticities for household income groups were similar for SEIFA groups. There are
also inherent limitations of survey data, such as misreporting, which may have affected the
baseline intake of SSBs. Cross-price elasticities of food substitutes by SEP were not available, so
these were not included [58]. Around 75% of soft drink sales are from supermarkets, and
prices may be slightly different to our estimates.
In some instances, we used costing frameworks from the US and NZ in the absence of Aus-
tralian estimates. NZ costs for policy advice provided by government agencies to parliament
related to new laws is likely to be similar to their Australian equivalents, as the legal systems
and number of new laws passed in Australia and NZ are similar. Costs to the government for
compliance and administration of the introduction of plain packaging of tobacco products in
Australia were similar to our estimates [46].
The model does not incorporate the effects of changes in SSB consumption on oral health
or indirect costs, such as reduced productivity due to absenteeism and disability, which means
that the societal savings from the intervention are likely to be substantially underestimated,
especially to those in the most disadvantaged groups. The assumptions for the quality of life
lost in children due to obesity are based on the best available evidence, but this evidence is
from only particular age groups of school-aged children, and we have assumed the effects are
similar for a wider age group.
Dedicating a portion of the substantial revenue generated from SSB taxes to efforts to
reduce and prevent obesity among the most disadvantaged populations could be a way to fur-
ther reduce concerns about the impact of the tax on low SEP groups. Hypothecation of taxes is
also effective in generating public support [59]. There is evidence in Australia that earmarking
the tax revenue for subsidising healthy food [60], tackling childhood obesity, and supporting
children’s sport [61] and health promotion initiatives [62] would raise the public support for
such a tax. Future studies could examine where to direct the revenue from an SSB tax for opti-
mal equity, efficiency, and affordability.
Many countries and jurisdictions around the world have committed to an SSB tax, and this
analysis shows that a 20% SSB tax is likely to result in a decrease in the purchase and consump-
tion of sugary drinks, leading to significant health gains and healthcare expenditure savings
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across all quintiles of SEP. The tax would result in considerable yearly revenue that the govern-
ment could use to reduce the regressive financial impacts, by funding programs to further
improve the health of the most disadvantaged. Australia should consider a tax on SSBs as part
of a suite of recommended policies to reduce the rates of obesity.
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S1 Table. Mean intake SSBs Australia, aged 2 years and over 1 
  Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Consumption of SSB Males Females Males Females Males Females Males Females Males Females 
Mean intake carbonated drinks 
(g/day) 145.0 96.5 143.9 74.1 125.9 73.9 128.0 71.1 110.2 51.1 
Relative standard error (%) 11.7 7.2 10.5 7.2 12.1 5.8 9.6 7.4 11.0 6.0 
Lower 95% CI 121.5 82.1 122.9 59.6 101.7 62.2 108.8 56.3 88.2 39.2 
Upper 95% CI 168.4 111.0 164.8 88.5 150.1 85.6 147.1 86.0 132.2 63.1 
Mean intake sports drinks 
(g/day) 7.7 7.7 4.4 4.4 8.2 8.2 8.4 8.4 8.2 8.2 
Relative standard error (%) 0.9 0.9 1.3 1.3 1.9 1.9 2.0 2.0 1.5 1.5 
Lower 95% CI 6.0 6.0 1.8 1.8 4.5 4.5 4.5 4.5 5.2 5.2 
Upper 95% CI 9.5 9.5 7.1 7.1 12.0 12.0 12.3 12.3 11.2 11.2 
Mean intake energy drinks 
(g/day) 5.2 5.2 5.1 5.1 7.0 7.0 3.1 3.1 3.0 3.0 
Relative standard error (%) 1.1 1.1 1.3 1.3 1.7 1.7 0.8 0.8 0.9 0.9 
Lower 95% CI 3.0 3.0 2.4 2.4 3.5 3.5 1.5 1.5 1.2 1.2 
Upper 95% CI 7.3 7.3 7.8 7.8 10.5 10.5 4.7 4.7 4.8 4.8 
Mean intake fruit drink (g/day) 51.3 46.2 39.2 25.1 46.7 31.0 30.9 28.5 38.3 32.4 
Relative standard error (%) 6.9 6.3 8.1 3.3 7.0 3.6 4.3 4.7 4.8 3.8 
Lower 95% CI 37.4 33.6 23.0 18.4 32.7 23.7 22.3 19.0 28.8 24.8 
Upper 95% CI 65.1 58.7 55.4 31.8 60.8 38.3 39.5 38.0 47.8 40.1 
Mean intake cordial diluted 
(g/day) 54.5 20.2 55.7 32.3 38.7 29.7 31.5 16.5 26.1 15.4 
Relative standard error (%) 8.3 4.3 9.7 5.0 7.8 6.4 7.3 3.1 5.1 3.4 
Lower 95% CI 37.8 11.6 36.4 22.4 23.1 17.0 17.0 10.4 15.9 8.5 
Upper 95% CI 71.2 28.7 75.0 42.3 54.3 42.5 46.1 22.6 36.3 22.3 
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S2 Table. Impact of a 20% tax on demand for SSBs by SEIFA quintile and total population  
% change 
demanded 
per capita 
Quintile 1 
 (lowest) 
Quintile 2 
 
Quintile 3 
 
Quintile 4  Quintile 5 
(highest)  
 
All 
households 
 
 Soft drinks 
(pop, soda) * 
-15.05 -14.84 -14.92 -13.87 -13.10 -11.52 
 Cordial 
(concentrate) -45.55 -40.86 -35.63 -32.58 -29.98 -33.23 
 Fruit drink -3.08 -14.99 -36.61 -19.36 -11.82 -25.50 
Notes: All non-zero effects significant at 10% level. 
*Soft drinks include standard soft drinks, sports and energy drinks, flavoured bottled water  
Price elasticities derived from Sharma et al2.  
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S3 Table. Estimating the cost of sugar-sweetened beverage tax legislation 
Variable Value $ Source or method of calculation 
Senate annual expenses 23,596,000 Average of annual expenses 2010-2015 Department of Senate Annual Reports3 
House of Representatives 
annual expenses 25,800,000 
Average of annual expenses 2010-2015. 
Department of House of Representatives 
Annual Reports4 
Office of Parliamentary 
Counsel - legislation 
drafting and publication 
15,690,000 Office of Parliamentary Counsel Budgets5  
Annual parliamentarians’ 
salaries 3,363,000 
Number of hours spent on legislation/total 
working hours in a year = 18% times total 
parliamentarians salaries from Senate 
budget statements - resource statements 
Third Party Drawdowns on behalf of other 
departments6   
Total annual cost of 
running the 
parliamentary service 
(PS) 
65,086,000 Sum of variables above 
Total annual cost of 
policy advice related to 
new laws provided by 
government agencies to 
parliament (PA) 
39,443,000 $59,273,246 from Wilson et al 
7 Converted 
to $AU 20108 
No. bills passed 170 Average of number of bills passed by Senate 9  
Regulatory impact 
statement (RIS) 440,000 Australian Government cost of RIS
10 
Average cost of new 
legislation 1,090,000 Total costs= PS+PA+RIS/no. bills 
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S4 Table. Cost effectiveness results of the sensitivity analyses  
20% sugar-sweetened beverage tax including flavoured milk 
 
Quintile 1 
(95%CI) 
Quintile 2  
(95%CI) 
Quintile 3  
(95%CI) 
Quintile 4  
(95%CI) Quintile 5 (95%CI) 
Total   
(95%CI) 
Total HALYs saved over 
lifetime (thousands) 
58.1  
(18.0, 97.7) 
54.9. 
(32.9, 76.7) 
54.6 
(22.9, 85.4) 
 34.9 
(30.1, 40.6) 
28.2 
(12.2, 44.3)  
192.7 
(75.8, 301.2) 
Total years of life saved over 
lifetime (thousands) 
44.3 
(13.6, 72.9) 
41.0. 
(24.76.7 ) 
41.1 
(17.2, 63.8) 
 25.9 
(23.0, 29.3) 
21.7 
(10.0, 33.6) 
121.1 
(47.8, 189.9) 
Total healthcare cost savings 
over lifetime (millions of 
dollars) 
473.0 
(145.6, 767.5) 
473.1 
(286.5, 656.4) 
476.2 
(196.9, 738.6) 
 325.0 
(273.6, 381.5) 
260.3 
(111.6, 407.7) 
 1,951.4 
(1,687.2, 2,218.3) 
Net cost per HALY saved Cost saving Cost saving Cost saving Cost saving Cost saving Cost saving 
Out-of-pocket healthcare 
costs saved over lifetime 
(millions of dollars) 
 40.2 
(34.8, 45.7) 
 40.7 
(35.2,46.3) 
 57.8 
(50.0, 65.8) 
 79.3 
(68.6, 90.2) 
 121.4 
(105.0, 138.0) 
339.5 
(293.6, 386.0) 
Out-of-pocket costs of tax 
(dollars per person, yearly) 
40.90  
(24.80, 64.0) 
37.30 
(22.80, 57.70)  
 33.30 
 (19.50, 51.60) 
30.60  
(17.80, 49.40) 
33.20  
(20.50, 51.10) 
34.10 
(20.80, 53.40) 
% expenditure food and non-
alcoholic drinks 
0.62% 0.40% 0.30% 0.25% 0.23% 0.32% 
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50% pass-through of 20% sugar-sweetened beverage tax (10% tax rate) 
 
Quintile 1 
(95%CI) 
Quintile 2  
(95%CI) 
Quintile 3  
(95%CI) 
Quintile 4  
(95%CI) Quintile 5 (95%CI) 
Total   
(95%CI) 
Total HALYs saved over 
lifetime (thousands) 
29.2  
(26.1, 32.6) 
27.3  
(4.6, 49.1) 
27.1  
(10.9, 43.7) 
16.5 
(14.1, 19.3) 
14.7  
(13.2, 16.4) 
89.0  
(33.6, 144.8) 
Total years of life saved over 
lifetime (thousands) 
22.1  
(20.9, 23.4) 
20.3  
(3.4, 36.3) 
20.5  
(8.4, 32.7) 
12.2  
(10.8, 13.9) 
11.2  
(10.5, 12.0) 
61.5  
(23.8, 99.2) 
Total healthcare cost savings 
over lifetime (millions of 
dollars) 
238.5  
(211.4, 265.0) 
235.7  
(40.3, 154.0) 
236.8  
(95.4, 376.9) 
154.0  
(129.8, 181.7) 
133.7  
(118.0, 151.3) 
 957.5 
(829.8, 1,102) 
Net cost per HALY saved Cost saving Cost saving Cost saving Cost saving Cost saving Cost saving 
Out-of-pocket healthcare 
costs saved over lifetime 
(millions of dollars) 
19.7 
(17.1, 22.7) 
 20.0 
(17.3,23.0) 
28.4 
(24.6, 32.7) 
38.9 
(33.7, 44.8) 
59.6 
(51.6, 68.6) 
 166.6 
(144.4, 191.8) 
Out-of-pocket costs of tax 
(dollars per person, yearly) 
 20.7 
(12.40, 31.80) 
17.10 
(12.50, 22.60)  
  17.90 
(11.30, 27.40) 
15.70 
(9.30, 25.10) 
17.20 
(10.60, 26.30) 
16.90 
(10.30, 25.80) 
% expenditure food and non-
alcoholic drinks 0.31% 0.18% 0.16% 0.13% 0.12% 0.16% 
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30% sugar-sweetened beverage tax 
 
Quintile 1 
(95%CI) 
Quintile 2  
(95%CI) 
Quintile 3  
(95%CI) 
Quintile 4  
(95%CI) Quintile 5 (95%CI) 
Total   
(95%CI) 
Total years of life saved over 
lifetime (thousands) 
70.5 
 (23.3, 112.6) 
69.4  
(47.1, 92.3) 
66.2 
(27.1, 100.0) 
43.8  
(37.5, 51.5) 
38.5 
(17.5, 58.0) 
224.5 
91.6, 346.0) 
Total healthcare cost savings 
over lifetime (millions of 
dollars) 
53.9  
(17.9, 85.6)  
51.9  
(35.6, 68.1) 
50.2  
(20.3, 75.9) 
32.6 
(28.7, 37.0) 
29.5 
(13.6, 43.9) 
155.5 
(62.9, 238.7) 
Net cost per HALY saved 574.4  (195.7, 919.7) 
598.6  
(405.8, 788.3) 
576.1 
(233.2, 865.6) 
407.4 
(341.1, 480.2) 
352.3 
(164.4, 536.2) 
2501.4 
 (2,181.9, 
2,820.4) 
Out-of-pocket healthcare 
costs saved over lifetime 
(millions of dollars) 
Cost saving Cost saving Cost saving Cost saving Cost saving Cost saving 
Out-of-pocket costs of tax 
(dollars per person, yearly) 
 51.6 
(6.1, 45.0) 
 52.2 
(6.2, 45.5)  
 74.2 
(8.8, 64.7) 
101.7 
 (12.1,88.7) 
 155.6 
(18.4,135.7) 
 435.2 
(379.7, 490.8) 
% expenditure food and non-
alcoholic drinks 
 51.40 
(39.10, 67.90) 
47.10  
(36.10, 61.10)  
  49.60  
(37.90, 62.70) 
46.70 
(38.30, 56.90) 
 33.50  
(20.70, 51.00) 
51.20 
(31.20, 80.10) 
Total HALYs saved over 
lifetime (thousands) 0.78% 0.50% 0.45% 0.39% 0.23% 0.48% 
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50c per litre tax 
 
Quintile 1 
(95%CI) 
Quintile 2  
(95%CI) 
Quintile 3  
(95%CI) 
Quintile 4  
(95%CI) Quintile 5 (95%CI) 
Total   
(95%CI) 
Total HALYs saved over 
lifetime (thousands) 
30.4 
(4.4, 54.7) 
31.0 
(4.0, 58.2) 
33.2 
(13.1, 51.3) 
20.3 
(17.5, 23.6) 
12.7 
(5.9, 19.5) 
167.5 
(148.5, 189.6) 
Total years of life saved over 
lifetime (thousands) 
23.1 
3.4, 42.2 
23.2 
2.8, 43.3 
25.1 
10.0, 39.1 
15.0 
13.3, 16.9 
9.7 
4.5, 14.9 
116.0 
108.8, 122.9 
Total healthcare cost savings 
over lifetime (millions of 
dollars) 
248.2 
34.8, 445.5 
264.3 
38.4, 486.3 
289.1 
117.3, 456.4 
188.9 
159.5, 220.1 
116.4 
53.2, 180.7 
1,141.0 
989.8, 1,309.7  
Net cost per HALY saved  23.5 (20.4, 27.0) 
 23.8 
 (20.6, 27.3) 
33.8 
(29.3, 38.8) 
46.4 
(40.2, 53.2) 
71.0 
(61.6, 81.5) 
 198.5 
(172.2, 227.9) 
Out-of-pocket healthcare 
costs saved over lifetime 
(millions of dollars) 
Cost saving Cost saving Cost saving Cost saving Cost saving Cost saving 
Out-of-pocket healthcare 
costs saved over lifetime 
(millions of dollars) 
34.40  
(31.90, 37.00) 
27.80 
(25.00, 30.90)  
  30.50  
(26.80, 34.70) 
23.60  
(20.60, 26.70) 
 25.70  
(23.70, 27.90) 
25.80 
 (23.80, 27.80) 
Out-of-pocket costs of tax 
(dollars per person, yearly) 
0.32% 0.42% 0.33% 0.21% 0.21% 0.18% 
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Chapter 5. Weighting health outcomes by socioeconomic position using 
stated preferences and social welfare functions 
This study investigated the second aim of the doctorate: Can appropriate equity 
weights be derived from people’s preferences for use in cost-effectiveness studies 
of obesity prevention policies in Australia? The outcomes of this study have been 
published as the following paper:  
Lal A, Siahpush M, Moodie M, Peeters A, Carter R.  (2017) Weighting health 
outcomes by socioeconomic position using stated preferences. Pharmacoeconomics 
Open. DOI 10.1007/s41669-017-0036-1.  
This section summarises the key points from the paper, followed by a copy of the 
published paper and the authorship statement. 
What is already known about the topic? 
Previous studies have derived weights from stated preferences of whether a low 
SEP group should be given priority for health programs over a high SEP group. 
However, the different approaches employed to both elicitations of preferences 
and derivation of the weights, resulted in derived weights of quite different 
magnitudes and therefore may be context and method specific.  
The trade-off that society is willing to make to promote a more equitable 
distribution of health can be represented as a social welfare function (SWF). SWFs 
are an economic construct that can be used to illustrate concerns for total health 
with aversion to inequalities between socioeconomic groups. A previous study 
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derived UK specific weights using people’s preferences to estimate the shapes of 
health-related SWFs. 
What does the paper add to existing knowledge? 
Further evidence is required before weights derived using SWFs have practical 
value. The range in the relative weights obtained was too wide to be of use for the 
intended purpose of applying them to CEA’s of policies aimed to prevent health 
conditions that have a social gradient in Australia. 
What insights does the paper provide for informing policy decision 
making? 
This paper confirms that the public may be willing to sacrifice health gains in 
order to reduce differences in average life expectancy between SEP groups. The 
objective of economic efficiency may not have primacy compared to other 
objectives for the general public.  
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Abstract
Background The trade-off that society is willing to make
to promote a more equitable distribution of health can be
represented as a social welfare function (SWF). SWFs are
an economic construct that can be used to illustrate con-
cerns for total health with aversion to inequalities between
socioeconomic groups.
Objective This study used people’s preferences to estimate
the shapes of health-related SWFs (HRSWFs). We tested
the suitability of this method to derive equity weights.
Methods A questionnaire was used to elicit preferences
concerning trade-offs between the total level of health and
its distribution among two socioeconomic groups. The
participant group was a sample of convenience that inclu-
ded a mix of health researchers, academics, clinicians,
managers, public servants and research students. The data
collected were used to develop HRSWFs with a constant
elasticity of substitution. The weight was calculated using
the marginal rate of substitution.
Results A marginal health gain to the lowest socioeco-
nomic position (SEP) group was valued 14.1–81.4 times
more than a marginal health gain to the high SEP group.
Conclusions Our results provide evidence to support the
idea that the public may be willing to make trade-offs
between efficiency and equity, and that they value health
gains differently depending on which socioeconomic group
receives the health gain. Further evidence is required
before such indicative weights have practical value.
Key Points for Decision Makers
The public may be willing to sacrifice health gains in
order to reduce differences in average life
expectancy between socioeconomic position groups.
The objective of economic efficiency may not have
primacy compared with other objectives for the
general public.
1 Background
In the developed world, the single strongest predictor of an
individual’s health is their position on the socioeconomic
spectrum [1]. This can be measured by income, education,
place of residence or occupation. On average, those at the
lower end of the spectrum are more likely to suffer from
diseases and have higher mortality rates and lower life
expectancies [1–5]. Table 1 demonstrates the differences in
life expectancy between the highest and lowest socioeco-
nomic groups in Australia. This social gradient of health is
also important for many racial and ethnic health differences
because socioeconomic position (SEP) can differ substan-
tially by race and ethnicity [6–9]. An important focus of
public health policy is the reduction of population health
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inequalities between SEP groups [10]. Addressing this
issue is a policy concern in many countries and is reflected
in risk factor and disease prevention policy statements [11].
Given health budget constraints, priority setting is an
essential task for policy makers. Achieving a balance
between maximising health gains per dollar spent and a fair
distribution of health gains across socioeconomic groups is
an important objective. Policy makers often utilise cost-
effectiveness analysis (CEA) to inform resource allocation
decisions. The results of CEA are summarised in an
incremental cost-effectiveness ratio (ICER) that represents
the additional costs and benefits of the intervention relative
to a comparator. ICERs are usually presented as a cost per
quality-adjusted life-year (QALY), a metric that enables
comparison between different interventions, because it
combines both mortality and morbidity effects. ICER
thresholds are the monetary value below which an inter-
vention is presumed ‘efficient’. In Australia, the ‘rule of
thumb’ is \50,000 Australian dollars (A$) per QALY
gained [12].
Despite SEP being the strongest predictor of health and
recognition of the policy significance of reducing health
inequalities between SEP groups, the underlying assump-
tion of economic evaluation methods is to value health
gains of SEP groups equally. Where this assumption does
not reflect society’s concerns about how benefits are dis-
tributed, the application of equity weights can compensate
for health inequalities by weighting the QALYs according
to characteristics of the people receiving them. These
weights can quantitatively express the extent to which
society is willing to trade overall health benefits in order to
promote a more equitable distribution of health. The
weights can be applied within economic evaluations either
by adjusting the QALY gains within the ICER or by
adjusting the ICER threshold [13].
Policies aimed at reducing inequalities between
socioeconomic groups might involve a lesser increase in
overall health benefits, but if achieving a balance between
equity and efficiency is the aim, equity weighting allows
for the maximisation of equity-adjusted health outcomes,
rather than just the maximisation of health outcomes [13].
One potential outcome of such weighting would be that
more resources would be allocated to low SEP groups to
reflect this broader concept of benefit. This goes to the
heart of what constitutes ‘value-for-money’ in economic
appraisal—what are the elements that should describe
community welfare in the social welfare function (SWF)?
Expressed another way, what is it that the Australian
community wants from its healthcare system? What are we
trying to maximise with available resources? The SWF is
an economic construct used to define our concept of benefit
and its various dimensions.
Interest in people’s preferences relating to fairness is
increasing and numerous studies have looked at whether
people prefer to give priority for health gains to one group
over another. For example, people are willing to sacrifice
quality-of-life gains to give priority to the most severely ill
[5–7], and those with dependents [14], and lower priority to
older people [30–36]. Of the 21 studies that have examined
giving priority in health services to persons in lower SEP
groups [15–35], nine studies found that people would give
priority to low SEP groups [20, 21, 27, 28, 30, 32–35].
However, the framing of the questions appears to have
influenced the responses. For example, in the studies in
which people were explicitly told that low SEP groups
have worse health outcomes, the majority of those sampled
gave priority to low SEP groups. A health-maximising
objective is not supported by survey respondents in many
contexts.
Four studies have calculated health weights for SEP
using empirical surveys [20, 30, 32, 35]. The weights
originated from either public opinion [30, 32, 35] or
politicians [20]. There are several ways of estimating
weights, such as through willingness-to-pay, person trade-
off exercises or discrete choice experiments [36]. Typi-
cally, respondents are surveyed and asked to make choices
designed to reveal the extent to which they would choose
equality (equal benefits received by all groups) or equity
(more benefits to the lowest SEP group). The four studies
based the weights on stated preferences of whether a low
SEP group should be given priority for health programmes
over a high SEP group and all studies indicated that people
were willing to give priority to the low SEP group.
However, the different approaches employed in both
elicitation of preferences and the derivation of weights
resulted in quite different magnitudes for the derived
weights. Wiseman [30] included questions about how to
allocate a budget of AU$10 million to programs benefiting
low- and high-income groups, whilst Norman et al. [35]
combined various dimensions such as gender, smoking
status and income and a separate weight for SEP was not
derived. In the Lindholm et al. [20] study, Swedish
politicians were asked to choose between programs
designed to prevent myocardial infarction deaths amongst
Table 1 Life expectancy by
income quintiles and years of
education: males aged 20 years,
Australia, 2007 [5]
Income quintile Years of education
Lowest quintile Highest quintile Gap B12 years [12 years Gap
Life expectancy (years) 74.9 81.1 6.2 75.5 80.1 4.6
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blue or white collar workers. The weights derived from the
Dolan and Tsuchiya [32] study were based on participants
choosing between two health programs that varied in the
number of years of life that would be added to low and high
SEP groups. Because of the different methods used to
calculate weights for SEP, it is not known whether results
differ due to method or underlying preferences. Adding to
this, results may well be context specific, which makes
generalisability more difficult. Unpacking these influences
requires further research, particularly research where dif-
ferences in method are not a confounding factor.
Our aims in this article are to investigate how willing
people in Australia are to make trade-offs between max-
imising health gains and achieving greater health equality
for SEP groups, and to derive weights that could potentially
be used in CEAs that analyse policies aimed to prevent
health conditions that have a social gradient in Australia.
We chose to use Dolan and Tsuchiya’s [32] methods
because of suitability to our context of examining prefer-
ences for health gains according to SEP, as well as ease of
understanding/execution and the current need for studies
with consistent methods. Dolan and Tsuchiya [32] used
stated preferences from the general public to estimate the
parameters of a health-related SWF (HRSWF) and we
wanted to test the suitability of this method to derive equity
weights for Australia.
2 Methods
2.1 Participants
The participant group (n = 131) was a convenience sample
that included a mix of researchers, academics, clinicians,
managers, public servants and research students attending
either the Australian and New Zealand Obesity Society
Annual Scientific Conference (Sydney, NSW, Australia,
16–18 October 2014) or the World Priorities 2014 Con-
ference (Melbourne, VIC, Australia, 10–12 November
2014). Delegates were invited to participate by way of
announcements prior to organised sessions. Questionnaires
were placed on empty seats at the venue before a session
began. Participants were asked to complete the survey and
place it in a collection box at the venue. Most participants
completed the survey during the session, but some took the
survey away and completed it in their own time. Envelopes
were provided if people wished to return the questionnaire
at a later date.
2.2 Questionnaire
The questionnaire was based on Dolan and Tsuchiya [32] and
the improvements to their questions made by Abasolo and
Tsuchiya [27] (outlined in this section). We modified the
questionnaires for the Australian context (see Electronic
Supplementary Material Online Resource 1). The question-
naire took participants approximately 5 min to complete.
Participants were asked to imagine they were helping
the Health Department to choose between alternative
health programs that involved a choice between efficiency
and health equity. They were told that, on average in
Australia, people from high-income groups live around
6 years longer than those from low-income groups (see
Electronic Supplementary Material Online Resource 1 for
full description). Using graphs, the participant was pre-
sented with a 6-year difference in life expectancy between
high and low socioeconomic groups (84 and 78 years,
respectively). It was explained that SEP is a measure of
one’s income, education and occupation.
Initially, participants were asked to make a choice
between Program A, which increases life expectancy of
both groups by 2 years, and Program B, which increases
life expectancy of the low SEP group by 4 years and does
not change the life expectancy of the high SEP group
(thereby reducing the health inequality between the
groups). They were told that the two groups were
approximately of equal size and the two programs cost the
same. Depending on their choice of responses, respondents
were directed to follow-up questions.
If participants chose Program B, the follow-up choices
have Program A remaining the same as Question 1, but
Program B gives reducing levels of life expectancy gains to
the low SEP group, with no changes to the life expectancy
of the high SEP group, showing the efficiency equity trade-
off. The expectation is that the respondent will switch to
Program A at a point beyond which further sacrifices in
efficiency to improve equity are no longer perceived to be
worthwhile [27]. Dolan and Tsuchiya [32] used two ver-
sions of the questionnaire, with the alternate version
responses decreasing in life expectancy by 1 year or half a
year. In order to not dilute the number of responses, we
used one version of the questionnaire that included a
combination of decreases of 1 year and half years. Table 2
presents all the questionnaire response options.
It might be considered unacceptable that a public policy
program should exclude a whole population subgroup from
benefiting, irrespective of their SEP. If participants chose
Program A in the initial choice, this may be because both
population groups receive something, whilst under Pro-
gram B the better-off will receive no health benefit. Fol-
lowing Abasolo and Tsuchiya’s [27] format, the follow-up
choices for those who initially choose Program A have
Program A remaining the same as in Question 1, but Pro-
gram B gives 1 year of increased life to the high SEP group
and reduces levels of life expectancy gains to the low SEP
group as per the previous follow-up choices.
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2.3 The Health-Related Social Welfare Function
(HRSWF)
The data collected were used to develop an HRSWF. The
SWF is taken from Dolan and Tsuchiya [32] and has a
constant elasticity of substitution (CES), i.e. the concavity
of the curve is constant.
W ¼ aHra þ bHrb
 1
r ;Ha;Hb ð1Þ
aþ b ¼ 1; r  1; r 6¼ 0;
where W is the HRSWF and Ha and Hb are the average
levels of health of groups of equal size. r measures the
degree of aversion to inequality and is represented by the
convexity of the iso-welfare curves (or social indifference
curves). The iso-welfare curves are lines showing different
bundles of health between which society is indifferent.
Figure 1 depicts the health possibility frontier (HPF)
and iso-welfare curves with differing levels of r. If r = –1,
there is no aversion to inequality, represented in the iso-
welfare curve by a straight line. The ‘maximum’ point is
where health is maximised. If r[ –1, there is aversion to
inequality and a diminishing Marginal Rate of Social
Substitution (MRSS) between the health of the two groups,
resulting in iso-welfare curves convex to the origin (in-
termediate point). At the extreme, the worst-off individual
is all that matters and r assumes a value of infinity and the
SWF will be L-shaped. The larger the value of r, the closer
one gets to the equal point, where the health of the low SEP
group is the same as the health of the high SEP group. The
point at which the iso-welfare curve is tangential to the
HPF represents the optimal distribution of health gains
across the two groups. The value of r in the baseline CES
specification was obtained using the goal seek function in
Microsoft Excel (Microsoft Corporation, Redmond, WA,
USA) by determining the value of r that makes W identical
at two points, X and Y [32].
The rate at which the welfare of the groups enters the
SWF is represented by the parameters a and b. For
example, it could be argued that less weight be given to
those who are more responsible for their poor health. In this
study, as per Dolan and Tsuchiya [32], anonymity is
assumed, implying that both groups are equally ‘deserving’
of any health gains.
Figure 2a, b illustrates the basis of the questions in the
HRSWF framework. In Fig. 2a H1 and H2 represent the life
expectancy of the high and the low SEP groups along the
vertical and horizontal axes, respectively. Point I (84, 78)
Table 2 Questionnaire response options: number of added years of life associated with the health program
Program A Program B
High SEP group: 84 years’
life expectancy
Low SEP group: 78 years’
life expectancy
High SEP group: 84 years’
life expectancy
Low SEP group: 78 years’
life expectancy
?2 (86) ?2 (80) 0 (84) ?4 (82)
?2 (86) ?2 (80) 0 (84) ?3 (81)
?2 (86) ?2 (80) 0 (84) ?2.5 (80.5)
?2 (86) ?2 (80) 0 (84) ?2 (80)
?2 (86) ?2 (80) 0 (84) ?1.5 (79.5)
Abasolo and Tsuchiya’s [27] amendment so some improvement flows to all SEP
?2 (86) ?2 (80) ?1 (85) ?3 (81)
?2 (86) ?2 (80) ?1 (85) ?2.5 (80.5)
?2 (86) ?2 (80) ?1 (85) ?2 (80)
?2 (86) ?2 (80) ?1 (85) ?1.5 (79.5)
Numbers in parentheses indicate life expectancy achieved given the added years of life
SEP socioeconomic position
Fig. 1 Alternative iso-welfare curves [38]. SEP socioeconomic
position
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represents the initial life expectancy of the two SEP
groups. The first question corresponds to a choice between
a move from point I to point a ‘Program A’ (?2, ?2)
versus a move from point I to point b ‘Program B’ (?0,
?4). If the respondents prefer the latter, then the subse-
quent choices are between a move from I to point a, versus
a move to points to the left of b on the horizontal line. The
point at which the respondent switches from Program B to
Program A indicates where the indifference curve through
point a (?2, ?2) intersects the horizontal line I - b. Once
indifference between the programs has been established,
the MRSS of the SWF can be calculated using the median
values from the questionnaires. Figure 2b represents the
basis of the questions in the HRSWF when everyone gets
something.
The weight inferred to the less advantaged group a
relative to group b is calculated from the MRSS:
 dHb
dHa
¼ Hb
Ha
 ð1þrÞ
: ð2Þ
The CES specification is used as the baseline
specification as per Dolan and Tsuchiya’s study because
it satisfies all the conventional requirements of a SWF: it is
individualistic, additive, non-decreasing (or monotonic),
strictly concave, exhibits constant relative inequality
aversion (or scale independence or homotheticity), and
with a ¼ b satisfies anonymity [32].
Two alternative SWF specifications were also used: the
parabolic and hyperbolic specifications. Under extreme
inequality aversion, where a reduction in inequality is
preferred even when it results in a loss in the health of the
worse off, and therefore the monotonicity principle is
violated, the CES specification cannot deal with these
preferences. The hyperbolic and the parabolic specifica-
tions accommodate these preferences. They are individu-
alistic, additive, inequality averse and symmetric. The
parabolic specification satisfies constant relative inequality
aversion, while the hyperbolic specification satisfies con-
stant absolute inequality aversion [32]. The mathematical
formulas for the hyperbolic and the parabolic specifications
can be found in the Electronic Supplementary Material
(Online Resource 2).
3 Results
Of the 131 questionnaires that were returned, three were
incomplete, leaving 128 that were analysed. Table 3 pre-
sents the demographics of the sample. The sample popu-
lation was largely females, tertiary educated and with
Australia as their place of residence.
The first column of Table 4 presents the implied points
of indifference. For the respondents who initially chose
Fig. 2 The iso-welfare curve and the life expectancy questions [30]:
left life expectancy of the high and the low SEP groups; right the basis
of the questions in the health-related social welfare function when
everyone gets something. In the figures, a is the outcome offered by
Program A; the horizontal broken line represents the set of options
(b to I) offered by the alternative Program B; d is the point at which
the median respondent is indifferent between the two programs, and
thus the point through which the iso-welfare curve crosses the broken
line at 84 years on the high SEP group axis. H1 life expectancy of the
more advantaged group, H2 life expectancy of the less advantaged
group, I initial point, SEP socioeconomic position
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Program B but switched at some point to Program A, their
point of indifference has been taken to be half-way
between the last point at which they chose B and the first
point at which they chose A. The 18% of respondents who
chose A in the initial pairwise comparison and did not
switch to B for any option were assumed to be inequality
neutral (first row). For those who always chose B, we
assumed that they were indifferent at the implied point
presented in the last row of the table, as per Dolan and
Tsuchiya’s [32] method. The subsequent columns of the
table show respondents’ associated inequality aversion
parameters, and their corresponding implied relative
weights to the low SEP group, given the options in Table 2.
The last column of Table 4 presents the distribution of
responses. The median responses are that 21% (whole
sample) and 22% (females) are indifferent between people
in the high and low SEP groups living to be 86 and
80 years, respectively (the outcome for choosing Program
A), and these groups living to be 84 and 80.25 years
respectively (the outcome for Program B). For males, the
median response (23%) was to give equal gains in life
expectancy to low and high SEP groups from the
beginning.
Depending on the SWF specification (CES, hyperbolic
or parabolic), the implication is that a marginal health gain
to the lowest SEP group is valued 14.1–81.4 times more
than a marginal health gain to the high SEP group. This is
the range of the ‘relative weight at initial point’ of the CES,
hyperbolic specification and parabolic specification. Fig-
ure 3 shows the three functions graphically.
4 Discussion
In this study, we found that the majority of people (82%)
value health gains differently depending on which SEP
group is receiving the health gain; a marginal health gain to
Table 3 Participant demographics (n = 128)
Variable n (%)
Gender
Female 88 (69)
Age (years)
18–34 44 (36)
35–44 26 (20)
45–54 32 (25)
C55 24 (19)
Education level
Trade or associate degree 4 (3)
Bachelor, Masters, professional degree 73 (57)
Doctorate 51 (40)
Country of residence
Australia 97 (76)
New Zealand 17 (13)
Other countries (USA, UK, Europe, Canada, Africa) 12 (9)
Not stated 2 (2)
Table 4 Inequality aversion parameters, weights and results
Indifference points as
inferred from
response options
CES Hyperbolic Parabolic Responses
(N = 28)
[n (%)]
Responses
female
(N = 88)
[n (%)]
Responses
male
(N = 40)
[n (%)]
Inequality
aversion
parametera
Relative
weight at
initial
pointb
Inequality
aversion
parametera
Relative
weight at
initial
pointb
Inequality
aversion
parametera
Relative
weight at
initial
pointb
(80,86) * (82,84) –1.00 1.00 0.00 1.00 0.00 1.00 23 (18) 14 (16) 9 (23)
(80,86) * (81.5,84) 4.61 1.52 5.57 1.52 0.02 1.51 11 (9) 6 (7) 5 (13)
(80,86) * (80.75,84) 16.64 3.69 16.25 4.02 0.05 3.87 25 (20) 18 (20) 7 (18)
(80,86) * (80.25,84) 34.68 14.07 26.34 81.41 0.08 45.80 27 (21) 19 (22) 8 (20)
(80,86) * (79.75,84) Unspecified Unspecified 41.36 –4.76 0.13 –4.96 6 (5) 5 (6) 1 (3)
(80,86) * (79.25,84) Unspecified Unspecified 67.38 –2.34 0.20 –2.37 15 (12) 11 (13) 4 (10)
(80,86) * (81.5,85) –8.10 0.59 –7.00 0.59 0.02 0.60 0 0 0
(80,86) * (80.75,85) 3.65 1.41 4.62 1.41 0.01 1.40 17 (13) 11 (13) 6 (15)
(80,86) * (80.25,85) 20.39 4.88 18.49 5.34 0.06 5.06 2 (2) 2 (2) 0
(80,86) * (79.75,85) Unspecified Unspecified 49.00 –3.45 0.15 –3.57 0 0 0
(80,86) * (79.25,85) Unspecified Unspecified 196.74 –1.32 0.60 –1.33 2 (2) 1 (1) 0
Median respondent and corresponding inequality aversion parameter and weights in italics
CES constant elasticity of substitution
a Inequality aversion parameter is r for the CES and C for the hyperbolic and the parabolic functions
b Relative weight at initial point is the implied equality weight given to group B relative to group A at the initial point where life expectancy for
groups A and B are 84 and 78 years, respectively
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the low SEP group is valued more than a marginal health gain
to the high SEP group. When there is a choice between a
program that reduces inequalities in life expectancy, whilst
possibly foregoing the opportunity to improve the health of
those who are better off, or a program that offers equality of
health gain to both groups, over 80% of participants chose
the former option. Females were more likely than males to
value health gains differently. Our results correspond to
previous studies whose findings indicate that in different
contexts the public may prefer a more equitable distribution
of healthcare resources for those in more disadvantaged
groups [20, 21, 27, 28, 30, 32–35].
The median marginal health gain to the low SEP group
compared with the high SEP group, or the relative weight,
was valued at between 14.1 and 81.4; these results entail
both a large range and high values compared with Dolan
and Tsuchiya’s obtained values of between 6.8 and 9.9. As
per Dolan and Tsuchiya’s study [32], CES was used as the
baseline specification, but very different weights were
obtained using the hyperbolic and parabolic specifications,
hence the wide range in values. These latter specifications
were used to accommodate the situation where a reduction
in inequality is preferred, even when it results in a loss in
the health of the worse off, which the CES specification
cannot deal with. The weights are intended to be applied to
the health gains in an ICER or to the ICER threshold, and
these weights are simply too large to be of practical use.
There are some possible explanations for the differences
in the weights we obtained. First, we used Australian life
expectancy figures, which were higher, and the difference
between groups was 6 years compared with Dolan and
Tsuchiya’s 5 years. Second, Dolan and Tsuchiya used two
rounds of questions, each on a different sample of people
with different options: one that decreased by half a year
each time and one that decreased by 1 year; this resulted in
Dolan and Tsuchiya’s [32] study offering different
response options to each subgroup of the sample as well as
more evenly spread weight values. We opted to do one
version of the questionnaire in order to not further dilute
the number of responses. Our questionnaire decreased life
expectancy mostly by half a year each time. The large
increase in the value of the weights from 4.02 and 81.41
using the parabolic function and from 3.87 to 45.86 using
the hyperbolic function can be explained as a mathematical
artefact.
The additional questions involved the option of ‘ev-
eryone gets something’, such that the high SEP group also
gets a small health gain. These were included because it
might be considered unacceptable that a population-level
public policy program should exclude a whole population
subgroup from benefiting. This resulted in a larger spread
of responses, with 17% of the group choosing one of these
options. In contrast, respondents in Dolan and Tsuchiya’s
[32] study were later asked if they would change their mind
if given the ‘everyone gets something’ option and none
chose to revise their answers. Giving all the benefits to the
low SEP groups was not acceptable to 17% of our sample.
We used a convenience rather than a representative
sample—a limitation of the study. Our sample was chosen
for practicality reasons, but also because the participants
worked in health-related areas and were assumed to have
the ability to complete the questions independently. In
Dolan and Tsuchiya’s [32] study, 54% were employed and
60% had the minimum level of education. This sampling
effect may be reflected in a number of ways. A larger
proportion of Dolan and Tsuchiya’s [32] sample chose the
egalitarian option (36 vs. 20%) and this may be a conse-
quence of the academic sample in our study. It has been
suggested that an academic sample is less likely to choose
the simple decision-making heuristic of ‘always choose the
more egalitarian option’ [37]. Deliberating ethical trade-
offs between improving health and reducing health
inequality may be considered cognitively demanding and
the difference in choices in our study may be explained by
how participants understood and processed the questions.
Around 19% of participants violate the monotonicity
principle, the case when any increase in individual health is
not considered an increase in social welfare and concern
for equality dominates the concern for efficiency. This
breaks away from the assumptions of a conventional SWF
in economics, but in the field of health economics is not
inconceivable [38].
Fig. 3 Graphical depiction of the constant elasticity of substitution,
parabolic and hyperbolic functions. A life expectancy at Program A
(80, 86), ces constant elasticity of substitution, D median response
with corresponding life expectancy (80.25, 84), I initial point (78, 84),
SEP socioeconomic position
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Deriving weights based on empirical surveys of stated
preferences poses several problems. There are inherent
issues with this type of data, such as the framing effects,
context and design of the questions. The participants may
not have carefully considered judgements about complex
distributive issues and could benefit from a deliberative
setting. Majority opinion can potentially be morally ques-
tionable [39], and it has, therefore, been suggested that
ethical analysis of empirical results also be carried out [40].
Public opinion by itself may not be appropriate to deter-
mine the specific value of weights [39].
Equity weights for SEP groups have proven to be dif-
ficult to apply in a practical way; there are no published
studies that have used weights for SEP in a CEA. It has
been suggested that weight data may simply be used to help
inform decision makers about which equity considerations
are valued the most, while allowing scope for the decision
maker to decide how much weight to place on these data in
particular circumstances [36].
Other methods, such as deriving weights from peoples’
preferences using regression analysis should be further
explored in future studies. Deriving weights for SEP using,
probit models [35], for example, could result in more
acceptably sized weights to use for weighting cost-effec-
tiveness analyses.
5 Conclusions
The equity weights derived imply that a marginal health
gain to a low SEP group is valued more than a marginal
health gain to a high SEP group. However, the range in the
relative weights obtained was too wide to be of use for the
intended purpose of applying them to CEAs of policies
aimed to prevent health conditions that have a social gra-
dient in Australia. Our results provide evidence to support
the idea that the public may be willing to sacrifice health
gains in order to reduce differences in average life expec-
tancy between SEP groups, and therefore that the objective
of economic efficiency may not have primacy with the
general public.
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 Chapter 6. Equity weights for socioeconomic position: two methods 
This study investigated the second aim of this doctorate: to explore whether 
appropriate equity weights could be derived for use in cost-effectiveness analysis 
studies of Australian obesity prevention policies. This study has been submitted as 
a research article to Value in Health and was revised and resubmitted on 15/03/18 
with the following details:   
Lal A, Mohebbi M, Sweeney R, Moodie M, Peeters A and Carter R. Equity weights for 
socioeconomic position: two methods – using surveys of stated preferences and 
using epidemiological data.  
Discrete choice experiments (DCE) have been shown to be a useful tool for 
investigating preferences for health allocation (Dolan and Tsuchiya, 2011; Norman 
et al., 2013) and provide for a more complete scenario description than other 
methods (such as time trade-off or standard gamble). Norman et al. (2013) used a 
DCE to combine various dimensions such as gender, smoking status and income 
to derive equity weights. In this study, separate equity weights for SEP were 
derived using similar methods to Norman et al. (2013). 
What is already known about the topic? 
Presently, the equity weights for socioeconomic position are unsatisfactory to 
weight health gains in cost-effectiveness analyses of public health interventions in 
Australia. Replication of a previously used method in England, of deriving weights 
using people’s preferences to form a health related social welfare function, 
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resulted in a range of weights that was too large to be used in practice. Deriving 
weights using non-preference based data is an unexplored area.   
What does the paper add to existing knowledge? 
Weights were derived using two distinct types of equity weights that are suitable 
for use in economics evaluations; i) weights based on stated preferences and ii) 
weights based on epidemiological data.  The equity weights derived for health 
gains to the lowest SEP group ranged from 1.3-1.8 based on stated preferences, and 
1.2-1.5 when epidemiological data was employed. This study has demonstrated that 
people are willing to make trade-offs between efficiency and equity.  
What insights does the paper provide for informing policy decision 
making?  
The preference weights indicate that people discriminate in favour of low-income 
groups when it comes to health gains. The epidemiological weights were 
consistent with the preference weights, indicating that people may well find the 
epidemiological approach acceptable. These weights could be used to aid decisions 
makers and stakeholders to explore alternative value judgments around equity in 
public health CEA analyses.  If a program is cost-ineffective yet improves equity, 
the weights could help decision-makers decide how much concern for equity is 
required for the program to be considered value for money.  
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Equity weights for socioeconomic position: two methods – using 
surveys of stated preferences and using epidemiological data  
Abstract 
Introduction 
There is an implicit equity approach in cost-effectiveness analysis (CEA) that values 
health gains of socioeconomic position (SEP) groups equally. An alternative approach 
is to integrate equity by weighting quality adjusted life years (QALYs) according to the 
SEP group.  Our aim was to use two approaches to derive equity weights for use in 
CEA in Australia, in contexts where the use of the traditional non-weighted QALYs 
could increase health inequalities between already disadvantaged groups. 
Methods   
Equity weights derived using epidemiological data employed burden of disease and 
mortality data by Socio-Economic Indexes for Areas (SEIFA) Index quintiles from the 
Australian Institute of Health and Welfare. Two ratios were calculated comparing 
Quintile 1 (lowest) to the total Australian population, and comparing Quintile 1 to 
Quintile 5 (highest).  Preference-based weights were derived using a discrete choice 
experiment survey (n=710). Respondents chose between two programs with varying 
gains in life expectancy going to a low or high income group. A probit model 
incorporating nominal values of the difference in life expectancy was estimated to 
calculate the equity weights.  
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Results  
The epidemiological-based weights ranged from 1.2 to 1.5, with larger weights when 
Q5 was the denominator. The preference-based weights ranged from 1.3 
(95%CI:1.2,1.4) to 1.8 (95%CI:1.6,2.0), with a tendency for increasing weights as the 
gains to the low-income group increased. 
Conclusions 
Both methods derived plausible and consistent weights. Using weights of different 
magnitudes in sensitivity analysis would allow the appropriate weight to be 
considered by decision-makers and stakeholders to reflect policy objectives. 
. 
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Introduction 
In the developed world, the single strongest predictor of an individual’s health is their 
position on the socioeconomic spectrum 1. Those who are more disadvantaged are 
more likely to suffer from disease, have higher mortality rates and lower life 
expectancies 1-6. It is therefore important that policies do not widen health inequities 
between socioeconomic position (SEP) groups. The importance of reducing health 
inequities is recognized globally 7. Action to achieve health equity is considered an 
imperative by the World Health Organization (WHO). As a WHO member state, 
Australia proposes to target people experiencing socioeconomic disadvantage in order 
to reduce health inequities 8. 
Given health budget constraints, policy makers often utilize cost-effectiveness analysis 
(CEA) to inform resource allocation decisions across competing priorities. It is usual 
practice in CEA to focus on ‘efficiency’ defined as maximizing health benefits for a 
given investment or minimizing cost for a specified outcome. Efficiency defined in 
terms of optimising health gain is important, but usually policy objectives also include 
the reduction of health inequities. While policy objectives embrace equity, the 
underlying assumption of economic evaluation is to value health gains of SEP groups 
equally, making it difficult to incorporate equity in a quantitative way. While policy 
objectives embrace equity, the underlying assumption of economic evaluation is to 
value health gains of (SEP) groups equally.  
One approach proposed in CEA is to integrate efficiency and equity by weighting 
quality adjusted life years (QALYs), the common outcome of interest in a CEA, 
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according to characteristics of the people receiving them. These weights can 
quantitatively express the extent to which society is willing to trade overall health 
benefits to promote a more equitable distribution of health. Equity weighting of 
health gains to disadvantaged groups could be useful when there is a trade-off 
between improving total health and health equity. Further, if a program were cost-
ineffective yet improved equity, the weights could help decision-makers decide the 
level of concern for equity required for the program for it to be considered value for 
money. This could be particularly important for remote areas where service delivery 
can be expensive. 
This study is focused on deriving equity weights for SEP. Currently, there is a lack of 
consensus on the algorithm for deriving equity weights 9. Previous studies on the 
derivation of such equity weights, have focused on stated preferences of members of 
the population or politicians. Discrete choice experiments have been shown to be a 
useful tool for investigating preferences for health allocation 10, 11. Norman et al. (2013), 
for example, combined various dimensions such as gender, smoking status and 
income to derive equity weights. However, separate equity weights for SEP by itself 
were not derived. In our study, we seek to derive equity weights for one dimension, 
SEP, using use a discrete choice experiment and the Norman et al. 10 methodology.  
Health economics has been influenced more recently by the ‘Decision Maker 
Approach’ (DMA) to economic evaluation, whereby the objectives of decision-makers 
are emphasised in social welfare theory 12. Under this approach, the weighting of 
outcomes need not be preference-based as with other normative foundations (such as 
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Orthodox economics that focuses on the market and responses to price signals and 
Extra-welfarism that focuses on health-related quality of life preferences). DMA allows 
for value to be assessed by means in addition to individual preferences for health, 
including need and reasoned argument 13. Burden of disease estimates, for example, 
are well established and provide reliable estimates of health needs experienced across 
socioeconomic groups 14. There is, therefore, a justification in economic theory for the 
use of robust, epidemiological data to derive equity weights.  
This paper presents two distinct ways of deriving equity weights for the most 
disadvantaged socioeconomic groups for use in economic appraisal. These weights 
could be applied to economic evaluations and priority setting exercises regardless of 
intervention or disease.  Equity weights for SEP are derived first, based on 
epidemiological differences between SEP groups, and second, based on people’s 
preferences using a discrete choice experiment. While reflecting different normative 
foundations in economics, the two methods of deriving the weight could be 
considered complementary. We discuss their merits and the suitability of the resultant 
weights for use in different contexts.  
 
Methods 
Equity weights were derived for the purpose of adjusting the health gains of 
disadvantaged groups. If the health gains of a group are valued more highly, the equity 
weight for that group would exceed one. The weights can then be used to adjust the 
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QALY gains resulting from an intervention in that group to be relatively higher than 
without equity weights.  
Calculation of equity weights based on epidemiological data 
Overview 
We explored health inequalities across SEP quintiles in selected population health 
indicators, viz: disability adjusted life years (DALYs) and all-cause mortality. To 
calculate the weights for each indicator, two ratios were used: Quintile 1/total 
Australian population and Quintile 1/Quintile 5. 
Socioeconomic position 
For the calculation of weights based on epidemiological data, socioeconomic position 
is represented by the Socio-Economic Indexes for Areas (SEIFA) Index of Relative 
Socio-Economic Disadvantage (IRSD) as measured by the Australian Bureau of 
Statistics (ABS). SEIFA quintiles represent groups of individuals who live in similarly 
ranked areas, based on a range of information such as income, qualifications and 
occupation skills 15. Each quintile comprises 20% of the population. The most 
disadvantaged group is SEIFA Quintile 1 (Q1).  
Equity weights based on burden of disease 
Burden of disease analysis measures the combined impact of fatal and non-fatal 
burden and considers age at death and severity of disease. The effects of different 
diseases are quantified in a consistent way and combined into a summary measure – 
the disability adjusted life year (DALY). DALYs are a combination of the estimates of 
years of life lost due to premature death (YLL) and years lived in ill health or with 
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disability (YLD), to take into account the total years of healthy life lost from disease 
and injury. The estimates of burden of disease are well established and perhaps the 
most widely used summary measure of a population’s health 14. 
Equity weights based on the Australian burden of disease estimates in 2011 16 were 
calculated as a rate ratio using the following formulae: 
Equity weight A =  
𝐴𝐴𝐴𝐴𝐴𝐴 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑡𝑡 𝐷𝐷𝐴𝐴𝐷𝐷𝐷𝐷 𝑏𝑏𝑏𝑏𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑄𝑄𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝐴𝐴 1
𝐴𝐴𝐴𝐴𝐴𝐴 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑡𝑡 𝐷𝐷𝐴𝐴𝐷𝐷𝐷𝐷 𝑏𝑏𝑏𝑏𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝐴𝐴𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑠𝑠𝑠𝑠    
Equity weight B =  𝐴𝐴𝐴𝐴𝐴𝐴 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑡𝑡 𝐷𝐷𝐴𝐴𝐷𝐷𝐷𝐷 𝑏𝑏𝑏𝑏𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑄𝑄𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝐴𝐴 1
𝐴𝐴𝐴𝐴𝐴𝐴 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑜𝑜𝑜𝑜 𝑠𝑠𝑜𝑜𝑠𝑠𝑠𝑠𝑡𝑡 𝐷𝐷𝐴𝐴𝐷𝐷𝐷𝐷 𝑏𝑏𝑏𝑏𝑠𝑠𝑠𝑠𝐴𝐴𝑠𝑠 𝑄𝑄𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝐴𝐴 5    
Equity weights based on all-cause mortality rates   
All-cause mortality is all deaths in a population irrespective of cause. Australian 
mortality rates were obtained from the Australian Institute for Health and Welfare 
(AIHW) 17. Mortality rates were calculated using the following formula: 
𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 𝑜𝑜𝑜𝑜 𝑑𝑑𝑁𝑁𝑑𝑑𝑑𝑑ℎ𝑠𝑠 𝑁𝑁𝑁𝑁𝑟𝑟𝑟𝑟𝑠𝑠𝑑𝑑𝑁𝑁𝑁𝑁𝑁𝑁𝑑𝑑 20142014 𝑝𝑝𝑜𝑜𝑝𝑝𝑁𝑁𝑝𝑝𝑑𝑑𝑑𝑑𝑟𝑟𝑜𝑜𝑝𝑝 × 100,000 
All mortality rates were directly age-standardised to the 2001 Australian standard 
population. These are revised every 25 years as recommended by the ABS and the 
AIHW, to align the revision cycle to represent the timespan of a generation 18. 
Equity weights based on all-cause mortality were calculated as a rate ratio using the 
following formulae: 
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Equity weight C =  
𝑀𝑀𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑠𝑠𝑠𝑠𝑀𝑀 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑄𝑄𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝐴𝐴 1
𝑀𝑀𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑠𝑠𝑠𝑠𝑀𝑀 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝐴𝐴𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑠𝑠𝑠𝑠𝑠𝑠 𝑝𝑝𝑜𝑜𝑝𝑝𝑏𝑏𝑡𝑡𝑠𝑠𝑠𝑠𝑠𝑠𝑜𝑜𝑠𝑠  
Equity weight D =  
𝑀𝑀𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑠𝑠𝑠𝑠𝑀𝑀 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑄𝑄𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝐴𝐴 1
𝑀𝑀𝑜𝑜𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑠𝑠𝑠𝑠𝑀𝑀 𝑠𝑠𝑠𝑠𝑠𝑠𝐴𝐴 𝑄𝑄𝑏𝑏𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝐴𝐴 5  
Calculation of preference based weights 
Overview  
The second part of the study used a discrete choice experiment survey designed to 
elicit population preferences regarding the allocation of health gain between 
hypothetical groups of potential participants. Discrete choice experiments are a widely 
acceptable method in health economics for direct evaluation of different policy-
relevant attributes of health care 19. A random-effects probit model using a generalized 
estimation equation (GEE) approach (i.e. population average model) 20was estimated, 
and the results were converted to equity weights.  
Discrete Choice Survey 
Participants (n=727) were asked to imagine they were helping the Health Department 
to choose between alternative hypothetical health programs that involved a choice 
between two attributes – ‘efficiency’ (defined as increasing the life expectancy of 
beneficiaries), and ‘health equity’ (defined indirectly through the income level of 
beneficiaries). The decision was taken to construct a simple design, as it was 
important to maximize comprehension of the questions and meant attributes and 
levels could be based upon the literature rather than qualitative focus groups. The 
average life expectancy (LE) of high and low income groups in Australia was used: 81 
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years for high-income and 75 years for low-income 5and consistent with Dolan et al21 
remained fixed throughout the choice sets. Two levels for income were included (high 
and low), and four levels of LE gain (1, 3, 6 or 10 years). The survey contained 11 choice 
sets (Table 1). This resulted in nine levels of LE gain differences, for example 1-3 = -2. 
The choice sets were chosen from the combinations of predicted range in life years 
lost associated with obesity related diseases  (1 , 3 ,6 or 10 years) 22, having regard to 
cognitive load, policy relevance and survey feasibility. We chose to include all possible 
combinations of 1, 3 and 6 years, as well as the sets containing the lowest and highest 
values (10 and 1, 1 and 10) in order to derive weights for the largest possible difference 
in years. We did not incorporate all choice sets containing 10 years because we 
considered the subset chosen to be adequate for the range of difference in years 
desired. We also thought there would be less burden and better engagement with 
participants with less questions. Binary levels were used for each dimension, that is, a 
choice of increase in life expectancy and income level from two options.  
Participants were told that, on average in Australia, people from high income groups 
live around 6 years longer than persons from low income groups and each participant 
was asked 11 choice exercises where income level and increase in life expectancy were 
varied. To prevent position bias the options were presented as A and B and were 
randomized. An example question is provided in Figure 1. (see Appendix 2 for full 
survey). 
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Table 1.  The 11 choice sets  
Choice set Income 
level 
LE Gain 
1 High 1 
Low 1 
2 High 1 
 Low 3 
3 High 1 
 Low 6 
4 High 1 
 Low 10 
5 High 3 
 Low 1 
6 High 3 
 Low 3 
7 High 3 
 Low 6 
8 High 10 
 Low 1 
9 High 6 
 Low 1 
10 High 6 
 Low 3 
11 High 6 
 Low 6 
Notes: LE, life expectancy. 
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Figure 1: Example of survey question
 
This study used online methods to recruit people from around Australia. An online 
panel company (CINT Pty Ltd) sent a link to the survey to people on their database 
until quotas for specific demographic characteristics such as sex, age and education 
were achieved. Quotas were imposed in an attempt to achieve a demographically 
representative profile of the Australian adult population in 2011. Each survey 
respondent was paid a small amount depending on the time spent completing the 
survey. The survey was accessed via a web link enabling participants to complete the 
survey at their own convenience. Background to the questions and an explanation of 
the task was provided at the beginning of the survey. After completion of the 11 
questions, there was the option for respondents to make further comments regarding 
the survey.    
Analysis 
A utility model (Utility Function 1) was used as per the methods of Norman et al 
(2013) in which the utility function 𝑗𝑗 in the choice set 𝑠𝑠 for survey respondent 𝑟𝑟 was 
assumed to be:  
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𝑈𝑈𝑠𝑠𝑠𝑠𝑖𝑖 = ∝ GAIN𝑠𝑠𝑠𝑠𝑖𝑖 +  𝛽𝛽𝑋𝑋′𝑠𝑠𝑠𝑠𝑖𝑖 GAIN𝑠𝑠𝑠𝑠𝑖𝑖  + 𝑣𝑣𝑠𝑠 + 𝜀𝜀𝑠𝑠𝑠𝑠𝑖𝑖    (1) 
GAIN is the gain in total life expectancy (LE) accruing to the hypothetical population 
group if the intervention was implemented and 𝑋𝑋𝑠𝑠 is the income level of the 
hypothetical income group. GAIN was calculated by subtracting the stated gain in LE 
of the low-income group for a given question, from the stated gain in LE for the high-
income group for that same choice. GAIN had the following possible values: -9, -5, -3, 
-2, 0, 2, 5, and 9 years. The error term (𝑣𝑣𝑠𝑠 + 𝜀𝜀𝑠𝑠)  comprises of a person-specific error 
term distributed independently and identically (iid) normal and a conventional 
random error term distributed iid normal. We considered a population average probit 
model using a robust method for estimating standard errors 23. This approach 
implemented a person-specific error term 𝑣𝑣𝑠𝑠 to take into account for the fact that 
choices made by an individual are not independent.  
To consider the possible nonlinearity of utility with respect to gain in total LE, a more 
flexible utility function indicated as Utility Function 2 was considered 10. 
𝑈𝑈𝑠𝑠 =  ∝ GAIN𝑠𝑠𝑠𝑠𝑖𝑖 + 𝜌𝜌GAIN𝑠𝑠𝑠𝑠𝑖𝑖2 +  𝛽𝛽𝑋𝑋′𝑠𝑠 GAIN𝑠𝑠𝑠𝑠𝑖𝑖  + 𝜏𝜏𝑋𝑋′𝑠𝑠𝑠𝑠𝑖𝑖GAIN𝑠𝑠𝑠𝑠𝑖𝑖2 + 𝑣𝑣𝑠𝑠 + 𝜀𝜀𝑠𝑠𝑠𝑠𝑖𝑖 (2) 
By introducing the 𝜌𝜌GAIN𝑠𝑠2term in Utility Function 2, the linearity of utility with 
respect to GAIN is relaxed. Also, by introducing the 𝜏𝜏𝑋𝑋′𝑠𝑠𝑠𝑠𝑖𝑖GAIN𝑠𝑠𝑠𝑠𝑖𝑖2  term the assumption 
is relaxed that the change in total utility associated with the health gain being received 
by a different group of hypothetical respondents is independent of the total gain 10.   
Utility function 1 assumes a linear link between gain and outcome, Utility function 2 
assumes a quadratic link between gain and outcome, and we also considered Utility 
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function 3 that assumes no parametric link between gain and outcome. As such, there 
is no specification of Utility function 3. Under Utility function 3, GAIN values of -9, -5, 
-3, -2, 0, 2, 3, 5, and 9 were considered nominal values rather than an interval scale 
measurement. Each nominal value of GAIN was compared with a reference value of 
zero GAIN. 
We compared performance (model fit) of the three different Utility functions: linear, 
quadratic and nominal using Akaike's and Schwarz's Bayesian information criteria 
(AIC and BIC) 24. AIC and BIC are information-based criteria that assess model 
goodness of fit. When comparing AIC and BIC values, the model with the smallest AIC 
and BIC value is usually the preferred model. 
Norman et al 10 derived equity weights using the marginal rates of substitution 
method, using GAIN as the value being compared. The value of an additional year of 
life for a hypothetical group was divided by the value of an additional year of life for a 
reference group based on Australian averages. However, because their hypothetical 
group had several dimensions, such as whether they were carers or smokers, this 
method was not suitable for our simplified DCE where income level was the only 
group characteristic.  
To derive our equity weights, we first compared the models using AIC and BIC 
statistics to determine the best fit. We then calculated the chance of the low-income 
group receiving GAIN by taking the exponential of the coefficients obtained from the 
RE probit, using GAIN = 0 as the reference category with a weight = 1. Weights were 
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derived for differences in GAIN to the low-income group of -9, -5, -3, -2, 0, 2, 3, 5, and 
9 years.  
Observable Heterogeneity  
To investigate heterogeneity in responses by the characteristics of respondents, we 
stratified the sample by sex, age, personal income and education level. It was then 
possible to determine whether their responses differed by age group, for example, 
using multivariate models.    
Results 
Epidemiology equity weights 
The weights based on epidemiology of population groups in Australia ranged from 1.21 
to 1.54. Table 2 presents the equity weights based on the ratios of: 1) burden of disease; 
and 2) all-cause mortality, for Q1 (lowest)/Q5 and Q1/the Australian population. 
Regardless of whether burden of disease or all-cause mortality was used, the derived 
weights were very similar. By construction, the weights are higher for the ratio Q1/Q5 
than Q1/the Australian population. 
Table 2 Equity weights based in epidemiological data 
 Quintile 1 v. Quintile 5 Quintile 1 v. Australian 
population 
Burden of disease  1.54 1.21 
All-cause mortality 1.46 1.18 
Notes: The ratios were derived based on actual Australian population numbers and 
not a sample, therefore standard errors or confidence intervals are not necessary. 
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Preference based equity weights 
Of the 727 people who started the survey, 710 completed all the questions, giving a 
completion rate of 98%. In the free text responses, respondents gave reasons for the 
choices they made and indicated that they had a general understanding of the 
questions.  
Table 3 compares the demographic details of the sample to the Australian population 
in 2011. The sample’s representativeness differs by characteristic. The breakdown by 
sex and location across Australian states is close to the total population. People in the 
sample were generally older, more educated and have a higher income than average.   
For the choice sets where the GAIN did not differ between the income groups, 62-66% 
of respondents chose the low-income group for the gains.   
The results of the RE probit models for Utility Functions 1, 2 and 3 are presented in 
Table 4. Under all Utility Functions, respondents were willing to favour programs with 
a greater health gain to the low-income group. The coefficient GAIN shows a similar 
pattern in all Utility Functions. For example, Utility Function 1 will increase by 0.0758 
(SE 0.0039) for each unit increase in GAIN to the low-income group. The GAIN effects 
remained statistically significant at the 5% level when the quadratic term GAIN2 was 
added (0.0755, SE 0.0039 Utility Function 2). There is a general GAIN trend observed 
in Utility Function 3 which sees increases in preference for the low-income group as 
the number of years increases, starting at -0.6585 (SE, 0.0478) for -9 years, increasing 
to 0.5648 (SE 0.0556) for +9 years. 
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Table 3: Survey sample demographics and representativeness 
 Variable  Sample 
(%) 
Population 
(%) 
Sex  Female 52.0 51.1 
Age  18-35 21.6 30.2 
36-55 45.8 36.4 
56 and over 32.7 33.4 
Education 
Level  
High school 24.9 47.1 
Trade, associate degree 33.1 30.6 
Bachelor degree or higher 42.0 22.2 
Income  <$32,000 34.4 51.4 
$32,000-$64,999 29.3 28.8 
$65,000-$103,999 26.2 13.0 
$104,000+ 10.1 6.8 
Location  New South Wales 32.3 32.0 
Victoria 27.2 24.9 
Queensland 20.6 20.1 
South Australia 8.2 7.2 
Western Australia 9.6 11.0 
Tasmania 1.3 2.2 
Australian Capital 
Territory 
1.0 1.6 
 
Personal income is significant in all three models. There is an adverse dose response 
association between personal income, both as an ordinal categorical factor (Utility 
Functions 1 and 2) and a nominal 4 levels factor (Utility function 3), with participants’ 
tendency to choose the program benefiting the low-income group. It is evident that 
the negative beta coefficients for personal income levels in Table 4 decrease from 0 in 
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the lowest personal income level to -0.4 in the highest personal income level, 
indicating as personal income increases, participants were less likely to choose the 
program benefiting the low-income group. This is also evident from negative beta 
coefficients for linear personal income models. (Utility Functions 1 (-0.1407, SE 
0.0365) and 2 (-0.1405, SE 0.0364).  
Sex, age and education level of participants were not significant in Utility Functions 1 
and 2, but models with age, sex and education level had better fit compared to models 
that excluded these factors (Wald chi2 = 529.74, df: 31, p=0.03). Therefore, they were 
included in further analyses. Two-way interactions were tested for all models and 
none were significant. 
For the calculation of the weights, the three utility functions in Table 4 were 
investigated; a linear, a quadratic and a nominal utility function that does not assume 
any parametric trend for utility weights. To compare the models’ fit, AIC and BIC 
criterion were used. There was a significant difference between Utility Function 1 
(linear) and Utility Function 2 (non-linear) (p = 0.001), and according to AIC and BIC 
values the non-linear model has better fit. There were also significant differences 
between Utility Function 2 and Utility Function 3 (nominal factors) (p < 0.0001), in 
addition AIC and BIC for the nominal model had the smallest values between the 
three candidate models. This means the nominal utility function (Utility Function 3) 
has better model performance compared to the linear and quadratic utility functions. 
Therefore Utility function 3 is the preferred choice for the calculation of the weights.  
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Table 4: Probit model results of the three utility functions 
 Utility 
Function 1 (SE) 
Utility Function 2 
(SE) 
Utility Function 3 
(SE) 
Constant 0.5539 (0.2226)** 0.5308 (0.2375)**     
Gain (years)† 0.0758 (0.0039)*** 0.0755 (0.0039)***  
Gain2 ††  -0.0007 (0.0004)  
Gain (nominal)†††    
Gain = -9 years   -0.6585 (0.0478) *** 
Gain = -5 years   -0.6295 (0.0456) *** 
Gain = -3 years   -0.0445 (0.0269) 
Gain = -2 years   -0.4353 (0.0399) *** 
Gain = 0 (no gain)   (base) 
Gain = 2 years   0.2387 (0.0345) *** 
Gain = 3 years   0.2330 (0.0367) *** 
Gain = 5 years   0.4202 (0.0434) *** 
Gain = 9 years   0.5648 (0.0556) *** 
Sex (ref. female) -0.0612 (0.0745) -0.0646 (0.0744) -0.0078 (0.0660) 
Age (23-35, 36-55, 55+) 0.0592 (0.0503) 0.0645 (0.0502) 0.1383 (0.0351) *** 
Education level (high 
school, trade or 
university) 
0.0080 (0.0486) 0.0069 (0.0486) 0.0447 (0.0442) 
Personal income# -0.1407 (0.0365)*** -0.1405 (0.0364)***  
Personal income 
(nominal)## 
   
<32,000   (base) = 0 
32,000-64,999   -0.2107 (0.0990) ** 
65,000-103,999   -0.2987 (0.1007) ** 
104,000+   -0.4018 (0.1316) ** 
Wald chi2 (df) 394.0.3 (5) 408.04 (6) 483.23 (13) 
AIC 6600.5 6601.0 6488.6 
BIC 6649.2 6656.7 6593.0 
Table Notes: Values presented as means. **5% level of statistical significance. ***1% level of statistical 
significance. Sex, age, education level and personal income relate to the respondents characteristics,† 
Linear gain was used in utility weight function 1, and 2; †† Quadratic gain was used in utility weight 
function 2; ††† Nominal gain was used in utility weight function 3; # Linear income was used in utility 
weight function 1, and 2; ## Nominal income was used in utility weight function 3. 
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The equity weights based on Utility Function 3 were derived by taking the exponential 
of the coefficients obtained from the RE probit of the Gains for Utility Function 3. 
(Table 5) GAIN = 0 is the reference category with a weight = 1. The weights represent 
the chance of the low-income group receiving the gain as the level of GAIN changes. 
The weights ranged from 0.52 (95% CI: 0.47, 0.57) to 1.76 (95% CI: 1.58, 1.96), with 
the tendency for increasing weights as the GAIN to the low-income group increased. 
Utility function 3 used for the calculation of the weights does not assume any trend for 
GAIN. This explains why the weight of 0.75 for -3 GAIN is larger than the weight of 
0.65 for -2 GAIN.  
Equity weights for the positive gains in life expectancy for the low-income group, that 
is 1.25 – 1.76, could be applied in practice, by weighting QALY gains in the most 
disadvantaged group. For example, for an intervention targeted to a low SEP group, 
applying a weight of 1.52 to 20,000 QALYs gained would increase the amount of 
QALYs to 30,400. The weights less than 1 are not intended for practical use. The 
weights are intended to be applied to increase the health gains of disadvantaged 
groups, a requirement therefore is that they are greater than 1. 
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Table 5: Equity weights derived from Utility Function 3 for the low-income 
group 
GAIN (years)* Equity weight (95% CI) 
-9 0.52 (0.47, 0.57) 
-5 0.53 (0.49, 0.58) 
-3 0.75 (0.69, 0.81) 
-2 0.65 (0.60, 0.70) 
0 1 
2 1.27 (1.19, 1.36) 
3 1.25 (1.16, 1.34) 
5 1.52 (1.40, 1.66) 
9 1.76 (1.58, 1.96) 
Table Notes: *GAIN indicates gain in life expectancy to the low-income group. For example -9 
indicates a 9 year gain to the high- income group. 
 
Discussion 
In our study the equity weights derived for health gains to the lowest SEP group 
ranged from 1.3-1.8 based on stated preferences, and 1.2-1.5 when epidemiological data 
was employed. The discrete choice experiment in this study has demonstrated that 
people are willing to make trade-offs between efficiency and equity and that health 
gains are valued differently, depending on which SEP group receives the gain. Simple 
maximization of total health was shown not to be the basis on which most people 
make health resource allocation decisions, supporting the results of previous studies 10, 
21, 25-30. The weights from all-cause mortality and burden of disease data resulted in 
very similar weights when the same reference groups were used, thus supporting the 
consistency of the weights. The epidemiological weights for Q1/Q5 using all-cause 
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mortality, burden of disease and the corresponding preference based weight for the 
gain in life expectancy of 5 years are very similar at 1.46, 1.54 and 1.52 respectively. 
Our weights are not directly comparable to the weights of Norman et al (2013), as 
theirs covered other dimensions of the hypothetical group, in addition to income 
level. This is the first study, to the best of our knowledge, to derive preference-based 
equity weights for SEP that could be applied in practice. People’s preferences have 
been the conventional method for valuing equity weights and we also believe this to 
be the first study to use epidemiological data to calculate weights for a disadvantaged 
SEP group. Equity weighting of health gains to disadvantaged groups is useful when 
there is a trade-off between improving total health and health equity. The weights 
derived could be used to aid decision-makers and stakeholders to explore alternative 
value judgments around equity. If a program is cost-ineffective yet improves equity, 
the weights could help decision-makers decide the level of concern for equity required 
for the program to be considered value-for-money. For example, a program with an 
incremental cost effectiveness ratio of $75,000/QALY could be reduced to $50,000 if 
an equity weight of 1.5 was applied.  
We used two different measures of SEP in the two approaches to equity weighting. 
This was necessary due to the epidemiological data being only available by SEIFA and 
not by income. It is common for health surveillance surveys to lack SEP data at the 
individual level. Area-based socioeconomic measures may omit substantial 
proportions of individual variation in education and income 31 but there is evidence 
that area-based measures capture the complex relationship between various economic 
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and social phenomenon that cannot be picked up by individual-based measures 32. 
Income was used as the SEP indicator in the stated preferences approach to facilitate 
ease of understanding. Ideally, the comparison of the two approaches would be more 
appropriate if we had used the same measure of SEP for both approaches.  
The purpose of the equity weight is to compensate for differences in health status that 
are systematically associated with social disadvantage. It would therefore be 
inappropriate to apply such weights to smokers for example, who may have lower life 
expectancy due to a freely chosen health-damaging behaviour.   
The choice of which approach to deriving the weight would depend on the preferences 
of stakeholders and policy makers. The epidemiological approach would be more 
suitable when resources for decision-makers are limited and a DCE is unlikely to 
occur. In the epidemiological approach two weights were calculated; one that 
compares the lowest quintile with the population average (A), the other compares the 
lowest quintile with the highest quintile (B). Each approach might be considered more 
preferable in different policy contexts. For example, (A) would be informative if the 
objective is to reduce average health-loss differences but maintain the current social 
gradient and (B) would be most appropriate where the policy objective is to reduce 
inequalities. Both sets of weights could be utilised in sensitivity analyses and 
considered as alternative equity parameters. Similarly, a low and high weight could be 
utilised if preference-based weights are used. Equity weighting analysis does not have 
to be used as an algorithm for resource allocation decisions 33. Rather, it is 
recommended that it be used as a tool to aid decision-making. Using different weights 
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in sensitivity analysis would allow the exploration of alternative value judgements 
around equity 33. 
We acknowledge some limitations in the design of the DCE. The choice sets were 
based on a format used by Dolan et al 21, with life expectancies that remain fixed. This 
was of interest to us as it reflects the inherent differences in life expectancy between 
the income groups. We therefore did not include all possible combinations of life 
expectancy in the choice sets, but we considered the subset chosen to be adequate for 
the range of difference in years desired. In doing so, we aimed to reduce the burden on 
participants. Additionally, prospect theory states that losses and gains are valued 
differently 34 and it is possible that posing the questions as gains in life expectancy 
rather than losses, could have resulted in framing effects. It is also possible that 
simplifying heuristics may have contributed noise to our data 35 The ‘take the best’ 
heuristic may have led to people choosing the group with the most health gains, 
however this health maximisation approach was not chosen by most respondents.  
We used an online panel company for the recruitment of participants and it is 
arguable that online panel participation is correlated with certain undetectable 
characteristics. Our sample was over-represented in the ages of 36-55 years, and with 
persons with higher education and higher incomes. Whilst quotas were applied to 
obtain a target number of respondents in each demographic group, it became 
apparent that quotas needed to be modified for age to obtain the desired sample size. 
We did not detect any differences based on education or in the age group that was 
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over-represented. However, there was a positive association with GAIN to the high-
income group as own income increased.  
We derived equity weights based on both epidemiological data and preferences to 
compare the methods and weights obtained. It could be argued that both sets of 
weights are valid, however deriving weights based on surveys of stated preferences can 
lead to several problems. There are inherent issues with this type of data, such as the 
context and design of the questions. The participants may not have carefully 
considered these distributive issues, and could have been aided by a deliberative 
setting. Objective data does not have these limitations.  
The results also indicate that as personal income increases individuals were less likely 
to choose the program that benefited the lowest income group. This could be 
interpreted as higher income groups being biased toward their own income group and 
the potential for their own gain. Epidemiological-based weights do not have these 
weaknesses and may therefore be considered a more suitable approach given the 
equity aim.  
One of the other strengths of the epidemiological weights method was the ease of 
obtaining the freely available data. The epidemiological weights were consistent with 
the preference weights, indicating that people may well find the epidemiological 
approach acceptable. However, even if it was coincidental that the preference-based 
weights are similar in magnitude to the epidemiological-based weights, it could be 
argued from a decision-maker perspective that calculating weights using unbiased 
epidemiological data would enable policy makers to reduce health inequity in an 
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ethical manner. Further research could be undertaken to see which weights are more 
acceptable to policy makers and to the public.    
There are measures of SEP similar to the SEIFA IRSD in other countries, enabling 
replicability of the results in other contexts. For example, in the UK, the Index of 
Multiple Deprivation (IMD) quintiles, incorporates measures of deprivation across 
domains of income, employment, health and disability, education and training, 
housing and services, living environment and crime. These indices are also available in 
South Africa, Northern Island, New Zealand and Scotland. 
Our aim was to derive weights that could be used in economic analysis of policies and 
programs in Australia; particularly in contexts where using the traditional non-
weighted QALYs could increase health inequalities between already disadvantaged 
groups. Application of our equity weights is the next step and it is hoped that they can 
be used to aid decisions makers and stakeholders faced with difficult trade-offs 
between equity and cost-effectiveness.    
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Chapter 7. Discussion and conclusions 
This chapter details the key findings on the specific research questions, followed 
by a discussion of the significance, merits and limitations of the studies. A 
synthesis of the implications of the findings for policy-makers is presented and 
recommendations for future research are explored.   
7.1 Research Question 1: How can equity be incorporated in cost-
effectiveness analyses of obesity prevention policies? 
The aim of this question was to explore the existing methods that provide 
evidence about health equity impacts and trade-offs in CEAs for public health 
interventions. Paper 1 (Chapter 3) systematically reviewed studies that have used 
socioeconomic position (SEP) subgroup analysis in CEA to incorporate equity into 
the analysis. The review revealed that while often discussed, implementation is 
rare. Incorporation of equity impacts into applied CEA is still relatively new and 
more work is required on the interpretation and comparison of the measures 
being reported in order to maximise the usefulness of the information.  
My paper showed that the key methods for addressing health equity concerns in 
CEA included: i) the use of health inequality measures to show the differences in 
health gains between SEP groups when two or more interventions are being 
compared; ii) the analysis of financial impacts, such as out-of-pocket treatment 
expenditures avoided across groups; iii) the use of subgroup specific morbidity and 
mortality data in the modelling and iv) the use of equity weights. The use of equity 
impact analysis techniques within economic analyses of public health 
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interventions is limited, with only 14 published CEAs comparing health impacts 
across SEP groups.   
Building on this literature base, Paper 2 (Chapter 4) incorporated the appropriate 
methods for the quantification of equity into a CEA of an obesity prevention policy 
for Australia. The aim of this paper was to apply equity impact methods for 
application in a CEA of a 20% sugar-sweetened beverage tax. Specifically, the 
distributional effects across SEP groups were investigated, in terms of both health 
and financial effects and a health equity impact analysis was conducted to 
compare different tax scenarios. The findings suggested that an SSB tax in 
Australia would be a ‘win-win’ in terms of both health equity and cost-
effectiveness. 
For the first time in a CEA of a sugar-sweetened beverage tax, each quintile of 
area-level socio-economic disadvantage was modelled separately. The analysis 
demonstrated that 49.5% of the total health gains in health adjusted life years 
(HALYs) would accrue to the two most disadvantaged quintiles. Five different tax 
scenarios were compared for their health equity impacts using concentration 
indices. The scenarios varied in the tax amounts and the included drinks, and all 
had a negative concentration index, indicating that the highest proportion of 
HALYs gained would be amongst the most disadvantaged quintiles. The 50% pass-
through of a 20% tax and the 50¢ per litre tax had the largest negative indices, 
indicating the most equitable scenarios.  
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In terms of financial impacts, the estimated increase in annual expenditure on 
SSBs was highest in the lowest SEIFA quintile compared to the highest quintile 
(0.54% increase vs 0.32% of expenditure on food and non-alcoholic drinks), 
representing a difference of less than AUD 5.00 per year. However, healthcare 
cost-savings as a percentage of household expenditure by quintile, were highest in 
the most disadvantaged groups as a percentage of household expenditure when 
compared to the least disadvantaged (1.23% vs 1.11%). Over the lifetime of the 
population cohort, the tax would save $1.7b (95% CI: $650m; $2.7b) in healthcare 
costs from $435.7b (95% CI: $308.1, $564.7) lowest SEIFA quintile to $254.7b (95% 
CI: 217.5, 296.0) in the highest quintile and raise $642m annually (95% CI: $348m; 
$1,117m). 
To my knowledge, this is the first study to examine the effects of an SSB tax across 
SEP groups on healthcare cost-savings (both overall and out-of-pocket), and on 
health gains in health adjusted life years (HALYs). The modelling used SEP-
specific SSB consumption, body mass index, morbidity and mortality data, and is 
the first CEA in Australia to examine an obesity prevention policy across SEP 
groups. Previous CEAs of SSB taxes have confined themselves to an examination of 
the impacts on the total population (Long et al., 2015; Veerman et al., 2016).   
These findings build on the growing evidence that a tax on SSBs would deliver the 
largest health gains for the lowest socioeconomic groups. The SSB tax in Mexico 
has been effective in reducing consumption of SSBs, with larger decreases for low-
income households (Colchero et al., 2017). A previous modelling study from 
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Australia showed that heavy purchasers of SSBs, particularly those from low-
income groups, would experience greater weight reductions (Sharma et al., 2014). 
The higher weight losses reported in that study compared to ours, can be 
attributed to age and sex differences in our modelling; we used age and sex 
specific consumption of SSBs giving more precise estimates, whereas Sharma et al 
(2014) used population average consumption.    
A recent systematic review describing the weight outcomes and financial burden 
of an SSB tax across different SEP groups identified seven studies examining 
weight outcomes, all with either similar reductions in weight across SEP groups or 
greater reductions for lower compared with higher SEP groups (Backholer et al., 
2016). The review reports on five studies that found the tax would be financially 
regressive, but with small differences of approximately USD 5.00 per year between 
high and low income households. This thesis reinforces these previous findings 
that for a 20% value-added tax in Australia, whilst the financial burden would be 
felt more by low SEP groups, the health gains would be disproportionately 
accumulated in those groups. 
The main limitations of this study, as with all studies based on simulation models, 
is that the results represent the best estimate of a potential effect in the absence of 
direct evidence. One of the main challenges of analysing distributional equity 
impacts is the data requirements. In the absence of income specific input data, an 
aggregate area-based indicator of SEP (SEIFA) was used, which is based on a range 
of information such as the income, qualifications, and occupation skills of the area 
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residents (Australian Bureau of Statistics, 2013). We have assumed that price 
elasticities for SEIFA quintiles would be similar to the price elasticities for the 
corresponding income group, that is, the most disadvantaged SEIFA quintile was 
matched with the lowest income group (Sharma et al., 2014).   
The societal savings from the intervention are likely to be substantially 
underestimated, especially to those in the most disadvantaged groups. This is 
because the model does not incorporate the effects of reduced SSB consumption 
on oral health or indirect costs, such as reduced productivity due to absenteeism 
and disability.  
Performing this type of distributional analysis will better inform policy decisions, 
particularly when the equity of a policy is questionable. I was able to explicitly 
demonstrate the health and financial impacts of the policy for each SEIFA quintile, 
as well as compare different policy scenarios for their equity impacts. I would 
recommend this type of analysis when for the policies under consideration there is 
evidence of differential effects by SEP that could potentially result in inequity.  
7.2 Research Question 2: Are there appropriate equity weights for use in 
Australian CEA studies for obesity prevention policies? 
Equity weighting analysis explores the level of concern for equity required for 
decision-makers to choose fairer but less cost-effective policy options. These 
weights can quantitatively express the extent to which society is willing to trade 
overall health benefits in order to promote a more equitable distribution of health. 
If the health gains of a group are valued more highly, the equity weight for that 
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group would exceed 1. The weights can then be used to adjust the QALY gains 
resulting from an intervention in that group to be relatively higher than without 
equity weights. This may offset, for example, the higher costs in service provision 
for this group. Currently, there is a lack of consensus amongst health economists 
for the algorithm of deriving equity weights. My second research question aimed 
to investigate whether appropriate equity weights exist for use in cost-
effectiveness analyses of Australian obesity prevention policies.  
Two studies have derived demand-side weights for SEP based on stated 
preferences valued between 6.8‒9.9 (Dolan and Tsuchiya, 2011; Wiseman, 2004). 
Because these two studies used different methods for both the elicitation of 
preferences and the calculation of weights, it is not clear whether their weights 
differ due to the method of deriving the weights or due to underlying consumer 
preferences. A previous Australian study asked participants to allocate a budget of 
$10m to health programs benefiting low and high income groups (Wiseman, 
2008). The quality of the study is questionable, however, given that: i) 50% of the 
373 respondents were from a convenience sample; ii) respondents experienced 
problems in answering the questions; and iii) 20%-27% of respondents did not 
answer the priority setting questions. Further, whilst they derived weights from 
two different methods, no guidance was provided on intended use and no 
conclusions were made about which method was best or which weights were the 
most appropriate.  
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The second study used stated preferences from the general public in England, who 
chose between two health programs that varied in the number of years of life that 
would be added to low and high SEP groups (Dolan and Tsuchiya, 2011). The 
weights are plausible, but because this was conducted in the UK, they may be 
context specific. The sample size of 130 was representative of the population of 
specific regions in England.  
Unpacking these influences on the derived weights required further research, 
particularly where differences in method are not a confounding factor. The aim of 
my third study was to replicate Dolan’s methods to derive equity weights for the 
Australian context. I chose Dolan’s et al. (2011) methods, because of its suitability 
to our context of examining preferences for health gains according to SEP, as well 
as ease of understanding/execution and the current need for studies with 
consistent methods.  
7.3 Research Question 2a: Can equity weights for use in Australian CEA 
studies for obesity prevention policies be derived using people’s 
preferences?  
I conducted two studies in this thesis to derive equity weights based on people’s 
preferences from surveys. My first study used people’s preferences to develop a 
health related social welfare function (HRSWF), based on the average levels of 
health and degree of aversion to inequality. However, the weights derived from 
this study were too large to be of practical use. Therefore, I conducted a second 
study involving the estimation of probit models to derive equity weights.  
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7.3.1 Preference based weights: Study 1 
Paper 3 (Chapter 4) aimed to derive equity weights based on a questionnaire to 
elicit preferences concerning trade-offs between the total level of health gains and 
its distribution among a low and a high socioeconomic group. The data collected 
were used to develop HRSWFs. The participant group (n= 131) was a convenience 
sample that included a mix of researchers, academics, clinicians, managers, public 
servants and research students. Participants were asked to imagine they were 
helping the Health Department and were asked to make choices between two 
programs that had differing increases in years of life expectancy of low and high 
SEP groups.  
The results provided evidence to support the idea that the public may be willing to 
make trade-offs between efficiency and equity, and that they value health gains 
differently depending on which socioeconomic group receives the health gain. A 
marginal health gain to the lowest socioeconomic (SEP) group was valued 14.1 - 
81.4 times more than a marginal health gain to the highest SEP group. The weights 
were intended to be applied to the health gains in an ICER, however these weights 
were simply too large to be of practical use. 
These results entailed both a large range and high values compared to Dolan’s 
study, which obtained values of 6.8 to 9.9. As per Dolan’s et al. study (2011), 
constant elasticity of substitution was used as the baseline specification, but very 
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different weights were obtained using the hyperbolic and parabolic specifications3; 
hence the wide range in values. The large weights can primarily be explained as a 
mathematical artifact from the use of the SWF specifications.  
Some other explanations also contribute to the differences in my derived weights 
compared to those of Dolan et al. Firstly, Australian life expectancy figures were 
used, which were higher than the UK, while the difference between groups was 6 
years compared to Dolan’s 5 years. Secondly, Dolan used two rounds of questions, 
each on a different sample of people and entailing different options; this resulted 
in their study offering different response options to each subgroup of the sample 
as well as more evenly spread weight values. My study entailed one version of the 
questionnaire to avoid further dilution of the number of responses.  
My study used a convenience sample rather than a representative sample. This was 
done for practicality reasons, but also because the participants had high education 
levels (97% had university degrees) and were assumed to be able to complete the 
questions independently. In Dolan’s et al. (2011) study, 54% of respondents were 
employed and 60% had the minimum level of education. This sampling difference 
                                                 
3 Under extreme inequality aversion, a reduction in inequality is preferred even when it results in a 
loss in the health of the worse-off. In this situation, the monotonicity principle is violated and the 
constant elasticity of substitution specification cannot deal with these preferences. The hyperbolic 
and the parabolic specifications accommodate these preferences. They are individualistic, additive, 
inequality averse and symmetric. The parabolic specification satisfies constant relative inequality 
aversion, while the hyperbolic specification satisfies constant absolute inequality aversion. 
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may be reflected in several ways. A larger proportion of their sample chose the 
egalitarian option ─ equal health gains (36% versus 20% in our study) and this 
may be a product of the academic sample in our study. It has been suggested that 
an academic sample is less likely to choose the simple decision-making heuristic, 
“always choose the more egalitarian option”(Shehzad et al., 2014).  
Deliberating ethical trade-offs between improving health and reducing health 
inequality may be considered cognitively demanding and the difference in 
responses between the studies may be explained by how participants understood 
and processed the questions. Another explanation could also be attributed to the 
fact that the Dolan study entailed face-to-face interviews, rather than online 
survey administration. Online surveys have been shown to be more likely 
associated with social desirability bias leading to more extreme egalitarian 
responses (Robson et al., 2016).  
More general limitations of using people’s preferences that also apply to 
‘Preference based weight Study 2’ are included in the section below.  
From my first study, the equity weights derived imply that a marginal health gain 
to a low SEP group is valued more than a marginal health gain to a high SEP 
group. However, the range in the relative weights obtained was too wide to be of 
use for the intended purpose of applying them to CEAs of policies aimed to 
prevent ill health that has a social gradient in Australia. The use of social welfare 
functions to derive equity weights appears to be a less than ideal method. I 
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therefore investigated different approaches for deriving demand-side equity 
weights.   
7.3.2  Preference based weight Study 2 
Paper 4 (Chapter 5) derived equity weights based on a discrete choice experiment. 
This is a technique that elicits preferences from choices between a finite set of 
alternatives. An online panel company was used to recruit 710 participants from 
around Australia. They were asked to choose between two programs that 
increased the life expectancy of high or low-income groups by a varying number of 
years. Utility functions based on a probit model incorporating nominal factors 
were estimated and used to derive the equity weights. The results indicated that 
most people are willing to make trade-offs between efficiency and equity. The 
weights ranged from 1.3 (95% CI: 1.2, 1.4) to 1.8 (95% CI: 1.6, 2.0) for life 
expectancy gains of between 2 to 9 years to the lowest SEP groups. The weights 
tended to increase as the gains to the low-income group increased. The methods 
used in this study resulted in more practical and plausible results than in Study 1.  
Study 2 was based on the methods of Norman et al (2013), however our resultant 
preference weights were not directly comparable to theirs as, in addition to 
income level, they covered other dimensions of the hypothetical group, such as 
smoking status. However, like ours, their low-income group weights were higher 
than their high-income group weights. Norman et al (2013) also tested an 
alternate method for deriving equity weights based on regression results, 
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compensating variation (Lancsar et al., 2011), but it had little effect on their 
results.   
Interestingly my derived weights were similar to epidemiological weights derived 
in this same paper (discussed in the next section). However, they are lower in 
comparison to the weights for disadvantaged groups obtained in previous studies, 
which ranged from 6.8-9.9 (Dolan and Tsuchiya, 2011; Wiseman, 2004). The 
differences in the underlying conceptual basis of the methods is the most plausible 
explanation for the different results.  
There are limitations, of course, with my study. An online panel company was 
used for the recruitment of participants and it is arguable that online panel 
participation may be correlated with certain undetectable characteristics, such as 
biases towards persons with low time costs and specific ethnicities (Craig et al., 
2013). Also, our sample was over-represented in the ages of 36 to 55 years, and 
with persons with higher education and higher incomes. Whilst quotas were 
applied to obtain a target number of respondents in each demographic group, it 
became apparent that these needed to be modified for age to obtain the desired 
sample size. Differences in responses were not detected based on education or in 
the age group that was over-represented. However, I found that as personal 
income increased, participants were less likely to choose the option benefiting the 
low-income group. This could be interpreted as higher income groups being 
biased toward their own income group and the potential for their own gain. If the 
152 
 
sample was not over-represented by higher-income participants the resulting 
weights may have been higher.  
The weights derived from people’s preferences are context specific to Australia and 
are therefore not intended to be generalizable to other countries. The questions in 
the survey, for example, refer to the life expectancy of Australians.  
My aim was to derive weights that could be used in economic analyses of policies 
and programs in Australia, particularly in contexts where use of traditional non-
weighted QALYs could increase health inequalities in already disadvantaged 
groups. This is the first study, to the best of my knowledge, to derive preference-
based equity weights for SEP that could be applied in practice. The weights 
derived from this study could potentially be applied to weight the QALY gains of 
disadvantaged groups in CEAs for the prevention of health conditions with a 
socioeconomic gradient. In practice, a policy that is considered cost-ineffective 
under usual methods, may be cost-effective when equity weights are applied. 
7.3.3 Limitations of preference data 
Deriving weights based on empirical surveys of stated preferences can lead to 
several concerns. The inherent issues with this type of data include framing effects 
and the context and design of the questions. Prospect theory (a behavioural 
economic theory) states that losses and gains can be valued differently from each 
other (Kahneman and Tversky, 1979) and it is conceivable that posing the 
questions as gains in life expectancy rather than losses could have resulted in 
framing effects. It is also possible that simplifying heuristics may have contributed 
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noise to the data (Lloyd, 2003). The ‘take the best’ heuristic may have led people 
to choose the group with the most health gains, however this health maximisation 
approach was not chosen by most respondents in either survey. Added to this, 
participants may not have well thought out judgements about complex 
distributive issues and a deliberative setting could be beneficial whereby different 
options can be discussed.  
The results indicate that as personal income increases, individuals were less likely 
to choose the program that benefited the lowest income group. This could be 
interpreted as higher income groups being biased toward their own income group 
and the potential for their own gain. Objective data does not have these 
limitations, and it is for this reason that in the next study, I looked at methods of 
deriving weights that were not based on people’s individual preferences.      
7.4 Research Question 2b: Can equity weights for use in Australian CEA 
studies for obesity prevention policies be derived using epidemiological 
data? 
The second part of Paper 4 derived equity weights based on epidemiological data. 
National burden of disease and mortality data by Socioeconomic Index for Areas 
quintiles (SEIFA) were used to calculate ratios comparing Quintile 1 (most 
disadvantaged) to: i) the Australian population as a whole; and ii) Quintile 5 (least 
disadvantaged). SEIFA is an area based index based on a range of information, 
such as the income, qualifications, and occupation skills of the area residents 
(Australian Bureau of Statistics, 2013). The epidemiological based weights ranged 
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from 1.2 to 1.5 when the comparator was the general population; but when 
Quintile 5 was the reference group, larger weights resulted, which is to be 
expected.   
Burden of disease estimates quantify the effects of different diseases in a 
consistent way and are combined into a summary measure – the disability 
adjusted life year (DALY) (Australian Institute of Health and Welfare, 2016). 
DALYs are a combination of the estimates of years of life lost due to premature 
death (YLL) and years lived in ill health or with disability (YLD), to describe the 
total years of healthy life lost from disease and injury. The estimates of burden of 
disease were chosen because they are well established and are perhaps the most 
widely used summary measure of a population’s health (Richardson, 2002a). 
While all-cause mortality data only consider fatalities, the weights based on both 
types of epidemiological data (DALYs versus mortality alone) resulted in very 
similar weights when the same reference groups were used. This supports the 
desirable quality of consistency, when equity weights are based on epidemiological 
data.  
People’s preferences have been the conventional method for valuing equity 
weights and to my knowledge, this is the first study to use epidemiological data to 
calculate weights for a disadvantaged SEP group. The normative foundation being 
applied is the ‘Decision-Maker Approach’ (DMA), whereby the weighting of health 
gains need not be preference based (Hurley, 2014). The concept of benefit (i.e. 
social welfare function) being maximised under this normative approach, reflects 
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the objectives of the decision-maker. For the Australian government, this 
combines with the Westminster system whereby governments are elected with a 
mandate from the electorate. While less developed than other normative 
foundations in health economics, such as orthodox welfarism and extra-
welfarism4, the approach allows a choice of applied methods (such as CEA, CUA, 
CBA, PBMA) that best suits the problem under analysis. 
Under DMA, many sources of valuation apart from the individuals affected by the 
policy are acceptable, and valuations could include information other than 
preferences, such as: reasoned argument, deliberative processes and consultations 
(Hurley, 2014). Under this approach the decision-makers, aided by analysts, act as 
agents for members of society and act as they think individuals should act (Hurley, 
2014).   
There are no direct comparisons that can be made with other studies. However, 
within Paper 4, the epidemiological weights for Q1/Q5 using: i) all-cause 
                                                 
4 Under orthodox welfarism the social welfare function is derived from the summation of 
individual utilities derived from participation in the market. Individuals are assumed to be the best 
judge of their own welfare and preferences are revealed through their purchases. A set of 
assumptions around perfect competition accompany these basic characteristics. This is generally 
regarded as elegant but of little practical use in policy. Under extra-welfarism the elements of the 
community welfare function are defined in a way that either: i) replaces individual utility with 
QALYs (hence leads to Culyer’s cost-utility analysis); or ii) adds extra elements to the welfare 
function, such as health or capabilities (Amartya Sen).  
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mortality; ii) burden of disease; and iii) the corresponding derived preference 
based weight (explained in the previous section) for the gain in life expectancy of 5 
years are surprisingly similar at 1.46, 1.54 and 1.52 respectively. This could indicate 
that people may well find the epidemiological approach both acceptable and easy 
to understand. Further qualitative research to test this would be required.  
One previous study derived weights for SEP without basing it on people’s stated 
preferences (Banham et al., 2011). Their method involved the use of a benchmark, 
such as the highest (least disadvantaged) SEP quintile intervention effect, and 
calculating equity weights based on the difference between highest and lowest 
(most disadvantaged) quintile specific intervention effects. However, this method 
of deriving weights is limited by the availability of good quality studies that 
provide evidence of intervention effectiveness by SEP.  
The weights derived from my epidemiological study are limited to the Australian 
context as they are based on Australian data. However, these methods could be 
easily applied in other countries; one of the strengths of the epidemiological 
weights method is the ease of obtaining the freely available burden of disease and 
mortality data. 
In this thesis I derived equity weights based on both epidemiological data and 
preferences to compare the methods and weights obtained. It could be argued that 
both sets of weights are valid. However, deriving weights based on empirical 
surveys of stated preferences poses several problems that have already been 
outlined. Objective data does not have these limitations. One of the strengths of 
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the epidemiological weights method was the ease of obtaining the freely available 
data. The preference weights indicate that people discriminate in favour of low-
income groups when it comes to health gains.  
If the epidemiologically based weights are the preferred option for decision-
makers, then both sets of weights comparing Q1/Australian population and Q1/Q5 
could be used in sensitivity analyses and considered as alternative equity 
parameters. Similarly, a low and high weight could be used if preference-based 
weights are preferred. It is not the intention that equity-weighting analysis be used 
as an algorithm for resource allocation decisions (Cookson et al., 2017b). Rather, it 
is recommended that it is used as a tool to aid decision-making. Using different 
weights in sensitivity analysis would allow the exploration of alternative value 
judgements around equity (Cookson et al., 2017b). 
7.5 Implications for policy makers 
As a response to rising policy concerns about health equity, economic evaluation 
techniques are gradually being enhanced to provide useful evidence about health 
equity impacts and any trade-offs between cost-effectiveness and health equity. 
However, the use of these techniques is still quite rare. Nonetheless, when priority 
setting is the goal, future CEAs for the prevention of health conditions for which 
there is a socioeconomic gradient should include health equity impact analyses 
whenever possible, to allow distributional health effects amongst SEP groups to be 
examined and equity impacts of interventions to be compared.  
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7.5.1 SSB tax 
The SSB tax analysis predicts that this policy is a ‘win-win’ in terms of cost-
effectiveness and increasing health equity. Importantly, in all five tax scenarios the 
health gains would be concentrated in the most disadvantaged groups. For each 
dollar invested into a 20% SSB tax, the returns on healthcare cost savings are $17. 
This suggests that Australia should consider a tax on SSBs as part of a suite of 
recommended policies to reduce the rates of obesity. 
One of the arguments raised against an SSB tax is that it would financially affect 
the most disadvantaged groups the hardest. My analysis shows that the most 
disadvantaged group would pay the most tax per capita, however the difference in 
tax paid between the lowest and highest group is very small at less than $5 
annually. Also, there would be greater out-of-pocket healthcare costs saved in the 
most disadvantaged groups. The tax would result in a considerable yearly revenue 
of over $640m that the government could use to reduce the regressive financial 
impact by funding programs to further improve the health of the most 
disadvantaged.  
7.5.2 Equity weights 
The two preference surveys conducted as part of this thesis indicate that the 
public may be willing to sacrifice health gains to reduce differences in average life 
expectancy between SEP groups. In other words, the objective of economic 
efficiency may not have primacy amongst the public when compared to other 
objectives such as health equity.  
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Equity weighting of health gains to disadvantaged groups is useful when there is a 
trade-off between improving total health and health equity. The weights derived 
in the paper “Equity weights for socioeconomic position: two methods – using 
surveys of stated preferences and using epidemiological data,” could be used to aid 
decision-makers and stakeholders to explore alternative value judgments around 
equity. If a program is cost-ineffective yet improves equity, the weights could help 
decision-makers decide the level of concern for equity required for the program to 
be considered value for money.  
As an example, a program with an ICER of $75,000/QALY would generally be 
considered cost-ineffective in Australia; yet the ICER could potentially be reduced 
to $50,000/QALY if an equity weight of 1.5 was applied to the QALY estimates 
used in the calculation of the cost-effectiveness ratio. The use of different weights 
in sensitivity analysis of CEAs would allow the exploration of alternative value 
judgements around equity. As with a cost-effectiveness threshold, this kind of 
equity benchmark could be useful to decision-makers as a way of justifying their 
decisions and encouraging transparency and consistency of decisions (Cookson et 
al., 2016).  
7.6 Recommendations for further research 
My systematic review highlighted the lack of studies using appropriate equity 
analyses in CEA. I found the main weakness to be that in the majority of studies 
where two or more interventions were being compared, the interpretation of the 
size differences of the inequality was left to the reader. This could be resolved by 
160 
 
the use of health inequality measures in future studies. Further, some studies 
omitted financial impacts when they were a potentially important aspect of the 
intervention and should have been included as part of an equity analysis. Another 
weakness in a few of the studies was the comparison of only the highest and 
lowest SEP groups, potentially omitting important results from the middle SES 
groups. Again, the use of an inequality measure would resolve this issue.  
The use of health inequality measures is a constructive way forward where the aim 
is to compare different intervention options for their health inequality impact to 
allow ease of comparison and ranking of the interventions. A limitation of the use 
of health inequality measures is that they are subject to misinterpretation. My 
review highlighted that more explicit interpretation of some of the inequality 
measures would have been useful, including the implication of the size of the 
differences, to improve ease of understanding for policy makers. Future studies 
should include a clear interpretation of each measure.    
Data requirements are one of the main challenges of this type of analysis, because 
SEP distributions of key parameters are required. One of the main challenges of 
quantifying health inequalities in health economic evaluations is the lack of 
effectiveness data on key population group characteristics, such as SEP. Trials are 
usually not designed or powered to detect SEP subgroup effects because of the 
additional resources required for the collection and analysis of subgroup data. The 
collection of SEP subgroup effectiveness data needs to be factored into the study 
protocol and budget when health inequality impacts are a desired output.  
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One of the advantages of subgroup CEA is that it is an existing modelling method 
that health economists are familiar with performing, particularly in health 
technology assessment for heterogeneous characteristics, such as treatment 
effects. If SEP subgroup health gains are available, health inequality measures can 
be included in future studies without difficulty.   
One of the intentions of this thesis was to derive equity weights that could be used 
to weight the health gains of the most disadvantaged SEP groups in Australia in 
cost-effectiveness analyses, using subgroup specific modelling where a trade-off is 
involved. Currently, there have been no studies published that have used equity 
weights for SEP in this way, therefore the practical application of this type of 
weight could be carried out in the future. Further work will be needed to see that 
equity weights perform as intended in a CEA and are acceptable to policy makers 
and the general public. A qualitative study could investigate any barriers to their 
use.   
Cost-side equity weights have been proposed for use in the economic evaluation of 
primary healthcare services in Australian Indigenous populations (Ong et al., 
2009) and could potentially be derived for low socioeconomic groups. Such a 
weight is based on the 'processes' of health service delivery for the definition of 
equity – that is 'equitable access for unequal need' - for example, when delivery of 
services is more costly in remote areas than cities. Research into a cost-side equity 
weight could be investigated for situations where the implementation of a public 
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health policy is more resource intensive for disadvantaged groups who may 
require a more targeted approach.   
Modelling SEP-specific mortality and morbidity of health outcomes, such as lower 
life expectancies and higher morbidity burden in low SEP groups, may result in the 
evaluation of this subpopulation having lower health gains and higher ICERs. 
Therefore, an intervention that is cost-effective overall may not be cost-effective in 
a low SEP group. By conducting sensitivity analyses to include the use of general 
population life expectancy, quality of life estimates and treatment cost variations, 
it is possible to check whether disadvantaged groups are being further 
disadvantaged, and whether applying an equity weight would be beneficial to the 
disadvantaged groups. 
Thinking more broadly, subgroup analysis is precisely what health economists do 
with marginal analysis and our various targeting strategies to establish efficiency. 
Economic analysis has always been used in this way to determine cost-
effectiveness for who, under what conditions. The novelty here is that I am 
proposing marginal analysis incorporate a broader concept of benefit that includes 
an equity objective – one that targets low SEP groups. 
The weights derived in this thesis are intended to be applied in the Australian 
context. If these weights are used successfully, future studies could employ these 
same methods in other countries to derive their own country-specific weights. 
However, providing a complete depiction of health equity impacts requires 
analysis of not only who gains, but also who suffers the opportunity costs of taking 
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scarce resources from other uses (Cookson et al., 2017a). Calculating the difference 
in benefit from choosing a more equitable option does not help the decision-
maker decide how big a sacrifice is worth making to pursue the most equitable 
approach. More empirical work is required to determine a realistic distribution of 
opportunity costs that credibly reflects the impact of disinvestment decisions 
(Asaria et al., 2014). This will vary depending on the funding source, for example 
taxation or public healthcare.  
Many countries and jurisdictions around the world have already committed to an 
SSB tax. Prospective studies could examine where to direct the revenue from an 
SSB tax to optimise equity, efficiency and/or affordability objectives. 
Hypothecation of taxes can also be effective in generating public support 
(Doetinchem, 2010). There is evidence in Australia that earmarking the tax 
revenue for subsidising healthy food (Morley et al., 2012), tackling childhood 
obesity, and supporting children’s sport (Martin et al., unpublished), would raise 
the level of public support for such a tax.  
A recent article reviewed formal methods that consider equity in the context of 
CEA for health technology assessment (HTA), covering multiple concepts and 
values relating to equity (Johri and Norheim, 2012). It identified one of the major 
obstacles hindering the use of formal equity methods in decision-making as being 
the variety of concepts and values discussed under the notion of equity. Focusing 
on one key aspect of equity, such as socioeconomic position, allows for clarity. 
Questions remain, however, about which equity methods are the most useful for 
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decision-makers and this is an area that could be explored further in a qualitative 
study.   
7.7 Conclusions  
Most CEAs of public health interventions either ignore health equity impacts or 
limit themselves to a description of their nature without any quantification. This 
makes it difficult for policy makers to prioritise or rank policies in terms of their 
cost-effectiveness and equity impacts in an objective way. The aim of this 
doctorate was to identify and incorporate methods of quantification of the equity 
impacts in CEAs for the prevention of health conditions such as obesity, which 
have been shown to have a socioeconomic gradient. This thesis focused on 
methods that could be applied to population level policies, as well as equity 
weights for health gains of disadvantaged groups.    
At a population level, the CEA of an SSB tax demonstrated the use of SEP specific 
modelling, enabling equity impact analysis. From my examination of the 
literature, this was the first CEA of a public health intervention in Australia that 
has included health inequality measures to allow comparisons and ranking of 
interventions for their health equity impact. This will be of value in contexts where 
priority setting of a range policies is being considered. My study was also the first 
to examine the total out-of-pocket financial impacts, including healthcare costs 
and taxes across SEP groups, another important factor when considering the 
equity of the policy.    
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Practical application of equity weighting of health gains for disadvantaged groups 
is yet to become common practice. Given the lack of consensus on the algorithm 
for deriving equity weights, I sought to derive demand-side equity weights for the 
Australian context using three methods. Two methods derived plausible equity 
weights that could potentially be used to weight health gains of disadvantaged 
groups in a CEA. This was the first study to derive equity weights for SEP in 
Australia, based on: i) epidemiological data; and ii) using probit models. However, 
further work will be needed to see if they do what is intended and are acceptable 
to policy makers and the public.  
There are still important gaps in research in this field, particularly in applied 
empirical work, but this doctorate has added to the limited body of relevant 
research. The methods discussed here enable equity concerns to be incorporated 
into the decision-making process in a quantitative and transparent way, with the 
intention of providing policy-makers with more constructive information 
regarding the health equity consequences of potential policies alongside CEA.  
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Cost-utility and cost-effectiveness studies including SEP subgroup analyses 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
Allen et al. 
(2015) 
England 
Aim: To determine 
health and equity 
benefits and cost-
effectiveness of 
policies to reduce or 
eliminate trans fatty 
acids from processed 
foods.  
Perspective: policy 
costs to government 
and industry.  
Study Type: CUA. 
Modelled EE. 
Intervention: 1) A ban of 
trans fatty acids in 
processed foods. 2) 
improved labelling of trans 
fatty acids. 3) bans on 
trans fatty acids in 
restaurants and 
takeaways. 
Comparator: do nothing. 
Population: deprivation 
quintiles. 
Time horizon 
Intervention: 5 years 
Tracking: 5 years 
Health care cost savings 
range from £19.2m in 
lowest quintile to £1.6m in 
highest quintile.  
Policy relevance: a total 
ban on trans fatty acids 
would lead to health 
benefits at least twice as 
large as other 
policy options, both in 
terms of total population 
benefit 
and reduction in 
inequality. 
Inputs: Mortality from coronary 
heart disease (CHD), Median 
survival undiagnosed CHD and no 
CHD, incident cases CHD 
Outcomes: deaths prevented, 
LYG, QALYs gained 
Inequity aversion weight: Y/N 
(value) 
Caveats from Discussion: data 
from a meta-analysis directly 
linking consumption 
of trans fatty acids to incidence 
of coronary 
heart disease. 
Key sensitivity- variation of costs 
where industry incurs 
substantial reformulation costs 
could reduce overall savings to 
£0-£22m. If reformulation costs 
to industry are substantial, these 
policy options would still be 
dominant over a “do nothing” 
scenario based on the best 
estimates, though the 
uncertainty leaves some 
possibility of net losses in the 
short term horizon.  
 Quality of study: strong 
Asaria et 
al. (2014) 
United 
Kingdom 
Aim: To assess the 
quantity and 
distribution of health 
gains related to 
increased participation 
in redesign options 
explored for UK NHS 
bowel cancer 
screening program.  
Intervention: 1) standard 
colorectal cancer 
screening with guaiac fecal 
occult blood test (gFOBT) 
to persons aged 60–74 
years. 2) Targeted 
reminder, universal 
screening. 
Policy relevance: “All three 
screening programs are 
health inequality 
increasing compared with 
no screening, But the 
current screening program 
with a targeted reminder 
reduces health inequality. 
The universal reminder 
Inputs: All-cause mortality, 
morbidity differences, screening 
uptake. 
Outcomes: QALYs, Inequality 
indices: relative gap index, 
relative index of inequality, Gini 
index, Atkison index, absolute 
First study to use complex 
inequality measures to 
demonstrate equity in CEA. 
Caveats from Discussion: Some 
aspects of the intervention-
generated inequality due to the 
screening programme arise 
Appendix 1. Summary of studies (Paper 1)
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
 
Perspective: National 
Health Service (NHS). 
 
Study Type: CUA  
Modelled EE. 
 
Comparator: no screening,  
Population: 30 year olds 
split by area level 
deprivation quintiles. 
Social class groupings 
mapped to deprivation 
measures. 
 
Time horizon 
Intervention: not stated. 
Tracking: life time. 
resulted in a greater 
population health 
improvement than the 
targeted reminder but was 
less attractive in terms of 
its impact on increasing 
health inequalities.  
gap index, slope index of 
inequality, Kolm index  
Inequity aversion weight: Y 
Atkinson index (ε = 1, 7, 30) 
Kolm index (α = 0.025, 0.1, 0.5)  
  
 
because of inequalities in uptake 
of gFOBT and 
follow-up colonoscopy. 
However, some of the health 
inequality impact arises through 
differing rates of morbidity  
and other-cause mortality (not 
related to bowel cancer directly) 
 
Key sensitivity: The ranking 
produced by social welfare 
indices was sensitive to the type 
and level of inequality aversion. 
 
Quality of study: strong 
 
Blakely et 
al. (2014) 
New 
Zealand 
Aim: To explore the 
potential for health 
inequality reduction by 
considering a wider 
range of vaccination 
scenarios. 
 
Perspective: health 
sector. 
 
Study Type: CUA. 
Modelled EE. 
Intervention: 1) HPV 
vaccination program of 
girls only (2) school-only 
program (3) inclusion of a 
new mandatory law 
requiring active opting-out 
of vaccination.  
 
Comparator: no 
vaccination program. 
 
Population: 12 year olds 
girls by area-based 
socioeconomic 
deprivation tertile. 
 
Time horizon 
ICERS $18,000/QALY, 
$21,800/QALY and 
29,800/QALY. All three 
interventions had greater 
health gains for those 
living in the most 
deprived.   
Inputs: Disease incidence rates. 
Background mortality rates and 
disease specific mortality rates. 
 
Outcomes: QALYs  
 
Inequity aversion weight: N  
Caveats from Discussion: As 
Maori have higher background 
mortality rates and higher 
morbidity, this essentially 
‘penalizes’ health gain for Maori 
in the analyses so they present 
an analysis with non-Maori 
morbidity and mortality rates 
applied to Maori. 
 
Key sensitivity: scenarios that 
shifted all ICERs to be about 
$50,000 or higher were 
those that excluded the 
morbidity impacts of HPV-
related disease. 
 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
Intervention: 1 year. 
Tracking: 20 years. 
Quality of study: strong.  
 
Gulliford 
et al. 
(2014) 
United 
Kingdom 
Aim: to determine 
whether the costs and 
outcomes of an 
intervention to 
promote physical 
activity were likely to 
be similar if the 
intervention 
was either equally 
effective at increasing 
physical activity 
in different deprivation 
categories, or less 
effective in more 
deprived groups. 
Perspective:  
 
Study Type: CUA. 
Modelled EE.  
Intervention: Brief 
intervention to promote 
physical activity in healthy 
individuals.  
Comparator: usual care 
i.e. no structured 
approach. 
 
Population: general 
population by area based 
quintile of deprivation.  
 
Time horizon  
Intervention: 5-year 
effect. 
Tracking: lifetime. 
Health gains greater in 
most deprived areas. 
When intervention is 30% 
less effective in most 
deprived areas, health 
gains still greater in most 
deprived areas.  
 
Inputs: Physical activity levels, 
incidence and prevalence of 
disease, mortality, and health-
care utilization, prevalence of 
depression. 
 
Outcomes: QALYs per 1000, Net 
health benefit QALYs per 1000, 
life years lived without disease 
per 1000 
 
Inequity aversion weight: N  
Caveats from Discussion: 
assumed that a sustained 
intervention might have an 
effect on physical activity that 
lasted as long as the 
intervention. 
 
 Key sensitivity: If 20% less 
effective 57% probability of 
being cost-effective, costs of 
intervention doubled, 50% of 
being cost-effective. 
 
Quality of study: strong 
 
Over et al. 
(2014) 
Netherlan
ds  
Aim: to evaluate the 
SEP differences in 
health benefits of 
tobacco control polices 
in Netherlands.  
 
Perspective: 
healthcare. 
 
Study Type: UA. 
Modelled EE. 
Intervention: 1) tax 
increase 2) full 
reimbursement of 
cessation support. 
 
Comparator: current 
practice. 
  
Population: population by 
4 levels of education. 
 
Time horizon  
The policies that had been 
expected to yield better 
results among lower SES 
groups were 
unable to reduce health 
disparities: Although those 
with low educational 
levels benefit from the 
interventions, those from 
other educational groups 
benefit more, especially in 
Inputs: % of never, former and 
current smokers in the reference 
year, start, stop and relapse rates 
for smoking. Relative risks of all-
cause mortality, incidence and 
prevalence of diseases, (1) price 
elasticity of tobacco, (2) 
participation rates, type of 
therapy. 
 
Outcomes: QALYs. 
 
Caveats from Discussion: Gains 
in life expectancy smaller for 
low SEP but gain more when 
they quit. Both effects included 
and counteract each other. 
Key sensitivity: Shortening the 
time horizon affected the ICERs 
in the scenarios in the same way 
as increasing discount rates: 
the costs per QALY decreased for 
the tax increase scenario and 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
Intervention: 5 years.  
Tracking: 75 years 
the case of 
reimbursement. 
Inequity aversion weight: N  increased for the reimbursement 
scenario. 
Quality of study: moderate 
study quality. Analysis of the 
health gains was misleading - 
based on absolute gains per 
group, not equal numbers in 
each group. 
Rush et al. 
(2014) 
New 
Zealand  
Aim: to compare a 
multi-component 
physical activity 
nutrition program in 
schools. 
Perspective: health 
funders.   
Study Type: CUA 
Trial EE. 
Intervention: multi-
component program to 
increase physical activity 
and encourage healthy 
eating in primary school 
children 
Comparator: no program 
 
Population: primary 
school children by school 
affluence deciles. 
 
Time horizon 
Intervention: 1 year 
Tracking:100 years 
ICERS all children $24,690. 
Decile 1-3 $36,737/QALY. 
Decile 4—7 
$17,891/QALY. 
Decile 8—10 
$33,098/QALY. Likely to be 
cost-effective when 
compared to healthcare 
treatment and prevention 
activities already funded 
by the New Zealand health 
system. 
 
Inputs: reduction in BMI 
 
Outcomes: QALYs 
 
 
Inequity aversion weight N. 
Impact on equity not discussed 
but was not a stated aim. 
Caveats from Discussion: 
Compared 2011 data with 
historical comparisons rather 
than RCT. 
Key sensitivity: The biggest 
effect on cost-effectiveness was 
increasing the rate of decay of 
BMI improvements after the 
first 5 years to 5%(∼$100,000) 
and 10% ($500,000), 
Quality of study: moderate  
Banham et 
al. (2011) 
Australia  
Aim: Illustrative 
framework to estimate 
average population 
health gains and 
conduct economic 
evaluations of health 
programs, across 
socioeconomic 
subgroups.  
Intervention: 
management of coronary 
heart disease in general 
practice. Includes 
repeated clinical review, 
optimised 
pharmacotherapy and 
lifestyle modification, with 
additional practice 
Actual ICERS: $/DALY 
range from 9,760 in lowest 
quintile to 7,500 in highest 
(per 100,000) 
 
Policy relevance:  
distributing the same, 
uniformly weighted 
resource per capita to 
each quintile would 
Inputs: effect size 
 
Outcomes: HALE, deaths, PYLD, 
DALY 
 
Inequity aversion weight: Yes 
Value: 1.32 reduce average 
health loss differences but 
maintain the current social 
gradient and 1.65 if policy 
Caveats from Discussion: 
Distributing the same, uniformly 
weighted resource per capita to 
each quintile would increase 
inequalities because of the 
differences in intervention 
effect size. 
 
Key sensitivity: none 
 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
Perspective: health 
system. 
 
Study Type: CUA 
Modelled EE.  
incentives for tracking 
patient outcomes. 
 
Comparator: usual care 
 
Population: by Index of 
relative socioeconomic 
disadvantage quintile. 
(Area) 
 
Time horizon  
Intervention: 2 years 
Tracking: 2 years 
increase inequalities 
because of the differences 
in intervention effect size. 
This can be changed by re- 
weighting the resource 
per capita with respect to 
a benchmark figure.  
 
objective is to reduce 
inequalities. 
Quality of study: strong 
 
Verguet et 
al. (2013) 
India and 
Ethiopia 
Aim: to estimate, 
across income 
quintiles, the health 
benefits 
the net financial 
consequences and the 
financial risk 
protection for 
households of UPF 
rotavirus vaccination.  
 
Perspective: 
government and 
patients 
 
Study Type: ECEA 
Modelled EE. 
Intervention: Public 
finance for 2 doses 
rotavirus vaccination 
 
Comparator: do nothing 
 
Population; Income 
quintiles 
 
Time horizon 
Intervention: not stated 
Tracking: first 5 years of 
life 
Policy relevance: In both 
countries more lives 
would be saved among 
the bottom income 
quintile compared to the 
top income quintile. 
Inputs: Relative risk ratio of 
rotavirus mortality ( probability 
of outpatient and inpatient visit 
for rotavirus diarrhoea, mean 
out-of-pocket outpatient and 
inpatient cost for rotavirus 
diarrhoea,  
 
Outcomes: DA, households’ 
expenditures averted, FRP 
 
Inequity aversion weight: N  
Caveats from Discussion: 
Modelling limitations: program 
costs and quality of vaccine. 
Back of envelope analysis’ for 
herd effects.  
 
Key sensitivity: A steep rise in 
vaccine price would dramatically 
alter the benefits. 
 
Quality of study: moderate. 
 
Verguet et 
al. (2015b) 
India 
Aim: using illustrative 
parameters for 
evaluating the 
Intervention: UPF of 
tuberculosis (TB) 
treatment - directly 
Policy relevance: 80% of 
the health benefits would 
be concentrated among 
Inputs: Treatment coverage 
before and after UPF, Non-DOTS 
coverage before and after UPF. 
ECEA is a new method that 
extends CEA analysis to 
incorporate distributional health 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
consequences of 
Universal Public 
Finance (UPF) to 
demonstrate the 
distributional effects of 
intervention uptake, 
crowding out of private 
expenditure and 
providing insurance for 
catastrophic 
expenditure. 
Perspective: societal.   
Study Type: ECEA. 
Modelled EE.  
observed treatment, 
short-course (DOTS).   
Comparator: no UPF for 
TB treatment. 
 
Population: income 
quintiles. 
 
Time horizon: not stated. 
Tracking: not stated. 
the bottom two income 
quintiles They would also 
benefit from 40% of the 
private expenditures 
averted, and 80% of total 
insurance value. 
 
 
Outcomes: DA, household 
expenditures averted, FRP. 
 
Inequity aversion weight: N.  
consequences, financial risk 
protection and private spending 
averted.  
 
Caveats from Discussion: 
financial barriers are not the 
only barriers preventing 
individuals from seeking care: 
lack of information and distance 
are also important. 
 
Key sensitivity: relative risk 
aversion, insurance benefits are 
sensitive to the level of TB 
treatment cost as a share of 
income. 
Quality of study: strong  
Levin et al. 
(2015) 
China. 
Aim: to evaluate the 
consequences of full 
public finance of HPV 
vaccination in China 
using ECEA 
methodology. 
 
Perspective: 
government, 
households 
 
Study Type: ECEA 
 
Modelled EE  
Intervention: HPV 
vaccination plus screening  
Comparator: current 
practice – screening only 
 
Population: income 
quintiles 
 
Time horizon 
Intervention: lifelong 
protection assumed. 
Tracking: age 9 to death 
Policy relevance Women 
in the lowest quintile, 
have the highest absolute 
numbers of DA and FRP 
from HPV vaccination. 
Inputs: Coverage, loss to follow 
up from treatment, mean GDP 
per capita, mean wage rate. 
 
Outcomes: DA, patient cost 
savings, savings as a % of 
income, cancer reduction 
 
Inequity aversion weight: N  
Caveats from Discussion: HPV 
vaccine not yet available in 
China. Best available published 
data from selected provinces, 
which does not fully capture the 
heterogeneity in disease 
burden, health systems, 
socioeconomic development 
and GDP per capita across 
China’s provinces 
 
Key sensitivity: Universal 
coverage of the HPV vaccination 
becomes even more favorable 
among individuals in lower 
income quintiles and provides 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
greater relative financial risk 
protection when treatment 
costs increased by an additional 
50 or 100 percent.  
 
Quality of study: moderate 
Johansson 
et al. 
(2015)Ethi
opia 
Aim: To evaluate the 
magnitude and 
distribution of 
expected health 
outcomes and FRP 
provided to individuals 
in the population. 
   
Perspective: 
government, 
households. 
 
Study Type: ECEA. 
Modelled EE. 
Intervention: 1)13-valent 
pneumococcal conjugate 
vaccine (PCV-13) for 
newborns 
2) Case management of 
pneumonia for under 5s. 
 
Comparator: do nothing 
 
Population: income 
quintiles 
 
Time horizon 
Intervention: birth to 5 
years. 
Tracking: birth to 5 years 
Policy relevance: both 
treatments had higher FRP 
and more deaths averted 
in the lowest income 
groups. 
Inputs: Relative risk ratio of 
mortality, proportion of pregnant 
women, coverage of treatment, 
probability of outpatient and 
inpatient visits 
 
Outcomes: DA, household 
expenditure averted,  severe 
episodes of pneumococcal 
pneumoniae averted, FRP 
 
Inequity aversion weight: N 
Caveats from Discussion: the 
higher income groups have more 
private expenditures averted 
from these policies since access 
to healthcare is higher in these 
groups. Model limitations no 
disease specific OOP costs, 
incidence distribution of various 
pneumococcal serotypes not 
taken into account, static 
model, no herd immunity. Assumes that pneumococcal 
deaths follow the same income 
gradient as all <5 deaths. 
  
Key sensitivity: subsidies on 
vaccines has substantial impact 
on health benefits and FRP. 
 
Quality of study: moderate 
 
Verguet et 
al. (2015a) 
China 
Aim: assess the 
distributional 
consequences across 
different wealth 
quintiles of a specific 
excise tax on 
Intervention: 50% increase 
in tobacco price through 
excise tax fully passed 
onto smokers 
 
Comparator: current price 
Policy relevance: 
substantial health gains, 
and reductions in 
expenditures on tobacco-
related disease, and 
financial risk protection 
Inputs: Smoking prevalence, 
cigarette consumption, relative 
use of health care, price elasticity 
of demand for cigarettes 
 
Caveats from Discussion: Wide 
range of elasticity estimates for 
China, therefore middle value 
was chosen. Assumed that no 
health benefits would arise from 
reduced tobacco consumption 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
cigarettes in terms of 
both financial and 
health outcomes. 
 
Perspective:  
Government, 
households  
 
Study Type: ECEA 
Modelled EE. 
 
Population: income 
quintiles 
 
Time horizon:  
Intervention: 50 years 
Tracking: 50 years. 
 
from higher tobacco 
taxation; these benefits 
would disproportionally 
favour the lower-income 
population quintiles  
Outcomes: LYS, change in 
expenditures on tobacco, 
expenditures on tobacco-related 
disease treatment averted, FRP 
 
 
Inequity aversion weight: N  
among continuing smokers. 
Model lacks dynamic age 
specific mortality from smoking. 
 
Key sensitivity: uncertainty 
around price elasticity of 
demand for tobacco- constant 
price elasticity, 25% and 100% 
price increase. 
 
Quality of study: moderate. 
 
Rheingans 
et al. 
(2014) 
India  
Aim: To estimate the 
impact and cost-
effectiveness of 
rotavirus vaccination 
across different 
geographic and socio-
economic settings in 
India. 
 
Perspective: not 
stated, appears to be 
health system 
 
Study Type: CUA. 
Modelled EE. 
Intervention: Rotavirus 
vaccination - 3-dose 
vaccine that would be 
delivered alongside DPT1–
3 through a routine 
immunization program. 
 
Comparator: no vaccine 
 
Population: by geographic 
region and income quintile 
 
Time horizon 
Intervention: first 5 years 
of life. Tracking: first 5 
years of life 
Actual ICERS :net cost per 
DALY ranging from $95-
$208 
 
Policy relevance: Rotavirus 
vaccines are most cost-
effective for the poor 
living in high mortality 
regions and states.  
Inputs: Vaccination coverage & 
timing, rotavirus mortality.   
 
Outcomes: DA, Costs averted 
 
Inequity aversion weight: N  
Caveats from Discussion: 
estimates of rotavirus mortality 
by region based on data 10 
years old. Other risk factors not 
considered may increase or 
decrease disparities in rotavirus 
mortality among economic 
groups. 
 
Key sensitivity: vaccination 
administration costs and 
rotavirus mortality uncertainty 
contributed approximately 50% 
and 25% respectively to the 
overall uncertainty of the CER, 
and rotavirus mortality 
contributed over 80% of the 
overall uncertainty of the health 
impact of vaccination.  
 
Quality of study: moderate. 
Author, 
Year, 
Country 
Aim and study type Intervention and 
comparator 
population 
Results Treatment of Equity Comments 
Dallongevi
lle et al. 
(2011) 
France 
Aim: to quantify cost- 
effectiveness 
of policies aimed at 
increasing Fruit and 
Vegetable (F&V) 
consumption.  
 
Perspective: not stated 
 
Study Type: CEA. 
Modelled EE. 
Intervention: (1) 3.4% 
reduction in VAT, (2) 
€100/year/person F&V 
stamp policy designed for 
low-income consumers 
(3) €10m information 
campaign. 
 
Comparator: do nothing 
 
Population: by income 
quartiles.  
 
Time horizon Intervention: 
1 year. 
Tracking: 1 year 
Policy relevance: 
Intervention through VAT 
reduction is more cost 
effective than subsidizing 
the consumption of some 
disadvantaged 
subpopulations. 
The price reduction does 
not reduce social 
inequalities. 
Inputs: Fruit and vegetable 
intake. 
 
Outcomes: DA, LYS, 
mean cost per DA and LYS 
Simple inequality measure: 
health disparity index compares 
first decile to all other deciles.  
 
Inequity aversion weight: N  
Caveats from Discussion: 
targeted and 
non-targeted policies to promote 
F&V intake have a modest impact on 
consumption and as a result on 
health gains. In case of (1), it is 
likely that the increase in F&V 
consumption would be linearly 
related to the budget.  
 
Key sensitivity: pessimistic and 
optimistic scenario for generic 
information campaign, more 
responsive 10 times higher 
impacts and health disparity 
increased.  
 
Quality of study: strong. 
 
Table notes: DALY: disability adjusted life years; HALE: health adjusted life expectancy; HPV: human papillomavirus; PYLD: prevalent years of healthy life lost to disability; Q: quintile, QALY: quality adjusted life years; SEP: socioeconomic position; VAT: value added tax. FRP: Financial risk protection, UPF universal public finance, DA deaths averted, LYS life years saved, LYG life years gained.  
  
Table 2 Studies examining only a low SEP group 
Author, Year, 
Country 
Aim and study type Intervention and 
comparator, population 
Study Results Treatment of Equity Comments 
An (2015), , 
USA.  
Aim: What are the life-time 
per capita costs of the 
program to the Federal 
government and average 
gains in quality-adjusted life 
expectancy to a 
Supplemental Nutrition 
Assistance Program (SNAP) 
participant?  
 
Perspective: societal. 
 
Study Type: CUA. 
Trial EE.  
Intervention: Incentive of 30 
cents for every dollar of SNAP 
benefits spent in participating 
retailers on targeted fruits 
and vegetables.  
Comparator: usual SNAP 
benefits 
 
Population: Low-income 
households receiving the 
SNAP. 
 
Time horizon 
Intervention: 1 year. 
Tracking: 100 years of age. 
Actual ICERS 
$16,172/QALY. 
 
Policy relevance: 
nationwide expansion of 
the Health Incentives 
Pilot is likely to nudge 
SNAP households 
towards purchasing and 
consuming more 
targeted fruits and 
vegetables. However, 
diet behaviour 
modification is 
proportional to price 
change.  
 
Inputs: consumption of 
targeted fruit and 
vegetables. 
 
Outcomes: QALYs. 
 
Inequity aversion 
weight: N. 
Caveats from Discussion: assumed a 
permanent price effect on 
fruit/vegetable intake. 
Key sensitivity: all-cause mortality risk 
ratio of fruit/vegetable intake tended 
to have the largest impact on the 
estimated ICER. However, even given 
an all-cause mortality risk ratio of 
fruit/vegetable intake two standard 
deviations above its base-case value 
(0.95), the estimated ICER is $40,661. 
Quality of study: moderate  
Wilson et al. 
(2015), USA 
Aim: to evaluate the cost-
effectiveness of a 
community-based 
intervention designed to 
improve physical activity 
levels and dietary intake 
and to reduce diabetes risk 
in a largely Hispanic 
population residing along 
the U.S.-Mexico border. 
 
Perspective: health care and 
patient. 
 
Study Type: CUA. 
Intervention: community-
based weight control program 
with weekly classes for 
healthy dietary and physical 
activity behaviours. 
 
Comparator: usual care. 
 
Population: low income 
migrants. 
 
Time horizon 
Intervention: 12 weeks. 
Tracking: 20 years. 
$57,430 and $61,893, 
respectively, per QALY 
gained for the 2% and 5% 
weight loss scenarios. 
 
Policy relevance: a 
culturally sensitive 
community based 
weight loss and 
maintenance 
intervention can be cost-
effective even when 
healthy weight 
individuals participate. 
Inputs: model included 
10,000 individuals who 
were demographically 
and physiologically 
matched to the baseline 
characteristics of 
Beyond Sabor 
participants in this 
study sample. No 
details provided. 
 
Outcomes: QALYs 
 
Inequity aversion 
weight: N 
Caveats from Discussion: the 
intervention experienced significant 
attrition between baseline and follow-
up. Those retained were better 
educated, older, and more likely to be 
married and had higher household 
income than those who dropped out 
of the program. 
 
Key sensitivity: Cost-effectiveness 
improves when using 3-year weight 
loss projections based on changes in 
sugar-sweetened beverage caloric 
consumption to $49,478 and $24,092 
Modelled EE.  for the 2% and5% weight loss 
scenarios. 
Quality of study: moderate.  
Goyder et al. 
(2014),  UK. 
Aim: To determine whether 
physical activity, 6 months 
after a brief intervention, is 
increased in those receiving 
physical activity ‘booster’ 
consultations delivered in a 
motivational interviewing 
(MI) style, either face to 
face or by telephone.  
Perspective: societal and 
NHS. 
 
Study Type: CUA. 
Trial EE.  
Intervention: 1) two sessions 
of MI, either face to face (‘full 
booster’) or 2) by telephone 
(‘mini booster’)  
Comparator: control. 
 
Population: previously 
sedentary people, aged 40–64 
years, living in deprived areas.  
Time horizon 
Intervention: 9 months. 
Tracking: lifetime. 
Actual ICERS  
Dominated. The 
intervention costs more 
and is no more effective 
than the comparator. 
 
Policy relevance: unlikely 
to represent a clinically 
effective or cost-effective 
intervention for the 
maintenance of recently 
acquired physical activity 
increases in deprived 
middle-aged urban 
populations. 
Inputs: total energy 
expenditure/day, 
mortality relative risk, 
HRQ0L, body weight, 
height, resource use of 
NHS services. 
 
Outcomes: QALYs. 
 
Inequity aversion 
weight: N. 
Caveats from Discussion: response 
rate of 7.1%, model does not directly 
consider the relationship between 
physical activity levels and morbidity 
risks  
Key sensitivity: full booster 
intervention may be cost-effective 
assuming a willingness-to-pay 
threshold of £20,000 per QALY as long 
as the cost of the intervention is 
below approximately £300 per 
participant.  
Quality of study: moderate 
Pukallus et al. 
(2013), 
Australia 
Aim: examine the costs and 
patient outcomes of a 
prevention programme for 
early childhood caries to 
assess its value for  
Government services. 
 
Perspective: health sector 
 
Study Type: CEA 
Trial  EE.  
Intervention: telephone 
prevention programme. 
 
Comparator: usual care. 
 
Population: Children aged 6 
months to 6 years in a low 
socioeconomic, socially 
disadvantaged area.  
 
Time horizon 
Intervention: 6 months to 6 
years 
Tracking: 6 months to 6 years 
Actual ICERS: dominant 
for every 100 children. 
 
Policy relevance: A 
telephone prevention 
programme provides 
significant cost savings to 
the health system. 
 
Inputs: caries 
incidence and public 
dental treatment costs 
 
Outcomes: Cost per 
caries prevented/100 
children. 
 
Inequity aversion 
weight: N 
Caveats from Discussion: the analysis 
did not include quality-of-life data or 
out-of-pocket costs and potential 
income losses for families. The savings 
would have been even better if these 
costs had been included in the 
analysis 
 
Key sensitivity: the results were most 
sensitive to the caries incidence in the 
telephone and usual care groups, the 
cost of general anaesthesia and the 
discount rate. 
 
3. Quality of study: moderate. 
Barton et al. 
(2012),  UK. 
Aim: Assess the cost-
effectiveness of using lay 
health trainers (LHT) to 
improve heart-health 
lifestyles in deprived 
communities. 
 
Perspective: National Health 
Service (NHS) and personal 
social services (PSS). 
 
Study Type: CUA. 
Trial EE. 
Intervention: LHT provide 
information, advice and 
support aimed at changing 
beliefs and behaviour for 
heart-health plus health 
promotion literature. 
Comparator: health 
promotion literature. 
 
Population: Adults from 
deprived communities with at 
least one of five CVD risk 
factors. 
 
Time horizon 
Intervention: 6 months. 
Tracking: 6 months. 
Actual ICERS: 
£14,480/QALY. 
 
Policy relevance: LHT 
provision was estimated 
to be cost-effective for 
people at risk of CVD. 
 
Inputs: EQ-5D. 
 
Outcomes: QALYs. 
 
Inequity aversion 
weight: N  
Caveats from Discussion: patient 
recruitment costs were not included, 
incomplete costs and QALY data. 
Key sensitivity: cost variations, max 
£22,000/QALY. 
Quality of study: moderate  
 
Lawson et al. 
(2010), 
Scotland 
Aim: to compare mass and 
targeted screening 
cardiovascular disease 
strategies in terms of 
effectiveness, cost-
effectiveness and coverage. 
 
Perspective: health sector 
 
Study Type: CEA. 
Modelled EE.  
Interventions: 1. Mass 
screening of the whole 
population 2. Screening 
individuals living in deprived 
communities 
3. Screening individuals with a 
family history of 
premature CVD 
4. Screening individuals who 
either lived in deprived 
communities or had a family 
history of premature 
cardiovascular disease 
5. Screening individuals who 
both lived in deprived 
communities and had a family 
history of 
premature cardiovascular 
disease 
To identify one person at 
high risk - screening 
deprived communities 
£141, family members 
£170, mass screening 
£1358.  
 
Policy relevance: 
Screening to identify 
individuals in need of 
primary prevention 
should focus on family 
members and deprived 
communities. 
Mass screening of the 
whole population may be 
difficult to justify as the 
incremental cost is much 
higher and incremental 
Inputs: the number 
needed to screen (NNS) 
to detect one person at 
high risk of CVD. 
 
Outcomes: cost per 
screening person at 
high risk 
 
Inequity aversion 
weight: N 
Caveats from Discussion: The models 
assumed identical unit costs for 
screening. In practice, the costs 
may be higher in deprived than 
affluent communities because of 
poorer uptake requiring more 
stringent efforts to attract 
participants. Assumed the aim of 
primary prevention was to reduce 
cardiovascular events in the 
population as a whole, did not 
consider their impact in relation to 
health inequalities. 
 
Key sensitivity: costs, using an analysis 
of extremes, and to the differential 
uptake of screened populations, 
relative rankings of the screening 
 
Population: people from 
deprived communities were 
defined as those in the 
bottom quintile of the 
Scottish Index of Multiple 
Deprivation (SIMD) 
 
Time horizon 
Intervention: not stated. 
Tracking: none 
effectiveness lower strategies, in terms of cost-
effectiveness, remained unchanged. 
 
Quality of study: moderate. 
Gustafson et 
al. (2009), , 
USA 
Aim: Assess the cost-
effectiveness of a 16-week 
weight loss intervention 
(Weight-Wise) for low- 
income midlife women.  
 
Perspective: payer. 
 
Study Type: CEA. 
Trial EE.  
Intervention: weekly group 
sessions, with the focus 
alternating by week on 
healthy eating or physical 
activity.  
Comparator: control usual 
care 
 
Population: age 40 to 64 
years, under or uninsured 
incomes at or below 200% of 
the federal poverty level, 
body mass index (BMI) 
between 25 and 45 kg/m2  
 
Time horizon 
Intervention:5 months 
Tracking:10 years 
$1862 /LYG 
 
Policy relevance: The 
results suggest that 
weight loss interventions 
for low-income women 
can be cost-effective for 
adoption in clinical 
settings.  
 
Inputs: changes in 
weight 
 
Outcomes: (cost per) 
LYG. 
 
Inequity aversion 
weight: N 
Caveats from Discussion: used 
previously calculated YLL assuming a 
similar mortality pattern with a large 
weighted sample. Therefore has large 
limitations in terms of generalizability 
of results.  
 
Key sensitivity: regain in weight lost 
still cost-effective. 
 
Quality of study: moderate. 
Goldstein et 
al. (2008)  , 
USA. 
Aim: To evaluate the cost- 
effectiveness of Medicaid-
based reimbursement for 
child restraint systems (CRS) 
disbursement and 
education for low-income 
Intervention: 1) no CRS 
disbursement or education. 2) 
universal Medicaid-based 
disbursement and education 
program. 
Comparator: vaccinations 
covered under the Vaccines 
$17,00/LYG, $60,000 per 
serious injury averted, 
$560,000/death averted  
 
Policy relevance: his 
analysis both 
underscores the need for 
Inputs: baseline 
restraint use rates. 
 
Outcomes: cost per life-
year saved, death, 
serious injury, and 
minor injury averted 
Caveats from Discussion: absence of 
utility measures for pediatric injury 
and the consequent inability to 
account for the negative health states 
of injury. Program costs may prove 
greater than those assumed in this 
analysis.  
children.  
Perspective: societal and 
payers.  
 
Study Type: CEA 
Modelled EE.  
for Children program.  
Population: low income 
children. 
 
Time horizon 
Intervention: 8 years cycle of 
recommended CRS use. 
Tracking: 8 years.  
and demonstrates the 
clinical and economic 
feasibility of action to 
reduce the burden of 
injury among low- 
income children.  
 
and medical, parental 
work loss, and future 
productivity loss costs 
averted. 
Inequity aversion 
weight: N. 
 
Key sensitivity: costs, mortality rates 
worst case $346,000/LYG, 
disbursement restricted to one seat 
would also increase cost per LYG. 
 
Quality of study: moderate. 
 
Finkelstein et 
al. (2006)  
USA. 
Aim: to quantify the 
effectiveness and cost-
effectiveness of the 
WISEWOMAN program by 
combining the most recent 
data from nine 
WISEWOMAN projects in 
eight states. 
 
Perspective: health system. 
 
Study Type: CEA. 
Trial EE.  
Intervention: WISEWOMAN 
program includes standard 
preventive services and 
tailored lifestyle 
interventions, culturally 
adapted to help develop a 
healthier diet, increase 
physical activity, and quit 
tobacco use. 
Comparator: usual care. 
 
Population: Low-income 
uninsured  women aged 
40–64. 
 
Time horizon 
Intervention: 1 year. 
Tracking: 1 year. 
Actual ICERS $4,400/LYG 
 
Policy relevance: If the 
best-case assumptions 
are correct WISEWOMAN 
may be an effective use 
of scarce healthcare 
resources. 
Inputs: blood pressure, 
cholesterol, body 
weight, smoking status.  
 
Outcomes: (Cost per) 
LYG, (cost per) % point 
reduction in CHD risk. 
 
Inequity aversion 
weight: N. 
Caveats from Discussion:  No control 
group. Only 24% of women screened 
for the program at baseline returned 
for their 1–year follow-up 
examination. 
 
Key sensitivity: cost-effectiveness of 
WISEWOMAN relies heavily on the 
assumptions about effectiveness 
among women not returning for 
annual re-screenings and 
sustainability of benefits beyond the 
intervention period. 
 
Quality of study: poor. 
 
Johnson-
Masotti et al. 
(2005), USA 
Aim: to evaluate the cost-
effectiveness of a multi-site 
community-level HIV 
prevention trial for low 
income women. 
 
Perspective: societal. 
 
Study Type: CUA. 
Intervention: intensive HIV 
prevention workshops and 
community events.  
 
Comparator: mailed HIV 
prevention informational 
pamphlet and a coupon that 
could be returned to receive 
10 free condoms. 
$37,433/QALY and 
$732,072/ HIV infection 
averted. 
 
Policy relevance: a 
promising and efficient 
community-level HIV 
prevention approach, 
Inputs:% engaging in 
unprotected sex, use of 
condoms  
 
Outcomes: QALYs, no. 
of HIV infections. 
 
Inequity aversion 
weight: N 
Caveats from Discussion: intervention 
costs obtained retrospectively, self-
reported sexual behavior data 
collected from participants is a 
potential source of error. 
 
Key sensitivity: including all the 
transient housing development 
residents (present for some, but not 
Trial EE.   
Population: women from low-
income housing 
developments. 
 
Time horizon 
Intervention: 12 months. 
Tracking: 18 years. 
with effects beyond the 
limited scope 
of individual or small 
group interventions. 
all, intervention activities) reduced the 
ICER to $19,741/QALY. Excluding them 
it increased to $83,524. 
 
Quality of study: moderate 
 
Ruger et al. 
(2008), USA 
Aim: To analyse the cost- 
effectiveness of individually 
tailored motivational 
interviewing (MI) for 
smoking relapse prevention. 
 
Perspective: societal. 
 
Study Type: CUA. 
Trial EE.  
Intervention: an average of 
three home visits that 
specifically employed MI to 
deliver a smoking 
intervention. 
 
Comparator: Usual care 
received standard prenatal 
care from their health-care 
provider at the clinic site. 
An up-to-5-minute 
intervention outlined the 
harmful effects of smoking 
during and after pregnancy. 
Self-help materials were also 
provided. 
 
Population: low income 
pregnant women. 
 
Time horizon 
Intervention: 6 months. 
Tracking: lifetime. 
Preventing relapse 
among MI ex-smokers 
compared to UC ex-
smokers was estimated 
at $628/QALY. $851/LY 
 
Policy relevance: among 
low-income pregnant 
women, MI can prevent 
relapse at relatively low 
cost whereas MI was 
more costly and no more 
effective than UC in 
promoting smoking 
cessation. 
Inputs: smoking 
cessation, relapse 
prevented. 
 
Outcomes: LY and 
QALYs . 
 
Inequity aversion 
weight: N 
Caveats from Discussion: They 
analysed savings in maternal and 
infant medical costs but did not have 
long-term morbidity and mortality 
data for children related to smoking-
related illnesses 
 
Key sensitivity: Inclusion in sensitivity 
analyses of net medical cost savings 
for infants and mothers as a result of 
sustained cessation and abstinence 
results in more favourable ICERS. 
 
Quality of study –  moderate 
 
Al et al. 
(2004),  Iran. 
Aim: assess the cost-
effectiveness of the breast 
cancer screening program 
implemented nationally for 
Intervention: Mammography 
screening. 
Comparator: routine care (no 
screening). 
 
$15,752/ identified case. 
 
Policy relevance: not 
cost-effective. Careful 
consideration is required 
Inputs: reported cases 
of breast cancer 
diagnosed. 
 
Caveats from Discussion: High costs of 
detection in comparison to other 
studies. The total number of detected 
cases as a result of the program was 
almost equal to that of the expected 
low socioeconomic women 
in Iran. 
 
Perspective: health system. 
 
Study Type: CEA. 
Modelled EE.  
Population: Women who 
were the sole heads of 
households receiving financial 
support. 
 
Time horizon 
Intervention: 1 year. 
Tracking:1 year. 
before introducing 
national mammography 
screening programs in a 
country. 
Outcomes: (Cost per) 
identified cancer case 
 
Inequity aversion 
weight: N  
cases when no screening program was 
carried out in Iran. Could be due to 
lack of trained personnel. 
 
Key sensitivity: minimum and 
maximum cost scenario.  
Quality of study: moderate. 
 
Crane et al. 
(2000), USA. 
Aim: To compare the costs 
involved in a multiple 
outcall strategy compared 
with the single outcall 
approaches to promote 
mammography among low 
income women. 
 
Perspective: health system. 
 
Study Type: CEA. 
Trial EE. 
Intervention: 1) outcall 
Alone 2) outcall preceded by 
a mailed card that invited 
participation and mentioned 
the importance of 
mammography 3) multiple 
outcall.  
Comparator: control. 
 
Population: shoppers in low 
income neighbourhoods. 
 
Time horizon 
Intervention: 6 months. 
Tracking: 6 months. 
Actual ICERS  
$131, $177 and $90 per 
changed participant 
 
Policy relevance: 
The multiple outcall 
intervention is 
consistently the most 
cost-effective 
intervention of the three. 
Inputs: women who had 
a mammogram 
 
Outcomes: Number 
changed to adherent 
(mammogram <2 years 
ago), cost per changed 
participant. 
 
Inequity aversion 
weight: N 
Caveats from Discussion: quasi-
experimental design. Because of a 
different recruitment strategy, women 
in the multiple outcall group were 
younger, better educated, healthier, 
and had a higher average income than 
women in the three arms of the 
original study. Differences in delivery 
of the interventions between the 
single and multiple outcall groups. 
 
Key sensitivity: Different non-
adherence rates affect costs.  
 
Quality of study: poor 
 Schweitzer 
et al. (1998). 
USA 
Aim: To identify the cost 
and cost-effectiveness of a 
mobile mammography 
program.  
 
Perspective: social welfare 
stated but costs are from 
health sector 
 
Study Type: CEA. 
Modelled EE.  
Intervention: mobile 
mammography van. 
 
Comparator: not stated. 
 
Population: women living 
below poverty. 
 
Time horizon 
Intervention: 13 years 
Tracking: not stated 
Actual ICERS  
Cost per detection 
ranged from $15,735-
$8,140 
 
Policy relevance: mobile 
mammography offers 
major advantages for 
patients including 
increases access and 
opportunities for cost 
savings 
Inputs: detection rate. 
 
Outcomes: number of 
detections, cost per 
detection. 
 
 
Inequity aversion 
weight: N. 
Caveats from Discussion: costs 
assumed 4 films per women screened, 
in reality may need more.  Costs of 
false positives not considered   
Key sensitivity: The more women 
screened, the cost per mammogram 
decreases.  
Quality of study: poor 
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Appendix 2. Survey from study using social welfare functions (Paper 3) 
‘Fairness’ in Health Outcomes – Does it Matter? 
Section 1 
In Australia, females live 84 years on average, while males live 80 years (a difference 
of 4 years of life). This raises issues of fairness in decisions about designing and 
funding health programs. 
Imagine you are a decision maker at the Department of Health and you have to 
choose between two health programs (A and B) that increase life expectancy. Both 
programs cost the same and the two groups benefiting from the programs are 
approximately of equal size.  
Question 1 
In the two graphs below, the blue part shows life expectancy at birth and the orange 
part shows the increase in life expectancy due to the health programs.  
As you can see, Program A in Question 1 is aimed at both males and females, while 
Program B is aimed only at males.  
Please indicate whether you would choose A or B or if you consider that both 
programs are equally good by ticking one box below the graphs. 
 
 
If ‘B’ chosen, online questionnaire will go to Question 2.  
If ‘A and B are equally good’ is chosen, online questionnaire will go to Question 3. 
If ‘A’ chosen, online questionnaire will go to Question 3.  
I prefer A        A and B are equally good           I prefer B      
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Question 2 
It may be that Program B is less effective than we had first thought. This will mean 
that the increase in life expectancy is less overall.  
Please indicate whether you would still choose B, or whether you would now choose 
A. 
 
           Program  A              Program  B      
           Program  A              Program  B      
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Question 2 continued 
For each of the choices below, please indicate whether you would still choose B, or 
whether you would now choose A. 
 
 
 
           Program  A        Program  B      
 
(Online questionnaire will go to Q4) 
       Program  A         Program  B      
           Program  A            Program  B      
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Question 3 
Now imagine that everyone benefits from an increase in life expectancy in Program 
B.  For each of the choices below, please tick one box to indicate whether you would 
choose A or B 
 
 
 
           Program  A            Program  B     
 
           Program  A            Program  B     
 
    Program  A            Program  B      
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Question 3 continued 
For each of the choices below, please indicate whether you would still choose B, or 
whether you would now choose A. 
 
           Program  A             Program  B      
 
           Program  A             Program  B      
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Question 4  
Now imagine that Program A is aimed only at the males. Program B is aimed at both 
groups. The two groups are of approximately equal size and the two programs would 
cost the same. Please tick one box to indicate whether you would choose A or B or if 
you consider that both programs are equally good. 
 
 
  
I prefer A          A and B are equally good      I prefer B      
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Section 2 
Socio-economic position (SEP) is a measure of a person’s level of income, education 
and occupation. Average life expectancy at birth differs according to SEP. In 
Australia, for example, people in the highest SEP group live 84 years on average, 
while people in the lowest SEP group live 79 years (i.e. a difference of 5 years of life). 
This raises issues of fairness in decisions about designing and funding health 
programs. 
Imagine you are a decision maker at the Department of Health in your country, and 
you have to choose between two health programs (A and B) that increase life 
expectancy. Both programs cost the same and the two groups benefiting from the 
programs are approximately of equal size.  
Question 5 
In the two graphs below, the blue part shows life expectancy at birth and the orange 
part shows the increase in life expectancy due to the health programs.  
As you can see, Program A is aimed at both SEP groups, while Program B is aimed 
only at the low SEP group.  
Please indicate whether you would choose A or B or if you consider that both 
programs are equally good by ticking one box below the graphs. 
 
 
If ‘B’ chosen, online questionnaire will go to Question 6.  
If ‘A and B are equally good’, online questionnaire will go to Question 7. 
If ‘A’ chosen, online questionnaire will go to Question 7.  
I prefer A          A and B are equally good       I prefer B     
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Question 6 
It may be that Program B is less effective than we had first thought. This will mean 
that the increase in life expectancy is less overall. For each of the choices below, 
please indicate whether you would still choose B, or whether you would now 
choose A. 
 
 
     Program A             Program B      
     Program A             Program B      
Program A             Program B      
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Question 6 continued 
For each of the choices below, please indicate whether you would still choose B, or 
whether you would now choose A. 
 
 
(Online questionnaire will go to Q9 demographics)  
Program A             Program  B      
Program A             Program B      
Program A             Program B      
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Question 7 
Now imagine that everyone benefits from an increase in life expectancy in Program 
B.  For each of the choices below, please tick one box to indicate whether you would 
choose A or B. 
 
 
  
Program A             Program B      
Program A             Program B      
Program A             Program B      
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Question 7 continued 
 
 
(Online questionnaire will go to Q9 demographics) 
  
Program A             Program B      
     Program A             Program B      
206 
 
Question 8 
Now imagine that Program A is aimed only at the lowest SEP group. Program B is 
aimed at both groups. The two groups are of approximately equal size and the two 
programs would cost the same. Please tick one box to indicate whether you would 
choose A or B or if you consider that both programs are equally good. 
 
 
  
I prefer A               A and B are equally good       I prefer B      
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Appendix 3. Survey from study using probit models (Paper 4) 
Equity weight survey  
Average life expectancy at birth differs according to income. In Australia, the highest 
income group live 81 years on average, while the lowest lives 75 years (a difference of 6 
years of life). This raises issues of fairness in decisions about designing and funding 
health programs. 
Imagine you are a decision maker at the Department of Health and you have to choose 
between two health programs (A and B) that increase life expectancy. Both programs 
cost the same and the two groups benefiting from the programs are of equal size.  
If you were asked to choose one of the two following programs, each of which would 
impact the health of 1000 people, which would you select? Answer options ‘Program A’, 
‘Program B’ 
Q1 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 1 year 1 year 
Q2 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 1 year 3 years 
Q3 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 1 year 6 years 
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Q4 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 1 year 10 years 
 
Q5 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 3 years 1 year 
 
Q6 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 3 years 3 years 
 
Q7 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 3 years 6 years 
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Q8 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 10 years 1 year 
 
Q9 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 6 years 1 year 
 
Q10 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 6 years 3 years 
Q11 
 Program A Program B 
The people in this group have an income which is High Low 
Without the program, the people will live until they 
are 81 75 
The program would increase their life expectancy by 6 years 6 years 
 
 
